Patent Grant
10842678
The present invention relates to apparatus and a medical wound dressing for aspirating, irrigating and/or cleansing wounds, and a method of treating wounds using such apparatus for aspirating, irrigating and/or cleansing wounds. It relates in particular to such an apparatus, wound dressing and method that can be easily applied to a wide variety of, but in particular chronic, wounds, to cleanse them of materials that are deleterious to wound healing, whilst retaining materials that are beneficial in some therapeutic aspect, in particular to wound healing.
Before the present invention, aspirating and/or irrigating apparatus therefor were known, and tended to be used to remove wound exudate during wound therapy. In known forms of such wound therapy, the offtake from the wound, especially when in a highly exuding state, is voided to waste, e.g. to a collection bag, as illustrated in DE-A-4 012 232.
Materials deleterious to wound healing are removed in this way.
However, materials that are beneficial in promoting wound healing, such as growth factors, cell matrix components, and other physiologically active components of the exudate from a wound are lost to the site where they can be potentially of most benefit, i.e. the wound bed, when such therapy is applied.
Such known forms of wound dressing and aspiration and/or irrigation therapy systems often create a wound environment under the dressing that thus may result in the loss of optimum performance of the body's own tissue healing processes, and slow healing and/or in weak new tissue growth that does not have a strong three-dimensional structure adhering well to and growing from the wound bed. This is a significant disadvantage, in particular in chronic wounds.
It thus would be desirable to provide a system of therapy which can remove materials deleterious to wound healing from wound exudate, whilst retaining materials that are beneficial in promoting wound healing in contact with the wound bed.
Dialysis is a known method of treating bodily fluids such as blood ex vivo, to cleanse them of materials that are deleterious to the body systemically. Removal of such materials by contact with the dialysate is the prime purpose of dialysis, whilst also retaining materials such as blood, cells and proteins. Other materials that may have an additional positive therapeutic action are potentially lost to the system through the dialysis membrane, which is also permeable to them. The balance of such materials in the bodily fluid in recirculation may thus be further depleted.
It would be desirable to provide a system of therapy which can remove materials deleterious to wound healing from wound exudate, without substantially diluting materials that are beneficial in promoting wound healing in contact with the wound bed, and which can continuously supply and recirculate such materials to the wound simultaneously.
Dialysis for treating bodily fluids is also a systemic therapy, since the treated fluid is returned to within the body. This is in contrast to a topical therapy in which the treated fluid is recycled outside the body, e.g. to a wound. Most dialysis also requires large amounts of bodily fluids such as blood, and consequently the relevant devices tend not to be portable. Even when in a highly exuding state, chronic wounds produce relatively little fluid to be treated compared with internal bodily systems and relatively little materials that are beneficial in some therapeutic aspect to be retained in the wound and/or its environment.
It is therefore desirable
It is also desirable
It is also desirable
Vascular supply to, and circulation in, tissue underlying and surrounding the wound is often compromised. It is therefore desirable to provide a system of therapy that retains and supplies therapeutically active amounts of materials that are beneficial in reversing this effect whilst removing deleterious materials, thereby promoting wound healing.
Thus, according to a first aspect of the present invention there is provided an apparatus for aspirating, irrigating and/or cleansing wounds, characterized in that it comprises
The means for flow switching between supply and recirculation may take any form that enables the wound simultaneously to be
Thus, if there is only one inlet pipe that passes through and/or under the wound-facing face of the wound dressing, the fluid reservoir is connected by the fluid supply tube to the flow path via means for flow switching as desired the into a fluid recirculation tube or a fluid offtake tube.
In this case, the means for flow switching between supply and recirculation may be a regulator, such as a T-valve. This is connected in turn to two parts of a fluid recirculation tube or a fluid offtake tube and the fluid supply tube, such that the desired flow switching between supply and recirculation is achieved.
If there are two or more inlet pipes, these may be connected respectively to a fluid supply tube or fluid recirculation tube, respectively having a first regulator and a second regulator, such as a valve or other control device for admitting fluids into the wound.
The desired flow switching between supply and recirculation is achieved by respectively having the first regulator open when the second regulator is shut, and vice versa.
The means for bleeding the flowpath may be situated in any appropriate part of the apparatus that is in contact with the irrigant and/or wound exudate, but is usually within the offtake and/or recirculation tubes. However, it is often as far downstream of and away from the reservoir and the fluid supply tube as possible, so that it may be used to prime the whole of the flowpath from the fluid reservoir via the fluid supply tube.
It may be a regulator, such as a valve or other control device, e.g. a T-valve that is turned to switch between bleed and recirculation, for bleeding fluids from the apparatus, e.g. to a waste reservoir, such as a collection bag.
Alternatively, flow switching between supply and recirculation may not be desired, but rather concomitant bleeding and/or recirculation is desired. The latter may occur when the volume of irrigant and/or wound exudate in recirculation is increased by continuing addition to it of
The means for bleeding the offtake and/or recirculation tubes may then be provided in the form of a regulator, such as a simple valve or other control device for admitting or blocking the passage of irrigant and/or exudate through a bleed line branching from the recirculation path.
The means for fluid cleansing may as desired be a ‘single-phase system.’
In this, the circulating fluid from the wound and the fluid reservoir passes through a self-contained system in which materials deleterious to wound healing are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the Wound bed. Such systems are described in further detail hereinafter in connection with the means for fluid cleansing.
Alternatively, where appropriate it may be provided in the form of a two-phase system, such as a dialysis unit, or a biphasic liquid extraction unit.
In this, the circulating fluid from the wound and the fluid reservoir passes through a system in which the fluid recirculates in indirect or (less usually, direct) contact with a second fluid (dialysate) phase, more usually a liquid, in which materials deleterious to wound healing are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the wound bed. Such systems are described in further detail hereinafter in connection with the means for fluid cleansing.
In use, typically, the means for flow switching between supply and recirculation tubes is set to admit fluid into the wound from the fluid reservoir but to close the wound to the fluid recirculation tube.
Then, any means for bleeding the offtake and/or recirculation tubes are is opened and the device for moving fluid through the wound and means for fluid cleansing is started.
The capacity of the apparatus flow path and the flow rate of irrigant and/or wound exudate from the wound will largely determine whether it is appropriate to run the device to prime the apparatus throughout the whole length of the apparatus flow path, i.e. to displace any existing fluid reservoir (often air) from the fluid recirculation path, and for how long it should be run. Typically, there is a preponderance of irrigant from the fluid reservoir over wound exudate in recirculation, so that use of the device for moving fluid through the wound is appropriate for this purpose.
It is allowed to run until the apparatus is primed throughout the whole length of the apparatus flow path.
Then, typically the means for bleeding the offtake and/or recirculation tubes is closed, and the means for flow switching between supply and recirculation tubes is set to close the wound to the fluid reservoir but to admit fluid into the wound from the fluid recirculation tube.
If the means for fluid cleansing is a two-phase system, such as a dialysis unit, or a biphasic extraction unit, the cleansing fluid is typically set in motion in contact with the surface of the selectively permeable integer, for example the polymer film, sheet or membrane. Of course, the cleansing fluid may less usually be static, and then this step is omitted.
As noted below in more detail, the volume of irrigant and/or wound exudate from the wound in recirculation may be increased by continuing addition to it of
Additionally or alternatively, it may be desired to apply a negative pressure to the wound by means of a device for moving fluid through the wound and means for fluid cleansing applied to the fluid in recirculation in the fluid recirculation tube downstream of and away from the wound dressing.
In such case, it may be desirable to provide a system in which concomitant bleeding and/or recirculation is possible, and to make the necessary adjustments to maintain the desired balance of fluid in recirculation by means of the means for bleeding the offtake and/or recirculation tubes.
The volume of irrigant and/or wound exudate from the wound in recirculation may be decreased by continuing loss from it of fluid passing from a cleansing fluid through a selectively permeable integer, for example in a system such as a dialysis unit.
Additionally or alternatively, it may be desired to apply a positive pressure to the wound by means of a device for moving fluid through the wound and means for fluid cleansing applied to the fluid in recirculation in the fluid recirculation tube upstream of and towards the wound dressing.
The means for flow switching between supply and recirculation may be similarly provided in a form in which concomitant supply and/or recirculation is possible, and to make the necessary adjustments to maintain the desired balance of fluid in recirculation by means of the means for flow switching.
It will be appreciated that where a positive or negative pressure is to be applied to the wound, at least one hollow body in the recirculation flow path to and from the wound bed should have sufficient resilience against the pressure to allow any significant compression or decompression of the irrigant fluid to occur.
In all embodiments of the apparatus, the type and material of such bodies (which are defined by a film, sheet or membrane) that are described by way of example herein to be suitable for use in the present invention will be largely capable of this function.
Thus, examples of suitable materials for bodies defined by a film, sheet or membrane, such as inlet or offtake and/or recirculation tubes and structures such as bags, chambers and pouches, filled with irrigant fluid, e.g. the backing layer of the wound dressing are suitably elastically resilient thermoplastic materials that are potentially capable of this function when pressure is applied in this way.
The present invention in this aspect provides several advantages.
One is that application of a positive pressure to the wound under the backing layer may make it possible to flood the tissue underlying the wound with one or more physiologically active components.
This may be effected in therapeutically active amounts, to promote greater wound healing than by treatment with the fluid physiologically active component(s) alone.
Such physiologically active components of the exudate that are beneficial to wound healing may be e.g. be enzymes or other species and may be supplied from the dialysate of a dialytic means for fluid cleansing.
It is believed that using the apparatus for aspirating, irrigating and/or cleansing wounds of the present invention cyclically the effects may be further enhanced.
Circulating wound fluid aids in movement of biological signalling molecules involved in wound healing to locations in the wound bed that are favourable to the wound healing process and/or to cells that would otherwise not be exposed to them, e.g. in a highly exuding wound.
This is especially the case in those embodiments of the apparatus of this first aspect of the present invention for aspirating, irrigating and/or cleansing wounds where there is an inlet or outlet manifold from which tubules radiate and run to the wound bed to end in openings that deliver and collect the fluid directly from the wound bed over an extended area.
Such materials include cytokines, enzymes, nutrients for wound cells to aid proliferation, oxygen, and other molecules that are beneficially involved in wound healing, such as growth factors, and others having beneficial effects (which may be further enhanced) in causing chemotaxis.
In all embodiments of the apparatus of this first aspect of the present invention for aspirating, irrigating and/or cleansing wounds, a particular advantage is the tendency of the wound dressing to conform to the shape of the bodily part to which it is applied.
The wound dressing comprises a backing layer with a wound-facing face which is capable of forming a relatively fluid-tight seal or closure over a wound and
The term ‘relatively fluid-tight seal or closure’ is used herein to indicate one which is fluid- and microbe-impermeable and permits a positive or negative pressure of up to 50% atm., more usually up to 15% atm. to be applied to the wound. The term ‘fluid’ is used herein to include gels, e.g. thick exudate, liquids, e.g. water, and gases, such as air, nitrogen, etc.
The shape of the backing layer that is applied may be any that is appropriate to aspirating, irrigating and/or cleansing the wound across the area of the wound.
Examples of such include a substantially flat film, sheet or membrane, or a bag, chamber, pouch or other structure of the backing layer, e.g. of polymer film, which can contain the fluid.
The backing layer may be a film, sheet or membrane, often with a (generally uniform) thickness of up to 100 micron, preferably up to 50 micron, more preferably up to 25 micron, and of 10 micron minimum thickness.
Its largest cross-dimension may be up to 500 mm (for example for large torso wounds), up to 100 mm (for example for axillary and inguinal wounds), and up to 200 mm for limb wounds (for example for chronic wounds, such as venous leg ulcers and diabetic foot ulcers.
Desirably the dressing is resiliently deformable, since this may result in increased patient comfort, and lessen the risk of inflammation of a wound.
Suitable materials for it include synthetic polymeric materials that do not absorb aqueous fluids, such as polyolefins, such as polyethylene e.g. high-density polyethylene, polypropylene, copolymers thereof, for example with vinyl acetate and polyvinyl alcohol, and mixtures thereof; polysiloxanes; polyesters, such as polycarbonates; polyamides, e.g. 6-6 and 6-10, and hydrophobic polyurethanes.
They may be hydrophilic, and thus also include hydrophilic polyurethanes.
They also include thermoplastic elastomers and elastomer blends, for example copolymers, such as ethyl vinyl acetate, optionally or as necessary blended with high-impact polystyrene.
They further include elastomeric polyurethane, particularly polyurethane formed by solution casting.
Preferred materials for the present wound dressing include thermoplastic elastomers and curable systems.
The backing layer is capable of forming a relatively fluid-tight seal or closure over the wound and/or around the inlet and outlet pipe(s).
However, in particular around the periphery of the wound dressing, outside the relatively fluid-tight seal, it is preferably of a material that has a high moisture vapour permeability, to prevent maceration of the skin around the wound. It may also be a switchable material that has a higher moisture vapour permeability when in contact with liquids, e.g. water, blood or wound exudate. This may, e.g. be a material that is used in Smith & Nephew's Allevyn™, IV3000™ and OpSite™ dressings.
The periphery of the wound-facing face of the backing layer may bear an adhesive film, for example, to attach it to the skin around the wound.
This may, e.g. be a pressure-sensitive adhesive, if that is sufficient to hold the wound dressing in place in a fluid-tight seal around the periphery of the wound-facing face of the wound dressing.
Alternatively or additionally, where appropriate a light switchable adhesive could be used to secure the dressing in place to prevent leakage. (A light switchable adhesive is one the adhesion of which is reduced by photocuring. Its use can be beneficial in reducing the trauma of removal of the dressing.)
Thus, the backing layer may have a flange or lip extending around the proximal face of the backing layer, of a transparent or translucent material (for which it will be understood that materials that are listed above are amongst those that are suitable).
This bears a film of a light switchable adhesive to secure the dressing in place to prevent leakage on its proximal face, and a layer of opaque material on its distal face.
To remove the dressing and not cause excessive trauma in removal of the dressing, the layer of opaque material on the distal face of the flange or lip extending around the proximal wound is removed prior to application of radiation of an appropriate wavelength to the flange or lip.
If the periphery of the wound dressing, outside the relatively fluid-tight seal, that bears an adhesive film to attach it to the skin around the wound, is of a material that has a high moisture vapour permeability or is a switchable material, then the adhesive film, if continuous, should also have a high or switchable moisture vapour permeability, e.g. be an adhesive such as used in Smith & Nephew's Allevyn™, IV3000™ and OpSite™ dressings.
Where a vacuum, is applied to hold the wound dressing in place in a fluid-tight seal around the periphery of the wound-facing face of the wound dressing, the wound dressing may be provided with a silicone flange or lip to seal the dressing around the wound; This removes the need for adhesives and associated trauma to the patient's skin.
Where the interior of, and the flow of irrigant and/or wound exudate to and through, the dressing is under any significant positive pressure, which will tend to act at peripheral points to lift and remove the dressing off the skin around the wound.
In such use of the apparatus, it may thus be necessary to provide means for forming and maintaining such a seal or closure over the wound against such positive pressure on the wound, to act at peripheral points for this purpose.
Examples of such means include light switchable adhesives, as above, to secure the dressing in place to prevent leakage.
Since the adhesion of a light switchable adhesive is reduced by photocuring, thereby reducing the trauma of removal of the dressing, a film of a more aggressive adhesive may be used, e.g. on a flange, as above.
Examples of suitable fluid adhesives for use in more extreme conditions where trauma to the patient's skin is tolerable include ones that consist essentially of cyanoacrylate and like tissue adhesives, applied around the edges of the wound and/or the proximal face of the backing layer of the wound dressing, e.g. on a flange or lip.
Further suitable examples of such means include adhesive (e.g. with pressure-sensitive adhesive) and non-adhesive, and elastic and non-elastic straps, bands, loops, strips, ties, bandages, e.g. compression bandages, sheets, covers, sleeves, jackets, sheathes, wraps, stockings and hose, e.g. elastic tubular hose or elastic tubular stockings that are a compressive fit over a limb wound to apply suitable pressure to it when the therapy is applied in this way; and inflatable cuffs, sleeves, jackets, trousers, sheathes, wraps, stockings and hose that are a compressive fit over a limb wound to apply suitable pressure to it when the therapy is applied in this way.
Such means may each be laid out over the wound dressing to extend beyond the periphery of the backing layer of the wound dressing, and as appropriate will be adhered or otherwise secured to the skin around the wound and/or itself and as appropriate will apply compression (e.g. with elastic bandages, stockings) to a degree that is sufficient to hold the wound dressing in place in a fluid-tight seal around the periphery of the wound,
Such means may each be integral with the other components of the dressing, in particular the backing layer.
Alternatively, it may be permanently attached or releasably attached to the dressing, in particular the backing layer, with an adhesive film, for example, or these components may be a Velcro™, push snap or twist-lock fit with each other.
The means and the dressing may be separate structures, permanently unattached to each other.
In a more suitable layout for higher positive pressures on the wound, a stiff flange or lip extends around the periphery of the proximal face of the backing layer of the wound dressing as hereinbefore defined.
The flange or lip is concave on its proximal face to define a peripheral channel or conduit.
It has a suction outlet that passes through the flange or lip to communicate with the channel or conduit and may be connected to a device for applying a vacuum, such as a pump or a piped supply of vacuum.
The backing layer may be integral with or attached, for example by heat-sealing, to the flange or lip extending around its proximal face.
To form the relatively fluid-tight seal or closure over a wound that is needed and to prevent passage of irrigant and/or exudate under the periphery of the wound-facing face of the wound dressing, in use of the apparatus, the dressing is set on the skin around the wound.
The device then applies a vacuum to the interior of the flange or lip, thus forming and maintaining a seal or closure acting at peripheral points around the wound against the positive pressure on the wound.
With all the foregoing means of attachment, and means for forming and maintaining a seal or closure over the wound, against positive or negative pressure on the wound at peripheral points around the wound, the wound dressing sealing periphery is preferably of a generally round shape, such as an ellipse, and in particular circular.
To form the relatively fluid-tight seal or closure over a wound and around the inlet pipe(s) and outlet pipe(s) at the point at which they pass through and/or under the wound-facing face, the backing layer may be integral with these other components.
The components may alternatively just be a push, snap or twist-lock fit with each other, or adhered or heat-sealed together.
The or each inlet pipe or outlet pipe may be in the form of an aperture, such as a funnel, hole, opening, orifice, luer, slot or port for connection as a female member respectively to a mating end of
Where the components are integral they will usually be made of the same material (for which it will be understood that materials that are listed above are amongst those that are suitable).
Where, alternatively, they are a push, snap or twist-lock fit, the may be of the same material or of different materials. In either case, materials that are listed above are amongst those that are suitable for all the components.
The or each pipe will generally pass through, rather than under the backing layer. In such case, the backing layer may often have a rigid and/or resiliently inflexible or stiff area to resist any substantial play between the or each pipe and the or each mating tube, or deformation under pressure in any direction.
It may often be stiffened, reinforced or otherwise strengthened by a boss projecting distally (outwardly from the wound) around each relevant tube, pipe or hose, or nozzle, hole, opening, orifice, luer, slot or port for connection to a mating end of a fluid recirculation tube and/or fluid supply tube or fluid offtake tube.
Alternatively or additionally, where appropriate the backing layer may have a stiff flange or lip extending around the proximal face of the backing layer to stiffen, reinforce or otherwise strengthen the backing layer.
The wound dressing may not comprise any integer under the backing layer in the wound in use.
However, this may not provide a system to distribute irrigant over a sufficient functional surface area to irrigate the wound at a practical rate. To be suitable for use, in particular in chronic wound dialysis, with relatively high concentrations of materials that are deleterious to wound healing, it may be advantageous to provide a system where wound irrigant and/or wound exudate may be distributed more evenly, or pass in a more convoluted path under the dressing over the wound bed.
Accordingly, one form of the dressing is provided with a ‘tree’ form of pipes, tubes or tubules that radiate from an inlet manifold to the wound bed to end in apertures and deliver the circulating fluid directly to the wound bed via the apertures. Similarly, there is an outlet manifold from which tubules radiate and run to the wound bed to end in openings and collect the fluid directly from the wound bed.
The pipes, etc. may radiate regularly or irregularly through the wound in use, respectively from the inlet or outlet manifold, although regularly may be preferred. A more suitable layout for deeper wounds is one in which the pipes, etc. radiate hemispherically and concentrically, to the wound bed.
For shallower wounds, examples of suitable forms of such layout of the pipes, etc. include ones in which the pipes, etc. radiate in a flattened hemiellipsoid and concentrically, to the wound bed.
Other suitable forms of layout of the pipes, etc. include one which have pipes, tubes or tubules extending from the inlet pipe(s) and/or outlet pipe(s) at the point at which they pass through and/or under the wound-facing face of the backing layer to run over the wound bed. These may have a blind bore with perforations, apertures, holes, openings, orifices, slits or slots along the pipes, etc.
These pipes, etc. then effectively form an inlet pipe manifold that delivers the circulating fluid directly to the wound bed or outlet pipe or collects the fluid directly from the wound respectively.
It does so via the holes, openings, orifices, slits or slots in the tubes, pipes, tubules, etc. over most of the wound bed under the backing layer.
It may be desirable that the tubes, pipes or tubules are resiliently flexible, e.g. elastomeric, and preferably soft, structures with good conformability in the wound and the interior of the wound dressing.
When the therapy is applied in this way, the layout of the tubes, pipes, tubules, etc. may depend on the depth and/or capacity of the wound.
Thus, for shallower wounds, examples of suitable forms of such layout of the tubes, pipes, tubules, etc. include ones that consist essentially of one or more of the tubes, etc in a spiral.
A more suitable layout for deeper wounds when the therapy is applied in this way may be one which comprises one or more of the tubes, etc in a helix or spiral helix.
Other suitable layouts for shallower wounds include one which have blind-bore, perforated inlet pipe or outlet pipe manifolds that circulate fluid in the wound when the dressing is in use.
One or both of these may be such a form, the other may be, e.g. one or more straight blind-bore, perforated radial tubes, pipes or nozzles.
Another suitable layout is one in which
As also mentioned herein, the backing layer that is applied may be any that is appropriate to the present system of therapy and permits a positive or negative pressure of up to 50% atm., more usually up to 25% atm. to be applied to the wound.
It is thus often a microbe-impermeable film, sheet or membrane, which is substantially flat, depending on any pressure differential on it, and often with a (generally uniform) thickness similar to such films or sheets used in conventional wound dressings, i.e. up to 100 micron, preferably up to 50 micron, more preferably up to 25 micron, and of 10 micron minimum thickness.
The backing layer may often have a rigid and/or resiliently inflexible or stiff area to resist any substantial play between other components that are not mutually integral, and may be stiffened, reinforced or otherwise strengthened, e.g. by a projecting boss.
Such a form of dressing would not be very conformable to the wound bed, and may effectively form a chamber, hollow or cavity defined by a backing layer and the wound bed under the backing layer.
It may be desirable that the interior of the wound dressing conform to the wound bed, even for a wound in a highly exuding state. Accordingly, one form of the dressing is provided with a wound filler under the backing layer.
This is favourably a resiliently flexible, e.g. elastomeric, and preferably soft, structure with good conformability to wound shape.
It is urged by its own resilience against the backing layer to apply gentle pressure on the wound bed.
The wound filler may be integral with the other components of the dressing, in particular the backing layer.
Alternatively, it may be permanently attached to them/it, with an adhesive film, for example, or by heat-sealing, e.g. to a flange or lip extending from the proximal face, so a not to disrupt the relatively fluid-tight seal or closure over the wound that is needed.
Less usually, the wound filler is releasably attached to the backing layer, with an adhesive film, for example, or these components may be a push, snap or twist-lock fit with each other.
The wound filler and the backing layer may be separate structures, permanently unattached to each other.
The wound filler may be or comprise a solid integer, favourably a resiliently flexible, e.g. elastomeric, and preferably soft, structure with good conformability to wound shape.
Examples of suitable forms of such wound fillers are foams formed of a suitable material, e.g. a resilient thermoplastic. Preferred materials for the present wound dressing include reticulated filtration polyurethane foams with small apertures or pores.
Alternatively or additionally, it may be in the form of, or comprise one or more conformable hollow bodies defined by a film, sheet or membrane, such as a bag, chamber, pouch or other structure, filled with a fluid or solid that urges it to the wound shape.
The film, sheet or membrane, often has a (generally uniform) thickness similar to that of films or sheets used in conventional wound dressing backing layers.
That is, up to 100 micron, preferably up-to 50 micron, more preferably up to 25 micron, and of 10 micron minimum thickness, and is often resiliently flexible, e.g. elastomeric, and preferably soft.
Such a filler is often integral with the other components of the dressing, in particular the backing layer, or permanently attached to them/it, with an adhesive film, for example, or by heat-sealing, e.g. to a flange
Examples of suitable fluids contained in the hollow body or bodies defined by a film, sheet or membrane include gases, such as air, nitrogen and argon, more usually air, at a small positive pressure above atmospheric; and liquids, such as water, saline.
Examples also include gels, such as silicone gels, e.g. CaviCare™ gel, or preferably cellulosic gels, for example hydrophilic cross-linked cellulosic gels, such as Intrasite™ cross-linked materials. Examples also include aerosol foams, where the gaseous phase of the aerosol system is air or an inert gas, such as nitrogen or argon, more usually air, at a small positive pressure above atmospheric; and solid particulates, such as plastics crumbs.
Of course, if the backing layer is a sufficiently conformable and/or e.g. an upwardly dished sheet, the backing layer may lie under the wound filler, rather than vice versa.
In this type of layout, in order for the wound filler to urge the wound dressing towards the wound bed, it will usually have to be firmly adhered or otherwise releasably attached to the skin around the wound. This is especially the case in those embodiments where the wound filler and the backing layer are separate structures, permanently unattached to each other.
In such a layout for deeper wounds when the therapy is applied in this way, the means for such attachment may also form and maintain a seal or closure over the wound.
Where the filler is over the backing layer, and the fluid inlet pipe(s) and outlet pipe(s) pass through the wound-facing face of the backing layer, they may run through or around the wound filler over the backing layer.
One form of the dressing is provided with a wound filler under the backing layer that is or comprises a resiliently flexible, e.g. elastomeric, and preferably soft, hollow body defined by a film, sheet or membrane, such as a bag, chamber, pouch or other structure, with apertures, holes, openings, orifices, slits or slots, or tubes, pipes, tubules or nozzles. It communicates with at least one inlet or outlet pipe through at least one aperture, hole, opening, orifice, slit or slot.
The fluid contained in the hollow body may then be the circulating fluid in the apparatus.
The hollow body or each of the hollow bodies then effectively forms an inlet pipe or outlet pipe manifold that delivers the circulating fluid directly to the wound bed or collects the fluid directly from the wound respectively via the holes, openings, orifices, slits or slots, or the tubes, pipes or hoses, etc. in the film, sheet or membrane.
When the therapy is applied in this way, the type of the filler may also be largely determined by the depth and/or capacity of the wound.
Thus, for shallower wounds, examples of suitable wound fillers as a component of a wound dressing include ones that consist essentially of one or more conformable hollow bodies defining an inlet pipe and/or outlet pipe manifold that delivers the circulating fluid directly to the wound bed or collects the fluid directly from the wound.
A more suitable wound filler for deeper wounds when the therapy is applied in this way may be one which comprises one or more conformable hollow bodies defined by, for example a polymer film, sheet or membrane, that at least partly surround(s) a solid integer. This may provide a system with better rigidity for convenient handling.
Unless the wound filler under the backing layer effectively forms an inlet pipe or outlet pipe manifold with a direct connection between the inlet pipe(s) and outlet pipe(s) at the point at which they pass through and/or under the wound-facing face and the wound bed is present, in order for aspiration and/or irrigation of the wound bed to occur, it is appropriate for one or more bores, channels, conduits, passages, pipes, tubes, tubules and/or spaces, etc. to run from the point at which the fluid inlet pipe(s) and outlet pipe(s) pass through and/or under the wound-facing face of the backing layer through or around the wound filter filler under the backing layer.
Less usually, the wound filler is an open-cell foam with pores that may form such bores, channels, conduits, passages and/or spaces through the wound filler under the backing layer.
Where the filler is or comprises one or more conformable hollow bodies defined by, for example a polymer film, sheet or membrane, it may be provided with means for admitting fluids to the wound bed under the wound dressing.
These may be in the form of pipes, tubes, tubules or nozzles running from the point at which the fluid inlet pipe(s) and outlet pipe(s) pass through and/or under the wound-facing face of the backing layer through or around the wound filler under the backing layer.
All of the suitable layouts for shallower wounds that comprise blind-bore, perforated inlet pipe or outlet pipe manifolds that circulate fluid in the wound when the dressing is in use, that are described hereinbefore, may be used under a wound filler under the backing layer.
In brief, suitable layouts include ones where one or both manifolds are annular or toroidal (regular, e.g. elliptical or circular, or irregular), optionally with blind-bore, perforated radial tubes, pipes or nozzles, branching from the annulus or torus; and/or
The inlet and/or outlet tubes, the fluid recirculation tube and the fluid supply tube, etc. may be of conventional type, e.g. of elliptical or circular cross-section, and may suitably have a uniform cylindrical bore, channel, conduit or passage throughout their length.
Depending on the desired fluid volume flow rate of irrigant and/or wound exudate from the wound, and the desired amount in recirculation, suitably the largest cross-dimension of the bore may be up to 10 mm for large torso wounds, and up to 2 mm for limb wounds.
The tube walls should suitably thick enough to withstand any positive or negative pressure on them, in particular if the volume of irrigant and/or wound exudate from the wound in recirculation is increased by continuing addition to it of wound exudate, and/or fluid passing from a cleansing fluid through a selectively permeable integer, for example the polymer film, sheet or membrane of a two-phase system, such as an dialysis unit. However, as noted below with regard to pumps, the prime purpose of such tubes is to convey fluid irrigant and exudate through the length of the apparatus flow path, rather than to act as pressure vessels. The tube walls may suitably be at least 25 micron thick.
The bore or any perforations, apertures, holes, openings, orifices, slits or slots along the pipes, etc. or in the hollow body or each of the hollow bodies may be of small cross-dimension.
They may then effectively form a macroscopic and/or microscopic filter for particulates including cell debris and micro-organisms, whilst allowing proteins and nutrients to pass through.
Such tubes, pipes or hoses, etc. through and/or around the filler, whether the latter is a solid integer and/or one or more resiliently flexible or conformable hollow bodies, are described in further detail hereinbefore in connection with the inlet pipe(s) and outlet pipe(s).
The whole length of the apparatus for aspirating, irrigating and/or cleansing wounds should be microbe-impermeable once the wound dressing is over the wound in use.
It is desirable that the wound dressing and the interior of the apparatus for aspirating, irrigating and/or cleansing wounds of the present invention is sterile.
The fluid may be sterilised in the fluid reservoir and/or the rest of the system in which the fluid recirculates, including the means for fluid cleansing, by ultraviolet, gamma or electron beam irradiation. This way, in particular reduces or eliminates contact of internal surfaces and the fluid with any sterilising agent.
Examples of other methods of sterilisation of the fluid also include e.g. the use of
It may be desirable that the interior of the wound dressing, the rest of the system in which the fluid recirculates, and/or the wound bed, even for a wound in a highly exuding state, are kept sterile after the fluid is sterilised in the fluid reservoir, or that at least naturally occurring microbial growth is inhibited.
Thus, materials that are potentially or actually beneficial in this respect may be added to the irrigant initially, and as desired the amount in recirculation increased by continuing addition.
Examples of such materials include antibacterial agents (some of which are listed above), and antifungal agents.
Amongst those that are suitable are, for example triclosan, iodine, metronidazole, cetrimide, chlorhexidine acetate, sodium undecylenate, chlorhexidine and iodine.
Buffering agents, such as potassium dihydrogen phosphate/disodium hydrogen phosphate may be added to adjust the pH, as may local analgesics/anaesthetics, such as lidocaine/lignocaine hydrochloride, xylocaine (adrenaline, lidocaine) and/or anti-inflammatories, to reduce wound pain or inflammation or pain associated with the dressing.
It is also desirable to provide a system in which physiologically active components of the exudate that are beneficial to wound healing are not removed before or after the application of fluid cleansing.
This may occur, e.g. by the passive deposition of materials that are beneficial in promoting wound healing, such as proteins, e.g. growth factors.
This may occur at any point in the flow path, e.g. in at least one inlet or outlet pipe.
The deposition of materials that are beneficial in promoting wound healing may be combated as follows:
Examples of coating materials for surfaces over which the circulating fluid passes include
The apparatus of the invention for aspirating, irrigating and/or cleansing wounds is provided with means for admitting fluids directly or indirectly to the wound under the wound dressing in the form of a fluid supply tube to a fluid reservoir.
The fluid reservoir may be of any conventional type, e.g. a tube, bag (such as a bag typically used for blood or blood products, e.g. plasma, or for infusion feeds, e.g. of nutrients), chamber, pouch or other structure, e.g. of polymer film, which can contain the irrigant fluid.
The reservoir may be made of a film, sheet or membrane, often with a (generally uniform) thickness similar to that of films or sheets used in conventional wound dressing backing layers, i.e. up to 100 micron, preferably up to 50 micron, more preferably up to 25 micron, and of 10 micron minimum thickness, and is often a resiliently flexible, e.g. elastomeric, and preferably soft, hollow body.
In all embodiments of the apparatus the type and material of the tubes throughout the apparatus of the invention for aspirating, irrigating and/or cleansing wounds and the fluid reservoir will be largely determined by their function.
To be suitable for use, in particular on chronic timescales, the material should be non-toxic and biocompatible, inert to any active components, as appropriate of the irrigant from the fluid reservoir and/or wound exudate in the apparatus flow path, and, in any use of a two-phase system dialysis unit, of the dialysate that moves into the circulating fluid in the apparatus.
When in contact with irrigant fluid, it should not allow any significant amounts of extractables to diffuse freely out of it in use of the apparatus.
It should be sterilisable by ultraviolet, gamma or electron beam irradiation and/or with fluid antiseptics, such as solutions of chemicals, fluid- and microbe-impermeable once in use, and flexible.
Examples of suitable materials for the fluid reservoir include synthetic polymeric materials, such as polyolefins, such as polyethylene, e.g. high-density polyethylene and polypropylene.
Suitable materials for the present purpose also include copolymers thereof, for example with vinyl acetate and mixtures thereof. Suitable materials for the present purpose further include medical grade poly(vinyl chloride).
Notwithstanding such polymeric materials, the fluid reservoir will often have a stiff area to resist any substantial play between it and components that are not mutually integral, such as the fluid supply tube towards the wound dressing, and may be stiffened, reinforced or otherwise strengthened, e.g. by a projecting boss.
The device for moving fluid through the wound and means for fluid cleansing may be any appropriate for this purpose, and may act at any appropriate point for this purpose.
It may apply a positive or negative pressure to the wound, although its prime purpose is to move fluid (irrigant from the fluid reservoir and/or wound exudate through the length of the apparatus flow path, rather than to apply a positive or negative pressure to the wound.
If applied to the fluid in recirculation in the fluid recirculation tube upstream of and towards the wound dressing and/or the fluid in the fluid supply tube towards the wound dressing (optionally or as necessary via means for flow switching between supply and recirculation), it will usually apply positive pressure (i.e. above-atmospheric pressure) to the wound bed.
Often the means for fluid cleansing is (most appropriately for its purpose) downstream of the wound dressing, and provides the highest resistance in the flow path. This is especially the case where the means for fluid cleansing is a single-phase system, e.g. with ultrafiltration through microapertures or micropores, thus enhancing applied positive pressure to the wound.
Where the device is applied to the fluid in recirculation in the fluid recirculation tube and/or the fluid in the fluid offtake tube downstream of and away from the wound dressing, it will usually apply negative pressure (i.e. below-atmospheric pressure or vacuum) to the wound bed.
Again, often the means for fluid cleansing is (most appropriately for its purpose) downstream of the wound dressing, and provides the highest resistance in the flow path, thus enhancing applied negative pressure to the wound.
The following types of pump may be used as desired:
The type and/or capacity of the device will be largely determined by
Such a device may also suitably be one that is capable of pulsed, continuous, variable, reversible and/or automated and/or programmable fluid movement. It may in particular be a pump of any of these types.
In practice, even from a wound in a highly exuding state, such a rate of exudate flow is only of the order of up to 75 microlitres/cm2/hr (where cm2 refers to the wound area), and the fluid can be highly mobile (owing to the proteases present). Exudate levels drop and consistency changes as the wound heals, e.g. to a level for the same wound that equates to 12.5-25 microlitres/cm2/hr.
Where materials deleterious to wound healing are removed by a two-phase system (see below), such as a dialysis unit, fluid is also potentially lost to the system through the means for fluid cleansing.
This may occur, e.g. through a dialysis polymer film, sheet or membrane which is also permeable to water, in addition to materials deleterious to wound healing.
The balance of fluid in recirculation may thus further decrease, but may be adjusted to minimise this undesired loss in a routine manner as described hereinbefore.
Hence, it will be seen that the circulating fluid from the wound will typically contain a preponderance of irrigant over wound exudate in recirculation from the fluid reservoir.
The type and/or capacity of the device will thus be largely determined in this respect by the appropriate or desired fluid volume flow rate of irrigant, rather than that of exudate, from the wound.
In practice, such a rate of flow of total irrigant and/or wound exudate will be of the order of 1 to 1000, e.g. 3 to 300, and less preferably 1 to 10 ml/cm2/24 hour, where the cm2 refers to the wound area.
The volume of irrigant and/or wound exudate in recirculation may vary over a wide range, but will typically be e.g. 1 to 8 l. (for example for large torso wounds), 200 to 1500 ml (for example for axillary and inguinal wounds), and 0.3 to 300 ml for limb wounds when the therapy is applied in this way.
In practice, suitable pressures are of the order of up to 25% atm such as up to 10% atm. positive or negative pressure on the wound bed, the apparatus being operated as a closed recirculating system.
The higher end of these ranges are potentially more suitable for hospital use, where relatively high % pressures and/or vacua may be used safely under professional supervision.
The lower end is potentially more suitable for home use, where relatively high % pressures and/or vacua cannot be used safely without professional supervision, or for field hospital use.
The device may be a peristaltic pump or diaphragm pump, e.g. preferably a small portable diaphragm or peristaltic pump. These are preferred types of pump, in order in particular to reduce or eliminate contact of internal surfaces and moving parts of the pump with (chronic) wound exudate, and for ease of cleaning.
It may suitably be one that applies positive pressure to the wound and/or the means for fluid cleansing. A preferred pump when the applied pressure is positive is a peristaltic pump, e.g. a small, portable peristaltic pump, mounted upstream of the means for fluid cleansing.
Where the pump is a peristaltic pump, this may be e.g. an Instech Model P720 miniature peristaltic pump, with a flow rate: of 0.2-180 ml/hr and a weight of <0.5 k. This is potentially useful for home and field hospital use.
The pump may suitably be one that applies negative pressure to the wound and/or the means for fluid cleansing.
A preferred pump when the applied pressure is negative is a diaphragm pump, e.g. a small, portable diaphragm pump, mounted downstream of the dressing or the means for fluid cleansing.
Where the pump is a diaphragm pump, and preferably a small portable diaphragm pump, the one or two flexible diaphragms that displace liquid may each be, for example a polymer film, sheet or membrane, that is connected to means for creating the pulsations. This may be provided in any form that is convenient, inter alia as a piezoelectric transducer, a core of a solenoid or a ferromagnetic integer and coil in which the direction of current flow alternates, a rotary cam and follower, and so on.
The outlet from the dressing passes to the means for fluid cleansing for removal of materials deleterious to wound healing from wound exudate, and in turn to the fluid recirculation tube(s).
The apparatus of the invention for aspirating, irrigating and/or cleansing wounds is provided with means for fluid cleansing, which may be
In the former, circulating fluid from the wound and the fluid reservoir passes through a self-contained system in which materials deleterious to wound healing are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing are returned to the wound.
The single-phase system may be of any conventional type.
Examples of the means for fluid cleansing in such a system include a macro- or microfiltration unit, which appropriately comprises one or more macroscopic and/or microscopic filters.
These are to retain particulates, e.g. cell debris and micro-organisms, allowing proteins and nutrients to pass through.
Alternatively, they also include an ultrafiltration unit, such as a one in which the cleansing integer is a filter for materials deleterious to wound healing, for example a high throughput, low protein-binding polymer film, sheet or membrane which is selectively impermeable to materials deleterious to wound healing, which are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing is passed by it.
The membrane may preferably be of a hydrophilic polymeric material, such as a cellulose acetate-nitrate mixture, polyvinylidene chloride, and, for example hydrophilic polyurethane.
Examples of less preferred materials include hydrophobic materials also including polyesters, such as polycarbonates, PTFE, and polyamides, e.g. 6-6 and 6-10, and hydrophobic polyurethanes, and quartz and glass fibre.
It has microapertures or micropores, the maximum cross-dimension of which will largely depend on the species that are to be selectively removed in this way and those to which it is to be permeable.
The former may be removed with microapertures or micropores, e.g. typically with a maximum cross-dimension in the range of 20 to 700 micron, e.g. 20 to 50 nm (for example for undesired proteins), 50 to 100 nm, 100 to 250 nm, 250 to 500 nm and 500 to 700 nm.
The filter integer may be a flat sheet or a membrane of a polymeric material in a more convoluted form, e.g. in the form of elongate structure, such as pipes, tubules, etc.
The system may be a chemical adsorption unit, for example one in which a particulate, such as a zeolite, or a layer, e.g. of a functionalised polymer has sites on its surface that are capable of removing materials deleterious to wound healing on passing the circulating fluid from the wound and the fluid reservoir over them.
The materials may be removed, e.g. by destroying or binding the materials that are deleterious to wound healing, by, for example chelators and/or ion exchangers, degraders, which may be enzymes.
Examples of such also include less specific chemical absorption and/or adsorption units, for example one in which a physical absorbent, such as activated carbon or a zeolite, has non-specific sites on its surface that are capable of removing materials deleterious to wound healing on passing the circulating fluid from the wound and the fluid reservoir over them.
The cleansing integer, for example the polymer film, sheet or other chemical absorption and/or adsorption means, etc should of course be capable of removing materials deleterious to wound healing at a practical rate for a given capacity of the apparatus flow path and the flow rate of irrigant.
In the two-phase system, circulating fluid from the wound and the fluid reservoir in indirect or (less usually, direct) contact with a second fluid (dialysate) phase, more usually a liquid.
Thus, in one form, a biphasic liquid extraction unit, the second fluid phase is (usually) a liquid that is immiscible with the circulating fluid from the dressing, over a surface of which the circulating fluid passes in direct contact with the cleansing fluid. Materials deleterious to wound healing are removed into the dialysate, and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the wound bed.
Examples of such means for fluid cleansing include those wherein the second fluid (dialysate) phase is perfluorodecalin and like materials
Alternatively, where appropriate it may be provided in a form in which the two fluids (recirculation fluid and dialysate) are separated by a significantly two-dimensional integer, for example a polymer film, sheet or membrane or hollow fibre or filament that is permeable to materials in the circulating fluid in the apparatus.
Again, materials deleterious to wound healing are removed into the dialysate, and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the wound bed.
In either form in which the two-phase system, such as a dialysis unit, is provided, in use typically the dialysate moves past the circulating fluid in the apparatus in a co- or preferably counter-current direction.
Pumps, such as peristaltic pumps, and/or valves control the direction of the two fluid flows.
However, the cleansing fluid may less usually be static, although this may not provide a system with sufficient (dynamic) surface area to remove materials deleterious to wound healing from wound exudate at a practical rate.
Typical dialysate flow rates in a dialytic means for fluid cleansing in the present apparatus for aspirating, irrigating and/or cleansing wounds are those used in the conventional type of two-phase system, such as a dialysis unit for systemic therapy.
The integer may be a film, sheet or membrane, often of the same type, and of the same (generally uniform) thickness, as those used in conventional two-phase system, such as a dialysis unit for systemic therapy.
The film, sheet or membrane may be substantially flat, and depending on any pressure differential across it may require other materials on or in it to stiffen, reinforce or otherwise strengthen it.
However, this may not provide a system with sufficient functional surface area to remove materials deleterious to wound healing from wound exudate at a practical rate.
To be suitable for use, in particular in chronic wound dialysis, with relatively high concentrations of materials that are deleterious to wound healing, it may be advantageous to provide a system in which the film, sheet or membrane of a polymeric material is in a more convoluted form.
This may be in the form of elongate structures, such as pipes, tubes hollow fibres or filaments or tubules of a round cross-section, e.g. elliptical or circular, e.g. in a parallel array with spaces therebetween.
The wound irrigant and/or wound exudate may recirculate through the inside and the cleansing fluid may pass into the spaces between adjacent pipes, tubes or tubules in a co- or preferably counter-current direction, or vice versa.
Again, materials deleterious to wound healing are removed into the dialysate, and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the wound.
Where the means for fluid cleansing is a two-phase system, e.g. in the form of a dialysis unit, or a biphasic extraction unit, the circulating fluid from the wound and the fluid reservoir passes across one surfaces of a significantly two-dimensional integer, for example a polymer film, sheet or membrane which is selectively permeable to materials deleterious to wound healing.
These are removed by passing a cleansing fluid across the other surface of the integer. The integer may be a film, sheet or membrane that is selectively permeable to the foregoing materials deleterious to wound healing.
Examples of these as above include
Examples of suitable materials for the film, sheet or membrane (typically in the form of conformable hollow bodies defined by the film, sheet or membrane, such as the structures described hereinbefore) include natural and synthetic polymeric materials.
The membrane may be of one or more hydrophilic polymeric materials, such as a cellulose derivative, e.g. regenerated cellulose, a cellulose mono-, di- or tri-esters, such as cellulose mono-, di- or tri-acetate, benzyl cellulose and Hemophan, and mixtures thereof.
Examples of other materials include hydrophobic materials, such as aromatic polysulphones, polyethersulphones, polyetherether-sulphones, polyketones, polyetherketones and polyetherether-ketones, and sulphonated derivatives thereof, and mixtures thereof.
Examples of other materials include hydrophobic materials, such as polyesters, such as polycarbonates and polyamides, e.g. 6-6 and 6-10; polyacrylates, including, e.g. poly(methyl methacrylate), polyacrylonitrile and copolymers thereof, for example acrylonitrile-sodium metallosulphonate copolymers; and poly(vinylidene chloride).
Suitable materials for the present membranes include thermoplastic polyolefins, such as polyethylene e.g. high-density polyethylene, polypropylene, copolymers thereof, for example with vinyl acetate and polyvinyl alcohol, and mixtures thereof.
The dialysis membrane should have a molecular weight cut off (MWCO) chosen to allow selective perfusion of species deleterious to wound healing that have been targeted for removal from the wound. For example, perfusion of the serine protease elastase (molecular weight 25900 Dalton) would require a membrane with MWCO >25900 Dalton. The MWCO threshold can be varied to suit each application between 1 and 3000000 Dalton.
Preferably, the MWCO should be as close as possible to this weight to exclude interference by larger competitor species.
For example, such a membrane with MWCO >25900 Dalton does not allow any significant amounts of the antagonist to elastase, alpha-1-antitrypsin (AAT) (molecular weight 54000 Dalton), which occurs naturally in wounds, to diffuse freely out of the wound fluid into the dialysate. The inhibitor, which is beneficial in promoting chronic wound healing, remains in contact with the wound bed, and can act beneficially on it, whilst the elastase that is deleterious to wound healing is removed.
Such use of the present apparatus is, e.g. favourable to the wound healing process in chronic wounds, such as diabetic foot ulcers, and especially decubitus pressure ulcers.
As noted hereinafter, antagonists, for example degrading enzymes, or sequestrating agents for elastase on the dialysate side of the membrane, may be used to enhance the removal of this protease from wound exudate.
Where it is desired to remove several different materials that are deleterious to wound healing, it may be advantageous to provide a system of modules in series, each of which removes a different material. This allows incompatible cleansing materials to be used on the same fluid and/or wound exudates.
Preferably any such system is a conventional automated, programmable system which can cleanse the wound irrigant and/or wound exudate with minimal supervision.
As noted above in more detail, fluid passes from a cleansing fluid through a selectively permeable integer.
This may be the typical permeable polymer film, sheet or membrane of a two-phase system, such as a dialysis unit.
Additionally, solutes or disperse phase species will pass from the dialysate into the irrigant and/or wound exudate through the dialysis polymer film, sheet or membrane.
This property may be used to perfuse materials beneficial to wound healing into the irrigant and/or exudate from a dialysate.
In this less conventional type of infusion feed, a broad spectrum of species will usually pass into the exudate and/or irrigant fluid from the dialysate.
These include
For the purposes of fluid cleansing in the apparatus of the present invention, both the single-phase system, such as an ultrafiltration unit, and two-phase system, such as a dialysis unit, may have captive (non-labile, insoluble and/or immobilised) species such as the following, bound to an insoluble and/or immobilised) substrate over and/or through which the irrigant and/or wound exudate from, the wound dressing passes in turn to the fluid recirculation tube(s):
Other physiologically active components of the exudate that are deleterious to wound healing may be removed in this way.
These may be removed with suitable chelators and/or ion exchangers, degraders, which may be enzymes, or other species.
The following types of functionalised substrate has sites on its surface that are capable of removing materials deleterious to wound healing on passing the circulating fluid from the wound and the fluid reservoir over them:
heterogeneous resins, for example silica-supported reagents such as:
The use of such captive (non-labile, insoluble and/or immobilised) species, such as the foregoing, bound to an insoluble and immobilised) substrate over and/or through which the irrigant and/or wound exudate from, the wound dressing passes has been described hereinbefore as suitable for the means for fluid cleansing.
However, they may additionally, where appropriate, be used in any part of the apparatus that is in contact with the irrigant and/or wound exudate, but often within the dressing, for removal of materials deleterious to wound healing from wound.
The means for fluid cleansing may additionally, where appropriate, comprise one or more macroscopic and/or microscopic filters.
These are to retain particulates, e.g. cell debris and micro-organisms, allowing proteins and nutrients to pass through.
Alternatively, a less conventional type of two-phase system (see above), such as a dialysis unit, may be used as the means for fluid cleansing. In this type, the dialysis polymer film, sheet or membrane is not an integer selectively permeable to materials deleterious to wound healing, such as proteases, such as serine proteases, e.g. elastase and thrombin; cysteine protease; matrix metalloproteases, e.g. collagenase; and carboxyl (acid) proteases;
It will however also permit components of the exudate from a wound and/or irrigant fluid that may be larger or smaller molecules, but are beneficially involved in wound healing to pass into and through it.
In the dialysate, or preferably in one or more solid structural integers with at least one surface in contact with the dialysate, in the means for fluid cleansing, there are one or more materials that can remove materials deleterious to wound healing from wound exudate, by being antagonists to such species, for example enzymes or others, such as protease inhibitors, such as serine protease inhibitors, such as 4-(2-aminoethyl)-benzene sulphonyl fluoride (AEBSF, PefaBloc) and Na-p-tosyl-L-lysine chloromethyl ketone (TLCK) and ε-aminocaproyl-ρ-chlorobenzylamide; cysteine protease inhibitors; matrix metalloprotease inhibitors; and carboxyl (acid) protease inhibitors;
They further include peptides (including cytokines, e.g. bacterial cytokines, such as α-amino-γ-butyrolactone and L-homocarnosine); and
In use of the two-phase system dialysis unit, of this less conventional type, a broad spectrum of species will usually pass into the dialysate from the exudate.
Some (mainly ionic) species will pass from the dialysate into the irrigant and/or wound exudate through the dialysis polymer film, sheet or membrane that is not very selectively permeable to materials deleterious to wound healing.
The components of the exudate from a wound and/or irrigant fluid will diffuse freely to and fro through it.
If (preferably) none of the dialysate is voided to waste, e.g. to a collection bag, a steady state concentration equilibrium is eventually set up between the dialysate and the irrigant and/or wound exudate, which is ‘topped up’ from the wound dressing.
Circulating wound fluid aids in the quicker attainment of this equilibrium of materials beneficial in promoting wound healing.
It also returns them to the site where they can be potentially of most benefit, i.e. the wound bed.
The target materials deleterious to wound healing also pass into the dialysate from the exudate through the dialysis polymer film, sheet or membrane that is not very selectively permeable to materials deleterious to wound healing.
Unlike the other components of the exudate from a wound and/or irrigant fluid, the target materials deleterious to wound healing come into contact with the dialysate, or preferably with one or more solid structural integers with at least one surface in the dialysate, and are removed by the appropriate antagonists, binders and/or degraders, chelators and/or ion exchangers and redox agents, etc. The cleansed fluid, still containing some materials that are beneficial in promoting wound healing, is returned to the recirculation tube.
Unlike the other components of the exudate from a wound and/or irrigant fluid the target materials are constantly removed from the dialysate, very little of these species will pass from the dialysate into the irrigant and/or wound exudate, and a steady state concentration equilibrium is not set up, even if the species are constantly ‘topped up’ from the wound dressing.
It is believed that circulating wound fluid aids in removal from recirculation of the materials deleterious to wound healing from wound exudate, whilst retaining materials that are beneficial in promoting wound healing in contact with the wound.
A particular advantage of this form of the two-phase system, is that where a material that can remove materials deleterious to wound healing from wound exudate is (cyto)toxic or bioincompatible, or not inert to any components that are beneficial in promoting wound healing, the system does not allow any significant amounts of antagonist to diffuse freely out of the dialysate into the irrigant fluid. The active material can act beneficially on the fluid however.
The film sheet or membrane is preferably a dialysis membrane of molecular weight cut off (MWCO) (as conventionally defined) chosen to allow perfusion of species targeted for sequestration or destruction.
For example, sequestration of the serine protease elastase (molecular weight 25900 Dalton) would require a membrane with MWCO >25900 Dalton.
The MWCO threshold can be varied to suit each application between 1 and 3000000 Dalton. Preferably, the MWCO should be as close as possible to this weight to exclude sequestering interference by larger competitor species.
Both the single-phase system, such as an ultrafiltration unit, and two-phase system, such as a dialysis unit, may be in modular form that is relatively easily demountable from the apparatus of the invention. The system may suitably comprise one or more such modules.
The conduits through which respectively
The apparatus of the invention for aspirating, irrigating and/or cleansing wounds is provided with means for bleeding the offtake and/or recirculation tubes, such as a regulator, such as a valve or other control device for bleeding fluids from the wound.
The device for moving fluid through the wound and means for fluid cleansing is used to move irrigant to the wound dressing and apply the desired positive or negative pressure on the wound bed.
The desired balance of fluid in recirculation tube will typically be regulated by means of
Thus, e.g. if
Once it has been primed throughout, e.g. to the desired positive or negative pressure on the wound bed, the apparatus may be operated as a closed recirculating system.
The means for flow switching between supply and recirculation tubes is set to close the wound to the fluid reservoir via the fluid supply tube, and the means for bleeding the offtake and/or recirculation tubes are also closed.
If
Once it has been primed throughout, e.g. to the desired positive or negative pressure on the wound bed, the apparatus cannot be operated as a closed recirculating system, without the pressure to the wound bed increasing, possibly undesirably.
The means for bleeding the offtake and/or recirculation tubes must be opened to some extent to relieve positive pressure on the wound bed. The bleed-off may be voided to waste, e.g. to a collection bag.
Materials that are beneficial in promoting wound healing may be lost to the site where they can be potentially of most benefit, i.e. the wound bed, when the therapy is applied in this way.
However, the balance of fluid in recirculation may be routinely adjusted to minimise this undesired loss.
The factors that determine the balance of fluid in recirculation in an apparatus with a two-phase system means for fluid cleansing in the form of a dialysis unit, or a biphasic extraction unit have been described hereinbefore in detail hereinbefore in connection with the operation of the apparatus. It is sufficient to note here that at some point after steady state recirculation established through the length of the apparatus flow path, it may be necessary that any bleed valve is opened, if overall the fluid level is increasing by transfer from the dialysate to an undesirable extent.
Other combinations, and the necessary adjustments to maintain the desired balance of fluid in recirculation tube by means of
The outlet from the means for bleeding the offtake and/or recirculation tubes may be collected and monitored and used to diagnose the status of the wound and/or its exudate.
The waste reservoir may be of any conventional type, e.g. a tube, bag (such as a bag typically used as an ostomy bag), chamber, pouch or other structure, e.g. of polymer film, which can contain the irrigant fluid that has been bled off. In all embodiments of the apparatus, the type and material of the waste reservoir will be largely determined by its function. To be suitable for use, the material need only be fluid-impermeable once in use, and flexible.
Examples of suitable materials for the fluid reservoir include synthetic polymeric materials, such as polyolefins, such as poly (vinylidene chloride).
Suitable materials for the present purpose also include polyethylene, e.g. high-density polyethylene, polypropylene, copolymers thereof, for example with vinyl acetate and mixtures thereof.
In a second aspect of the present invention there is provided a conformable wound dressing, characterised in that it comprises a backing layer with a wound-facing face which is capable of forming a relatively fluid-tight seal or closure over a wound and has
The dressing is advantageously provided for use in a bacteria-proof pouch.
Examples of suitable forms of such wound dressings are as described by way of example hereinbefore.
It is desirable
Thus, in a third aspect of the present invention there is provided a method of treating wounds to promote wound healing using the apparatus for aspirating, irrigating and/or cleansing wounds of the present invention.
The present invention will now be described by way of example only with reference to the accompanying drawings in which:
It has a single-phase system means for fluid cleansing in the form of an ultrafiltration unit.
It has a two-phase system means for fluid cleansing in the form of a dialysis unit, or a biphasic extraction unit.
In these,
It has a single-phase system means for fluid cleansing in the form of an ultrafiltration unit.
It has a two-phase system means for fluid cleansing in the form of a dialysis unit, or a biphasic extraction unit.
It has a single-phase system means for fluid cleansing in the form of an ultrafiltration unit.
Referring to
The ultrafiltration unit (17) is a single-phase system. In this the circulating fluid from the wound and the fluid reservoir passes through a self-contained system in which materials deleterious to wound healing are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the wound bed.
(In a variant of this apparatus, there are two inlet pipes (6), which are connected respectively to a fluid supply tube (7) and fluid recirculation tube (13), respectively having a first valve (19) for admitting fluid into the wound from the fluid reservoir (12) and a second valve (20) for admitting fluid into the wound from the recirculation tube.
Usually in use of the apparatus, when the first valve (19) is open, the second valve (20) is shut, and vice versa.)
In use of the apparatus (1), the valve (16) is opened to a collection bag (not shown), and the T-valve (14) is turned to admit fluid from the fluid reservoir to the wound dressing through the fluid supply tube (7) and inlet pipe (6). (In the variant of this apparatus having two inlet pipes (6), which are connected respectively to a fluid supply tube (7) and fluid recirculation tube (13), the first valve (19) for admitting fluid into the wound from the fluid reservoir (12) is opened and the second valve (20) is shut, and vice versa.)
The pump (18) is started to nip the fluid recirculation tube (13) with the peripheral rollers on its rotor (not shown) to apply a low positive pressure on the wound. It is allowed to run until the apparatus is primed throughout the whole length of the apparatus flow path and excess fluid is voided to waste via the bleed T-valve (16) into the collection bag (not shown).
The T-valve (14) is then turned to switch from supply and recirculation, i.e. is set to close the wound to the fluid reservoir (12) but to admit fluid into the wound from the fluid recirculation tube (13), and the bleed T-valve (16) is simultaneously closed.
(In the variant of this apparatus, where there are two inlet pipes (6), which are connected respectively to a fluid supply tube (7) and fluid recirculation tube (13), the first valve (19) is closed and a recirculating system set up by opening the second valve (20) for admitting fluid into the wound from the recirculation tube (13).
The circulating fluid from the wound and the fluid reservoir (12) passes through the ultrafiltration unit (17). Materials deleterious to wound healing are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube (13) to the wound bed.
The recirculation of fluid may be continued as long as desired.
Switching between supply and recirculation is then reversed, by turning the T-valve (14) to admit fluid from the fluid reservoir to the wound dressing through the fluid supply tube (7) and inlet pipe (6).
(In the variant of this apparatus having two inlet pipes (6), which are connected respectively to a fluid supply tube (7) and fluid recirculation tube (13), the first valve (19) for admitting fluid into the wound from the fluid reservoir (12) is opened and the second valve (20) is shut, and vice versa.)
The bleed valve (16) is simultaneously opened, so that fresh fluid flushes the recirculating system.
The running of the pump (18) may be continued until the apparatus is flushed, when it and the fluid recirculation is stopped.
If, e.g. the wound is in a highly exuding state, there is a positive change in the balance of fluid in recirculation. It may be necessary to bleed fluid from recirculation, by opening the bleed T-valve (16) to bleed fluid from the recirculation tube (13).
Referring to
In this, there is one system through which the circulating fluid from the wound and the fluid reservoir passes and from which deleterious materials are removed by selectively permeable contact with a second system, through which passes a cleansing fluid.
The dialysis unit (23) thus has an internal polymer film, sheet or membrane (24), selectively permeable to materials deleterious to wound healing, which divides it into
The dialysis unit (23) thus has a dialysate inlet pipe (28) connecting to a dialysate supply tube (29) which passes to a peristaltic pump (38), e.g. preferably a small portable peristaltic pump, acting on the dialysate supply tube (29) with the peripheral rollers on its rotor (not shown) to supply cleansing fluid across the surface of the polymer film, sheet or membrane (28) in the first chamber (25) from a dialysate reservoir (not shown) via a valve (34).
The dialysis unit (23) also has a dialysate outlet pipe (30) connecting to a dialysate outlet tube (31) which passes to waste via a second bleed T-valve (36) into, e.g. a collection bag (not shown).
Operation of this apparatus is similar to that of
The pump (38) is started to nip fluid dialysate tube (29) with the peripheral rollers on its rotor (not shown) to pump cleansing fluid to the first chamber from a dialysate reservoir (not shown) and out to waste via the bleed valve (36) into the collection bag (not shown).
The dialysis unit (23) is a module (or scrubbing cartridge) with a substrate that changes colour to indicate the presence of detrimental factors in the cleansed fluid, and that the scrubbing cartridge is exhausted and should be renewed.
Referring to
The backing layer (42) extends in use on a wound over the skin around the wound. On the proximal face of the backing layer (43) on the overlap (44), it bears an adhesive film (45), to attach it to the skin sufficiently to hold the wound dressing in place in a fluid-tight seal around the periphery of the wound-facing face (43) of the wound dressing.
There is one inlet pipe (46) for connection to a fluid supply tube (not shown), which passes through and/or under the wound-facing face (43), and one outlet pipe (47) for connection to a fluid offtake tube (not shown), which passes through and/or under the wound-facing face (43).
Referring to
This comprises a generally frustroconical, toroidal conformable hollow body, defined by a membrane (49) which is filled with a fluid, here air or nitrogen, that urges it to the wound shape.
The filler (48) may be permanently attached to the backing layer with an adhesive film (not shown) or by heat-sealing.
The inlet pipe (46) and outlet pipe (47) are mounted centrally in the backing layer (42) above the central tunnel (50) of the toroidal hollow body (48) and each passes through the backing layer (42), and each extends in pipes (51) and (52) respectively through the tunnel (50) of the toroidal hollow body (48) and then radially in diametrically opposite directions under the body (48).
This form of the dressing is a more suitable layout for deeper wounds.
Referring to
The pouch (63) communicates with the inlet pipe (46) through a hole (64), and thus effectively forms an inlet pipe manifold that delivers the circulating fluid directly to the wound when the dressing is in use.
An annular second membrane (65) with openings (66) is permanently attached to the backing layer (42) by heat-sealing to form an annular chamber (67) with the layer (42).
The chamber (67) communicates with the outlet pipe (47) through an orifice (68), and thus effectively forms an outlet pipe manifold that collects the fluid directly from the wound when the dressing is in use.
Referring to
This comprises a circular backing layer (42) and a filler (69), in the form of an inverted frustroconical, solid integer, here a resilient elastomeric foam, formed of a thermoplastic, or preferably a cross-linked plastics foam.
It may be permanently attached to the backing layer (42), with an adhesive film (not shown) or by heat-sealing.
A circular upwardly dished sheet (70) lies under and conforms to, but is a separate structure, permanently unattached to, the backing layer (42) and the solid integer (69).
A circular upwardly dished first membrane (71) with apertures (72) is permanently attached to the sheet (70) by heat-sealing to form a circular pouch (73) with the sheet (70).
The pouch (73) communicates with the inlet pipe (46) through a hole (74), and thus effectively forms an inlet pipe manifold that delivers the circulating fluid directly to the wound when the dressing is in use.
An annular second membrane (75) with openings (76) is permanently attached to the sheet (70) by heat-sealing to form an annular chamber (77) with the sheet (70).
The chamber (77) communicates with the outlet pipe (47) through an orifice (78), and thus effectively forms an outlet pipe manifold that collects the fluid directly from the wound when the dressing is in use.
Alternatively, where appropriate the dressing may be provided in a form in which the circular upwardly dished sheet (70) functions as the backing layer and the solid filler (69) sits on the sheet (70) as the backing layer, rather than under it. The filler (69) is held in place with an adhesive film or tape, instead of the backing layer (42).
Referring to
This comprises a circular backing layer (42) and a filler (79), in the form of an inverted generally hemispherical integer, here a resilient elastomeric foam or a hollow body filled with a fluid, here a gel that urges it to the wound shape, and permanently attached to the backing layer with an adhesive film (not shown) or by heat-sealing.
The inlet pipe (46) and outlet pipe (47) are mounted peripherally in the backing layer (42).
A circular upwardly dished sheet (80) lies under and conforms to, but is a separate structure, permanently unattached to, the backing layer (42) and the filler (79).
A circular upwardly dished bilaminate membrane (81) has a closed channel (82) between its laminar components, with
The membrane (81) also has apertures (86) between and along the length of the turns of the channel (82).
The inner surface (87) of the dish formed by the membrane (81) is permanently attached at its innermost points (88) with an adhesive film (not shown) or by heat-sealing to the sheet (80). This defines a mating closed spirohelical conduit (89).
At the outermost end of its spiral helix, the conduit (89) communicates through an opening (90) with the outlet pipe (47) and is thus effectively an outlet manifold to collect the fluid directly from the wound via the apertures (86).
Referring to
The chamber (94) communicates with the outlet pipe (47) and is thus effectively an outlet manifold from which tubules (99) radiate hemispherically and run to the wound bed to end in openings (100). The tubules (99) collect the fluid directly from the wound via the openings (100).
Referring to
These pipes (101), (102) have a blind bore with orifices (103), (104) along the pipes (101), (102). These pipes (101), (102) respectively form an inlet pipe or outlet pipe manifold that delivers the circulating fluid directly to the wound bed or collects the fluid directly from the wound respectively via the orifices.
In
In
Referring to
Referring to
Under the latter is a circular upwardly dished sheet (111) which conforms to, but is a separate structure, permanently unattached to, the solid filler (110). Through the sheet (111) pass the inlet pipe (46) and the outlet pipe (47), to run over the wound bed. These pipes (101), (102) again have a blind bore with orifices (103), (104) along the pipes (101), (102).
Alternatively (as in
In
Thus, in
The topmost (first) layer (121) (which is the most distal in the dressing in use) is a blank square capping layer.
The next (second) layer (122), shown in
The next (third) layer (123) is another square layer, with inlet manifold apertures (129) through the layer (123) in an array such that the apertures (129) are in register with the inlet manifold slot (126) through the second layer (122) (shown in
The next (fourth) layer (124), shown in
It also has an outlet manifold slot (131) through it.
The slot (131) runs to one edge (132) of the layer (124) on the opposite side of the manifold stack (120) from the edge (127) of the layer (122), for connection to a mating end of a fluid outlet tube (not shown).
It spreads into three adjacent branches (133) in a parallel array in the spaces between the apertures (130) in the layer (124) and in register with the spaces between the apertures (129) in the layer (122).
The final (fifth) layer (125) is another square layer, with inlet manifold apertures (134) through the layer (125) in an array such that the apertures (134) are in register with the inlet manifold apertures (130) through the fourth layer (124) (in turn in register with the apertures (129) through the third layer (123). It also has outlet manifold apertures (135) in the layer (125) in an array such that the apertures (135) are in register with the outlet manifold slot (131) in the fourth layer (124).
It will be seen that, when the layers (121) to (125) are attached together to form the stack (120), the topmost (first) layer (121), the inlet manifold slot (126) through the second layer (122), and the third layer (123) cooperate to form an inlet manifold in the second layer (122), which is in use is connected to a mating end of a fluid inlet tube (not shown).
The inlet manifold slot (126) through the second layer (122), and the inlet manifold apertures (129), (130) and (134) through the layers (123), (124) and (125), all being mutually in register, cooperate to form inlet manifold conduits though the third to fifth layers (123), (124) and (125) between the inlet manifold in the second layer (122) and the proximal face (136) of the stack (120).
The third layer (121), the outlet manifold slot (131) through the fourth layer (124), and the fifth layer (125) cooperate to form an outlet manifold in the fourth layer (124), which is in use is connected to a mating end of a fluid outlet tube (not shown).
The outlet manifold slot (131) through the fourth layer (124), and the outlet manifold apertures (135) through the fifth layer (125), being mutually in register, cooperate to form outlet manifold conduits though the fifth layer (125) between the outlet manifold in the fourth layer (124) and the proximal face (136) of the stack (120).
Referring to
It has bypass (711) around the pump (17), as a protection of the pump against any blockage in the system.
It is activated automatically by appropriate means, e.g. it is normally blocked by a bursting disc (not shown), or a pressure-activated motorised valve. An alternative to the by-pass (711) is a pressure sensor in the system that will detect excessive load or pressure, and shut down the pump. Referring to
The latter is a two-phase system with a dialysis unit (21), but is one in which dialytic fluid passes only once across the surface of the dialytic membrane (28) in the first chamber (25) from a dialysate reservoir (not shown) to waste via a second bleed T-valve (36) into, e.g. a collection bag (not shown).
This variant has a dialysate recirculation tube (811) running between a first T-valve (816) on the inlet side of the dialysate pump (23) and a second T-valve (817) to permit the pump (23) to recirculate the dialysate once the circuit is primed in multiple passes through the dialysis unit (21).
The operation of the system will be apparent to the skilled person. Referring to
This comprises respectively a generally downwardly domed or toroidal, or oblately spheroidal conformable hollow body, defined by a membrane (349) which is filled with a fluid, here air or nitrogen, that urges it to the wound shape.
The filler (348) is permanently attached to the backing layer via a boss (351), which is e.g. heat-sealed to the backing layer (342).
An inflation inlet pipe (350), inlet pipe (346) and outlet pipe (347) are mounted centrally in the boss (351) in the backing layer (342) above the hollow body (348). The inflation inlet pipe (350) communicates with the interior of the hollow body (348), to permit inflation of the body (348). The inlet pipe (346) extends in a pipe (352) effectively through the hollow body (348). The outlet pipe (347) extends radially immediately under the backing layer (342).
In
In
In all of
Similarly, the outlet pipe (347) effectively collects the fluid radially from the wound periphery when the dressing is in use.
Referring to
This also comprises a generally toroidal conformable hollow body, defined by a membrane (349) which is filled with a fluid, here air or nitrogen, that urges it to the wound shape.
The filler (348) may be permanently attached to the backing layer (342) via a first boss (351) and a layer of foam (364) formed of a suitable material, e.g. a resilient thermoplastic. Again, preferred materials include reticulated filtration polyurethane foams with small apertures or pores.
The first boss (351) and foam layer (364) are respectively heat-sealed to the backing layer (342) and the boss (351).
An inflation inlet pipe (350), inlet pipe (346) and outlet pipe (347) are mounted centrally in the first boss (351) in the backing layer (342) above the toroidal hollow body (348).
The inflation inlet pipe (350), inlet pipe (346) and outlet pipe (347) respectively each extend in a pipe (353), (354) and (355) through a central tunnel (356) in the hollow body (348) to a second boss (357) attached to the toroidal hollow body (348).
The pipe (353) communicates with the interior of the hollow body (348), to permit inflation of the body (348). The pipe (354) extends radially through the second boss (357) to communicate with an inlet manifold (352), formed by a membrane (361) that is permanently attached to the filler (348) by heat-sealing in the form of a reticulated honeycomb with openings (362) that deliver the irrigant fluid directly to the wound bed over an extended area. The pipe (355) collects the fluid flowing radially from the wound centre when the dressing is in use.
This form of the dressing is a more suitable layout for deeper wounds
In
Examples of contents for the body (348) also include gels, such as silicone gels or preferably cellulosic gels, for example hydrophilic cross-linked cellulosic gels, such as Intrasite™ cross-linked materials. Examples also include aerosol foams, and set aerosol foams, e.g. CaviCarer™ foam.
Referring to
This is defined by an upper impervious membrane (361) and a lower porous film (362) with apertures (364) that deliver the irrigant fluid directly from the wound bed over an extended area. A number of configurations of the chamber (363) are shown, all of which are able to conform well to the wound bed by the arms closing in and possibly overlapping in insertion into the wound.
In a particular design of the chamber (363), shown lowermost, on of the arms extended and provided with an inlet port at the end of the extended arm. This provides the opportunity for coupling and decoupling the irrigant supply remote from the dressing and the wound in use.
An inlet pipe (346) and outlet pipe (347) are mounted centrally in a boss (351) in the backing layer (342) above the chamber (363). The inlet pipe (346) is permanently attached to, and communicate with the interior of, the chamber (363), which thus effectively forms an inlet manifold. The space above the chamber (363) is filled with a loose gauze packing (364).
In
A variant of the dressing of
In
In
In
Referring to
In
In
In
Referring to
The device for moving fluid through the wound and means for fluid cleansing (17) in
In the apparatus (1) shown in
The vacuum pump assembly comprises a tank (911) with
The vacuum pump (918) is controlled by a pressure feedback regulator (919) through an electrical line (920), the regulator receiving signals from a tank sensor (921) in the upper part of the tank (911), and a dressing sensor (922) in the wound space respectively via lines (923) and (924).
The operation of the apparatus (1) is similar to that of the apparatus in
The pressure feedback regulator (919) regulates the pressure at the wound and/or the tank (911).
If the amount of fluid in circulation becomes excessive, e.g. because the wound continues to exude heavily, the waste pump (914) may be started to transfer fluid from the lower part of the tank (911) to the waste bag (915).
The use of the apparatus of the present invention will now be described by way of example only in the following Examples:
A single phase circuit essentially as in
Prior to inoculation with the test organism (S aureus NCTC 10788), the wound reservoir was filled with 45 ml sterile MRD (maximum recovery diluent) and then the MRD was inoculated with the test organism to give a final concentration of 104 cfu/ml.
The culture was allowed to pre-circulate around the circuit (bypassing the sterile 0.22 μm filter) prior to being circulated through the filtration device. A sample (0.5 ml) of the pre-circulation fluid was taken from port S1 at 30 and 60 minutes. This was serially diluted in MRD to 10−3 and duplicate 1 ml tryptone soya agar (TSA) plates were repared from each dilution according to a standard validated protocol. Plates were incubated for at least 72 hours at 32° C. prior to counting.
After 1 hour, the fluid was allowed to circulate through the filtration device. 0.5 ml samples of the circulating fluid were taken from ports S1 at T=10, 30, 50 and 70 minutes and S2 at T=0, 20, 40, 60 and 80 minutes. All samples were enumerated as described above.
Results
Conclusions
The single phase system was able to immediately remove bacterial cells from the wound circuit after passing through 0.22 .mu.m filter by approximately 3 logs and cause a gradual reduction in the overall numbers of circulating bacteria.
a) Preparation of an Immobilised Elastase Antagonist—a Conjugate (‘the Inhibitor’) of 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF) with poly(maleic anhydride-alt-methylvinylether), and with 1% 5-(2-aminoethylamino)-1-naphthalenesulfonic acid (EDANS) Fluorescent Tag
To a magnetically stirred solution of MAMVE (1.646 g, 10.5 mmol units) in DMF (100 ml) was added EDANS (30.4 mg, 0.1 mmol) in DMF (2 ml). After 15 minutes, a solution of AEBSF hydrochloride (2.502 g, 10.4 mmol) and triethylamine (1.056 g, 10.4 mmol) in DMF (20 ml) was added dropwise. After 5 h, this solution was precipitated dropwise into 0.5 M HCl (2000 ml), Buchner filtered and washed with 0.5 M HCl. The product was vacuum desiccated to dryness and stored at −4° C. Yield 3.702 g, 98%.
To a magnetically stirred solution of MAMVE (2.000 g, 12.8 mmol units) in DMF (100 ml) was added EDANS (37.0 mg, 0.1 mmol) in DMF (2 ml). After 15 minutes, a solution of phenethylamine (1.537 g, 12.7 mmol) in DMF (10 ml) was added dropwise. After 5 h, this solution was precipitated dropwise into 0.5 M HCl (2000 ml), Buchner filtered and washed with 0.5 M HCl. The product was vacuum desiccated to dryness and stored at room temperature.
Yield 3.426 g, 97%.
b) Elastase Inhibition
A two-phase circuit essentially as in
The cleansing means is a MiCroKros Cross Flow Syringe Filter (Spectrum Labs Inc) PS/400K MWCO 8 cm2, with two separate chambers, any fluid in the outer being held static.
The outer chamber was filled with 2 mg/ml Inhibitor solution (˜1 ml in TRIS) and connected up to the tubing. The inlet and outlet tubing was placed in a TRIS solution and TRIS was flushed through the inner chamber of the MiCoKros syringe and the tubing for 5 mins. The tubing was then emptied. 2 ml of elastase (0.311 mg/ml) was pipetted into the wound circuit.
The tubes were placed in the reservoir and the pump and the timer were started simultaneously.
10 microlitre samples were taken every hour from the wound circuit for six hours and assayed in the following way immediately after sampling. A control of static elastase was assayed at every time point in order to determine the decrease in activity over the 6 hours.
c) Elastase Activity Assay
The elastase substrate N-Succ-(Ala)3-nitronilide was prepared (10 mg/ml in DMSO). 25 microlitre of the N-Succ-(Ala)3-nitronilide (10 mg/ml) was added to 2.475 ml of TRIS in a 4.5 ml capacity disposable cuvette. This mixing was completed 10 mins before the elastase solution was due to be added into the cuvettes (in order to ensure the substrate was mixed well). The 10 microlitre sample was then added to each cuvette and mixed well. The sample was incubated at room temp for 40 mins and the absorbance at 405 nm recorded.
Results and Conclusions
The average of all the elastase control experiments was used to calculate the 100% activity for 0 h.
The results indicate that for the elastase+Tris solution there is a 60-70% drop in activity. This can be explained as a dilution effect as the 2 ml of elastase mix with the 1 ml TRIS in the outer chamber (⅔). This indicates that the system is inert to elastase and the complete mixing/diffusion across the membrane occurs within 3 h.
The elastase+MAMVE-AEBSF within the 6 h shows a 90% drop in elastase activity.
A two-phase circuit essentially as in
The cassette was loaded with one of the following:
Each dialysis cassette was placed in a Slide-A-Lyzer chamber. In this arrangement, the cassette load is separated from the recirculating first fluid by the 10,000 MWCO membrane referred to above.
Transferrin (10 mg/ml, 35 ml volume) was injected into the sample port and circulated around the flow system by a Masterflex pump (Model No. 7523-37) at different flow rates (0.54, 0.82, 1.08 and 1.35 ml/min) for 8 hours.
Samples were collected at 0, 2, 4, 6 and 8 hours.
The iron content of the samples was measured using a ferrozine assay as follows: The sample was mixed with 50 mM acetate buffer, pH 4.8 to liberate iron from transferrin. Ascorbate (30 mM) was added to the sample to reduce released Fe (III) ions to Fe (II) ions. Ferrozine (5 mM) was mixed with the sample forming a coloured complex with Fe (II) ion. The absorbance was measured using UNICAM UV4-100 UV-Vis spectrophotometer V3.32 (serial no. 022405).
Results and Conclusions
Starch-DFO picked up iron from transferrin in a dose dependent manner over 8 hours. Approximately 20-25% iron removal occurred in the presence of 200 mg/ml of starch-DFO after 8 hours recirculation.
In the presence of different concentrations of starch control or PBS the iron content of transferrin dropped slightly due to a dilution effect but then slowly returned to normal, suggesting that iron pick-up by starch-DFO was mediated by DFO alone.
The iron pick-up profile for transferrin was similar at different flow rates suggesting that flow had no effect on iron transfer across the dialysis membrane.
A two-phase circulation system essentially as in
The wound circuit was flushed first with ethanol and then with sterile water as per the manufacturers' instruction. The wound reservoir was filled with 20 ml of sterile water. The wound pump was run at a speed setting of 100, which generated a measured flow rate of 2.09 ml−1 in the wound circuit. The dialysate circuit was flushed first with ethanol and then with sterile water as per the manufacturers instruction. The dialysate reservoir was filled with 20 ml of sterile water. The dialysate pump was run at a speed setting of 100, which generated a measured flow rate of 1.93 ml min−1 in the dialysate circuit. Samples (1 ml) were removed from the wound and the dialysate reservoirs by means of a length of silicone tube with a luer fitting attached to a 2 ml syringe
At the start of the experiment, 5 ml of sterile water was removed from the dialysate reservoir and 5 ml of a 5 mg ml−1 solution of gentamycin sulphate was added (EP standard gentamycin sulphate, CRS; (activity 616 IU mg−1)). Both the wound and the dialysate pumps were started at the same time. Samples were removed from the dialysate circuit and the wound circuit at intervals over 230 minutes. No volumes were replaced during the experiment.
Samples (1 ml) were diluted with 2 ml of sterile water and the UV absorbance at 190 nm was checked to get an approximate measure of the movement of gentamycin from the dialysate circuit to the wound circuit using a previously generated standard curve.
Samples were subsequently analysed with a quantitative zone of inhibition assay for gentamycin activity according to an assay that uses Staphylococcus epidermidis as the indicator bacteria.
Results and Conclusions
The results of the antimicrobial activity-zone of inhibition assays of the fluid show that the level of gentamycin in the wound circuit increases steadily over 230 min with the rate of increase slowing as the levels of drug in the two circuits approach each other. The gentamycin levels in the dialysate circuit show a steady decrease as expected if drug is moving from the dialysate circuit to the wound circuit. At the pressure and flow rates useful in clinical practice, drugs for wound healing can be delivered in acceptable quantities and on an acceptable timescale.
A two-phase circuit essentially as in
Into the internal cavity of separate 15 ml capacity Slide-A-Lyzer cassettes was injected 5 ml of each stock solution:
The cassettes were laid flat and into the upper, outer cavity was aliquoted 15 ml of GSSG stock solution (50 microM GSSG prepared in distilled water (30.6 mg/l). This was circulated around the first phase circuit. The latter was sampled (1 ml) every hour for 6 h in total into 1.5 ml capacity disposable UV cuvettes. At the end of this period, each aliquot was assayed using a Glutathione Assay Kit (from Calbiochem). Triplicates were averaged and SD determined for each data point. These data were plotted as GSSG concentration versus time for each of the three control systems.
Results & Conclusions
GSSG was depleted by the combination of GR and its cofactor NADP to a significantly greater extent than by GR or NADP alone. Thus depletion is not attributable to non-specific binding. Approximately 40% of GSSG was depleted in 6 h at the stated enzyme and cofactor concentrations.
The exchange of extra cellular signalling molecules called auto-inducers is used by bacteria and is essential to the co-ordinatation of the expression of key bacterial virulence genes activated at a critical bacterial cell density, and thus to achieving successful bacterial colonization and invasion of tissue. The system is called Quorum Sensing. Conversely, (usually enzymic) degradation or sequestration of the autoinducer species is one way to disrupt the essential communication and aid the prevention of infection in wounds.
The AiiA enzyme is a degrader of the 3-oxododecylhomoserine lactone signal molecule which is used by S. aureus as an autoinducer.
The AiiA enzyme used is one produced at the University of Nottingham and is bound to a maltose binding protein.
a) Preparation of AiiA Enzyme Bound to a Polymer Support
Cyanogen bromide activated Sepharose 6 MB (from Sigma) (200-300 μm diameter for a higher through-flow rate) were washed in 1 mM hydrochloric acid and allowed to soak and swell for a period of 30 minutes. The gel was washed with multiple volumes of distilled water and then with NaHCO3/NaCl pH 8.5 and used immediately.
The AiiA enzyme solution (approx. 1 mg/ml) was added to the polymer support beads and allowed to stand at 4° C. overnight. The coupled beads were washed with pH 8.5 NaHCO3/NaCl and stored as a slurry. The washings from the beads were also collected in order to determine the amount of uncoupled enzyme and hence the coupling efficiency.
Blank, uncoupled beads were used as a control.
Different amounts of the enzyme coupled beads, 1 mg, 10 mg and 100 mg, are trapped in a chamber defined by two glass frits across a cylindrical glass cylinder with axial inlet and outlet ports for throughflow, which formed the cleansing means in a single phase system, which also has a sample port downstream of a cleansing means. A 10 microM stock of 3-oxododecylhomoserine lactone (ODHSL) is pumped through the chamber at 1.93 ml min−1 and 37° C. for 6 hr.
The circulating fluid is sampled (1 ml) every hour for 6 h in total into 1.5 ml capacity disposable UV cuvettes.
At the end of this period, each aliquot was assayed using the assay of Swift et al. 1997, J. Bacteriol. 179: 5271-5281, which uses bioluminescence-based plasmid reporter systems in E. coli. The 100 mg sample shows an 86% reduction in ODHSL concentration in 6 hours.
| Number | Date | Country | Kind |
|---|---|---|---|
| 0224986.0 | Oct 2002 | GB | national |
This application is a continuation of U.S. application Ser. No. 15/647,111, filed on Jul. 11, 2017, which is a continuation of U.S. application Ser. No. 14/585,786, filed on Dec. 30, 2014, which is a continuation of U.S. application Ser. No. 14/584,274, filed on Dec. 29, 2014, which is a continuation of U.S. application Ser. No. 14/485,633, filed on Sep. 12, 2014, which is a continuation of U.S. application Ser. No. 13/363,320, filed Jan. 31, 2012, and issued as U.S. Pat. No. 8,834,451, which is a divisional of U.S. application Ser. No. 12/416,829, filed Apr. 1, 2009 and issued as U.S. Pat. No. 8,398,614, which is a continuation of U.S. application Ser. No. 10/533,275, filed Nov. 9, 2005 and issued as U.S. Pat. No. 7,524,315, which is the national stage application of PCT/GB03/04647, filed Oct. 28, 2003, which claims priority to GB 0224986.0, filed Oct. 28, 2002. The disclosure of each of these prior applications is incorporated by reference in its entirety and should be considered a part of this specification.
| Number | Name | Date | Kind |
|---|---|---|---|
| 695270 | Beringer | Mar 1902 | A |
| 765746 | Miner | Jul 1904 | A |
| 846674 | Funk | Jul 1907 | A |
| 1066934 | Manney | Jul 1913 | A |
| 1355679 | McConnell | Oct 1920 | A |
| 1355846 | Rannells | Oct 1920 | A |
| 1385346 | Taylor | Jul 1921 | A |
| 1480562 | Mock | Jan 1924 | A |
| 1585104 | Montgomery | May 1926 | A |
| 1732310 | Naibebt et al. | Oct 1929 | A |
| 1863534 | Odell | Jun 1932 | A |
| 1936129 | Fisk et al. | Nov 1933 | A |
| 1975504 | Formhals et al. | Oct 1934 | A |
| 2122121 | Tillotson | Jun 1938 | A |
| 2195771 | Estler | Apr 1940 | A |
| 2232254 | Morqan | Feb 1941 | A |
| 2280915 | Johnson | Apr 1942 | A |
| 2318888 | Sanders | May 1943 | A |
| 2367690 | Purdy | Jul 1943 | A |
| 2338339 | La Mere et al. | Jan 1944 | A |
| 2366799 | Luisada | Jan 1945 | A |
| 2385683 | Burton et al. | Sep 1945 | A |
| 2547758 | Keeling | Apr 1951 | A |
| 2568933 | Robbins | Sep 1951 | A |
| 2632443 | Lesher | Mar 1953 | A |
| 2682873 | Evans et al. | Jul 1954 | A |
| 2910763 | Lauterbach | Aug 1955 | A |
| 2969057 | Simmons | Jan 1961 | A |
| 3026526 | Montrose | Mar 1962 | A |
| 3026874 | Stevens et al. | Mar 1962 | A |
| 3042041 | Jascalevich | Jul 1962 | A |
| 3111948 | Burgeni | Nov 1963 | A |
| 3115138 | McElvenny et al. | Dec 1963 | A |
| 3171410 | Towle, Jr. et al. | Mar 1965 | A |
| 3217707 | Werding | Nov 1965 | A |
| 3238937 | Stein | Mar 1966 | A |
| 3274155 | Saunders et al. | Sep 1966 | A |
| 3286711 | MacLeod | Nov 1966 | A |
| 3288140 | McCarthy | Nov 1966 | A |
| 3315665 | MacLeod | Apr 1967 | A |
| 3334626 | Schimmel | Aug 1967 | A |
| 3364931 | Hirsch | Jan 1968 | A |
| 3367332 | Groves | Feb 1968 | A |
| 3465748 | Kravchenko | Sep 1969 | A |
| 3478736 | Roberts et al. | Nov 1969 | A |
| 3486504 | Austin, Jr. | Dec 1969 | A |
| 3568675 | Harvey | Mar 1971 | A |
| 3572340 | Lloyd et al. | Mar 1971 | A |
| 3610238 | Rich, Jr. | Oct 1971 | A |
| 3624821 | Henderson | Nov 1971 | A |
| 3633567 | Sarnoff | Jan 1972 | A |
| 3646155 | Scott et al. | Feb 1972 | A |
| 3682180 | McFarlane | Aug 1972 | A |
| 3712298 | Snowdon et al. | Jan 1973 | A |
| 3763857 | Schrading et al. | Oct 1973 | A |
| 3783870 | Schachet | Jan 1974 | A |
| 3786801 | Sartorius | Jan 1974 | A |
| 3787882 | Fillmore et al. | Jan 1974 | A |
| 3794035 | Brenner et al. | Feb 1974 | A |
| 3808178 | Gaylord et al. | Apr 1974 | A |
| 3809086 | Schachet et al. | May 1974 | A |
| 3809087 | Lewis, Jr. | May 1974 | A |
| 3826254 | Mellor | Jul 1974 | A |
| 3841331 | Wilder et al. | Oct 1974 | A |
| 3859989 | Spielberg | Jan 1975 | A |
| 3871376 | Kozak | Mar 1975 | A |
| 3871377 | Treace et al. | Mar 1975 | A |
| 3872862 | Hume | Mar 1975 | A |
| 3874387 | Barbieri | Apr 1975 | A |
| 3896810 | Akiyama | Jul 1975 | A |
| 3908642 | Vinmont et al. | Sep 1975 | A |
| 3908664 | Loseff | Sep 1975 | A |
| 3922957 | Ogle et al. | Dec 1975 | A |
| 3928629 | Chandra et al. | Dec 1975 | A |
| 3938540 | Holbrook et al. | Feb 1976 | A |
| 3954105 | Nordby et al. | May 1976 | A |
| 3961625 | Dillon | Jun 1976 | A |
| 3972328 | Chen | Aug 1976 | A |
| 3988793 | Abitbol | Nov 1976 | A |
| 3993080 | Loseff | Nov 1976 | A |
| 4029598 | Neisius et al. | Jun 1977 | A |
| RE29319 | Nordby et al. | Jul 1977 | E |
| 4073294 | Stanley et al. | Feb 1978 | A |
| 4080970 | Miller | Mar 1978 | A |
| 4095599 | Simonet-Haibe | Jun 1978 | A |
| 4102342 | Akiyama et al. | Jul 1978 | A |
| 4112947 | Nehring | Sep 1978 | A |
| 4112949 | Rosenthal et al. | Sep 1978 | A |
| 4117551 | Books et al. | Sep 1978 | A |
| 4136696 | Nehring | Jan 1979 | A |
| 4149541 | Gammons et al. | Apr 1979 | A |
| 4169563 | Leu | Oct 1979 | A |
| 4172455 | Beaussant | Oct 1979 | A |
| 4178938 | Au | Dec 1979 | A |
| 4180074 | Murry et al. | Dec 1979 | A |
| 4184510 | Murry et al. | Jan 1980 | A |
| 4212296 | Schaar | Jul 1980 | A |
| 4217894 | Franetzki | Aug 1980 | A |
| 4219019 | Coates | Aug 1980 | A |
| 4224945 | Cohen | Sep 1980 | A |
| 4228798 | Deaton | Oct 1980 | A |
| 4250882 | Adair | Feb 1981 | A |
| 4252119 | Coates | Feb 1981 | A |
| 4256109 | Nichols | Mar 1981 | A |
| 4261363 | Russo | Apr 1981 | A |
| 4266545 | Moss | May 1981 | A |
| 4275721 | Olson | Jun 1981 | A |
| 4278089 | Huck et al. | Jul 1981 | A |
| 4294240 | Thill | Oct 1981 | A |
| 4297995 | Golub | Nov 1981 | A |
| 4316466 | Babb | Feb 1982 | A |
| 4341207 | Steer et al. | Jul 1982 | A |
| 4360015 | Mayer | Nov 1982 | A |
| 4360021 | Stima | Nov 1982 | A |
| 4366169 | White | Dec 1982 | A |
| 4373519 | Errede et al. | Feb 1983 | A |
| 4382441 | Svedman | May 1983 | A |
| 4392853 | Muto | Jul 1983 | A |
| 4392860 | Huck et al. | Jul 1983 | A |
| 4404924 | Goldberg et al. | Sep 1983 | A |
| 4418691 | Yannas et al. | Dec 1983 | A |
| 4419097 | Rowland | Dec 1983 | A |
| 4421109 | Thornton | Dec 1983 | A |
| 4432354 | Lasley | Feb 1984 | A |
| 4444548 | Andersen et al. | Apr 1984 | A |
| 4459139 | vonReis et al. | Jul 1984 | A |
| 4465485 | Kashmer et al. | Aug 1984 | A |
| 4466431 | Tharrat et al. | Aug 1984 | A |
| 4468227 | Jensen | Aug 1984 | A |
| 4469092 | Marshall et al. | Sep 1984 | A |
| 4475909 | Eisenberg | Oct 1984 | A |
| 4480638 | Schmid | Nov 1984 | A |
| 4499896 | Heinecke | Feb 1985 | A |
| 4508256 | Radel et al. | Apr 1985 | A |
| 4524064 | Nambu | Jun 1985 | A |
| 4525166 | Leclerc | Jun 1985 | A |
| 4527064 | Anderson | Jul 1985 | A |
| 4529402 | Weilbacher et al. | Jul 1985 | A |
| 4529553 | Faltynek | Jul 1985 | A |
| 4534356 | Papadakis | Aug 1985 | A |
| 4538920 | Drake et al. | Sep 1985 | A |
| 4540412 | Van Overloop | Sep 1985 | A |
| 4543100 | Brodsky | Sep 1985 | A |
| 4551141 | McNeil | Nov 1985 | A |
| 4561435 | McKnight et al. | Dec 1985 | A |
| 4568327 | Seufert | Feb 1986 | A |
| 4569674 | Phillips | Feb 1986 | A |
| 4573965 | Russo | Mar 1986 | A |
| 4578060 | Huck et al. | Mar 1986 | A |
| 4587101 | Marsoner et al. | May 1986 | A |
| 4592750 | Kay | Jun 1986 | A |
| 4605399 | Weston et al. | Aug 1986 | A |
| 4608041 | Nielsen | Aug 1986 | A |
| 4624656 | Clark et al. | Nov 1986 | A |
| 4640688 | Hauser | Feb 1987 | A |
| 4643641 | Clausen et al. | Feb 1987 | A |
| 4655202 | Potter et al. | Apr 1987 | A |
| 4655754 | Richmond et al. | Apr 1987 | A |
| 4655766 | Theeuwes et al. | Apr 1987 | A |
| 4657006 | Rawlings et al. | Apr 1987 | A |
| 4661093 | Beck et al. | Apr 1987 | A |
| 4664662 | Webster | May 1987 | A |
| 4681562 | Beck et al. | Jul 1987 | A |
| 4690134 | Snyders | Sep 1987 | A |
| 4699134 | Samuelsen | Oct 1987 | A |
| 4710165 | McNeil et al. | Dec 1987 | A |
| 4713052 | Beck et al. | Dec 1987 | A |
| 4714739 | Arkles | Dec 1987 | A |
| 4738249 | Linman | Apr 1988 | A |
| 4740202 | Stacey | Apr 1988 | A |
| 4743232 | Kruger | May 1988 | A |
| 4753231 | Lang et al. | Jun 1988 | A |
| 4753536 | Spehar et al. | Jun 1988 | A |
| 4759354 | Quarfoot | Jul 1988 | A |
| 4764167 | Tu | Aug 1988 | A |
| 4765316 | Marshall | Aug 1988 | A |
| 4767026 | Keller | Aug 1988 | A |
| 4771919 | Ernst | Sep 1988 | A |
| 4778446 | Jensen | Oct 1988 | A |
| 4778456 | Lokken | Oct 1988 | A |
| 4787888 | Fox | Nov 1988 | A |
| 4792328 | Beck et al. | Dec 1988 | A |
| 4795428 | Hwang | Jan 1989 | A |
| 4795435 | Steer | Jan 1989 | A |
| 4798583 | Beck et al. | Jan 1989 | A |
| 4798603 | Meyer et al. | Jan 1989 | A |
| 4813931 | Hauze | Mar 1989 | A |
| 4813942 | Alvarez | Mar 1989 | A |
| 4817594 | Juhasz | Apr 1989 | A |
| 4820265 | DeSatnick et al. | Apr 1989 | A |
| 4820284 | Hauri | Apr 1989 | A |
| 4826494 | Richmond et al. | May 1989 | A |
| 4828546 | McNeil et al. | May 1989 | A |
| 4834110 | Richard | May 1989 | A |
| 4836192 | Abbate | Jun 1989 | A |
| 4838253 | Brassington et al. | Jun 1989 | A |
| 4838883 | Matsuura | Jun 1989 | A |
| 4840187 | Brazier | Jun 1989 | A |
| 4841961 | Burlage et al. | Jun 1989 | A |
| 4841962 | Berg et al. | Jun 1989 | A |
| 4846164 | Martz | Jul 1989 | A |
| 4851545 | Song et al. | Jul 1989 | A |
| 4863449 | Therriault et al. | Sep 1989 | A |
| 4867150 | Gilbert | Sep 1989 | A |
| 4872450 | Austad | Oct 1989 | A |
| 4875473 | Alvarez | Oct 1989 | A |
| 4878901 | Sachse | Nov 1989 | A |
| 4882213 | Gaddis et al. | Nov 1989 | A |
| 4902277 | Marhies et al. | Feb 1990 | A |
| 4906233 | Moriuchi et al. | Mar 1990 | A |
| 4917112 | Kalt | Apr 1990 | A |
| 4921488 | Maitz et al. | May 1990 | A |
| 4921492 | Schultz | May 1990 | A |
| 4923444 | Daoud et al. | May 1990 | A |
| 4925447 | Rosenblatt | May 1990 | A |
| 4929477 | Will | May 1990 | A |
| 4930997 | Bennett | Jun 1990 | A |
| 4931519 | Song et al. | Jun 1990 | A |
| 4936834 | Beck et al. | Jun 1990 | A |
| 4941882 | Ward et al. | Jul 1990 | A |
| 4950483 | Ksander et al. | Aug 1990 | A |
| 4953565 | Tachibana et al. | Sep 1990 | A |
| 4955893 | Yannas et al. | Sep 1990 | A |
| 4969880 | Zamierowski | Nov 1990 | A |
| 4969881 | Viesturs | Nov 1990 | A |
| 4972829 | Knerr | Nov 1990 | A |
| 4979944 | Luzsicza | Dec 1990 | A |
| 4981474 | Bopp et al. | Jan 1991 | A |
| 4990137 | Graham | Feb 1991 | A |
| 4994022 | Steffler et al. | Feb 1991 | A |
| 4997425 | Shioya et al. | Mar 1991 | A |
| 4997438 | Nipper | Mar 1991 | A |
| 5000164 | Cooper | Mar 1991 | A |
| 5009635 | Scarberry | Apr 1991 | A |
| 5010883 | Rawlings et al. | Apr 1991 | A |
| 5011381 | Neward | Apr 1991 | A |
| 5030202 | Harris | Jul 1991 | A |
| 5033650 | Colin et al. | Jul 1991 | A |
| 5034006 | Hosoda et al. | Jul 1991 | A |
| 5035884 | Song et al. | Jul 1991 | A |
| 5055198 | Shettigar | Oct 1991 | A |
| 5056510 | Gilman | Oct 1991 | A |
| 5064653 | Sessions et al. | Nov 1991 | A |
| 5071409 | Rosenberg | Dec 1991 | A |
| 5073172 | Fell | Dec 1991 | A |
| 5080493 | McKown et al. | Jan 1992 | A |
| 5080661 | Lavender et al. | Jan 1992 | A |
| 5086763 | Hathman | Feb 1992 | A |
| 5086764 | Gilman | Feb 1992 | A |
| 5088483 | Heinecke | Feb 1992 | A |
| 5089606 | Cole et al. | Feb 1992 | A |
| 5100395 | Rosenberg | Mar 1992 | A |
| 5100396 | Zamierowski | Mar 1992 | A |
| 5106362 | Gilman | Apr 1992 | A |
| 5106629 | Cartmell et al. | Apr 1992 | A |
| 5112323 | Winkler et al. | May 1992 | A |
| 5113871 | Viljanto et al. | May 1992 | A |
| 5115472 | Park et al. | May 1992 | A |
| 5115801 | Cartmell et al. | May 1992 | A |
| 5134994 | Say | Aug 1992 | A |
| 5141503 | Sewell, Jr. | Aug 1992 | A |
| 5145933 | Grisoni et al. | Sep 1992 | A |
| 5149331 | Ferdman et al. | Sep 1992 | A |
| 5152757 | Eriksson | Oct 1992 | A |
| 5153231 | Bouquet et al. | Oct 1992 | A |
| 5160315 | Heinecke et al. | Nov 1992 | A |
| 5160322 | Scheremet et al. | Nov 1992 | A |
| 5160328 | Cartmell et al. | Nov 1992 | A |
| 5167613 | Karami et al. | Dec 1992 | A |
| 5176663 | Svedman et al. | Jan 1993 | A |
| 5178157 | Fanlo | Jan 1993 | A |
| 5181905 | Flam | Jan 1993 | A |
| 5184077 | Day et al. | Feb 1993 | A |
| 5195977 | Pollitt | Mar 1993 | A |
| 5197945 | Cole et al. | Mar 1993 | A |
| 5201780 | Dinsmoor et al. | Apr 1993 | A |
| 5215519 | Shettigar | Jun 1993 | A |
| 5215539 | Schoolman | Jun 1993 | A |
| 5218973 | Weaver et al. | Jun 1993 | A |
| 5222714 | Morinigo et al. | Jun 1993 | A |
| 5228431 | Giarretto | Jul 1993 | A |
| 5234419 | Bryant et al. | Aug 1993 | A |
| 5238732 | Krishnan | Aug 1993 | A |
| 5243968 | Byun | Sep 1993 | A |
| 5249709 | Duckworth et al. | Oct 1993 | A |
| 5261893 | Zamierowski | Nov 1993 | A |
| 5263922 | Sova et al. | Nov 1993 | A |
| 5264218 | Rogozinski | Nov 1993 | A |
| 5266928 | Johnson | Nov 1993 | A |
| 5267952 | Gardner | Dec 1993 | A |
| 5279550 | Habib et al. | Jan 1994 | A |
| 5279608 | Cherif Cheikh | Jan 1994 | A |
| 5288431 | Huber et al. | Feb 1994 | A |
| 5307791 | Senoue et al. | May 1994 | A |
| 5322695 | Shah et al. | Jun 1994 | A |
| 5328614 | Matsumura | Jul 1994 | A |
| 5333760 | Simmen et al. | Aug 1994 | A |
| 5336209 | Porzilli | Aug 1994 | A |
| 5336219 | Krantz | Aug 1994 | A |
| 5348392 | Bouquet et al. | Sep 1994 | A |
| 5354261 | Clark et al. | Oct 1994 | A |
| 5358494 | Svedman | Oct 1994 | A |
| 5360398 | Grieshaber et al. | Nov 1994 | A |
| 5360445 | Goldowsky | Nov 1994 | A |
| 5362543 | Nickerson | Nov 1994 | A |
| 5364381 | Soga et al. | Nov 1994 | A |
| 5380280 | Peterson | Jan 1995 | A |
| 5380294 | Persson | Jan 1995 | A |
| 5397848 | Yang et al. | Mar 1995 | A |
| 5419768 | Kayser | May 1995 | A |
| 5419772 | Teitz et al. | May 1995 | A |
| 5425742 | Joy | Jun 1995 | A |
| 5437651 | Todd et al. | Aug 1995 | A |
| 5445604 | Lang | Aug 1995 | A |
| 5447492 | Cartmell et al. | Sep 1995 | A |
| 5456660 | Reich et al. | Oct 1995 | A |
| 5462514 | Harris | Oct 1995 | A |
| D364679 | Heaton et al. | Nov 1995 | S |
| 5466229 | Elson | Nov 1995 | A |
| 5476664 | Robinson et al. | Dec 1995 | A |
| 5480377 | Cartmell et al. | Jan 1996 | A |
| 5484427 | Gibbons | Jan 1996 | A |
| 5486158 | Samuelson | Jan 1996 | A |
| 5487889 | Eckert et al. | Jan 1996 | A |
| 5489280 | Russell | Feb 1996 | A |
| 5489304 | Orgill et al. | Feb 1996 | A |
| 5490984 | Freed | Feb 1996 | A |
| 5492313 | Pan et al. | Feb 1996 | A |
| 5496605 | Augst et al. | Mar 1996 | A |
| 5497788 | Inman et al. | Mar 1996 | A |
| 5498338 | Kruger et al. | Mar 1996 | A |
| 5505210 | Clement | Apr 1996 | A |
| 5527293 | Zamierowski | Jun 1996 | A |
| 5527923 | Klingler et al. | Jun 1996 | A |
| 5531855 | Heinecke et al. | Jul 1996 | A |
| 5536233 | Khouri | Jul 1996 | A |
| 5538500 | Peterson | Jul 1996 | A |
| 5540922 | Fabo | Jul 1996 | A |
| 5549584 | Gross | Aug 1996 | A |
| 5549585 | Maher et al. | Aug 1996 | A |
| 5559538 | Nguyen et al. | Sep 1996 | A |
| 5562107 | Lavender et al. | Oct 1996 | A |
| 5577994 | Celik | Nov 1996 | A |
| 5578317 | Mulder | Nov 1996 | A |
| 5579765 | Cox et al. | Dec 1996 | A |
| 5582596 | Fukunaga et al. | Dec 1996 | A |
| 5588958 | Cunningham et al. | Dec 1996 | A |
| 5593395 | Martz | Jan 1997 | A |
| 5599289 | Castellana | Feb 1997 | A |
| 5603946 | Constantine | Feb 1997 | A |
| 5609271 | Keller et al. | Mar 1997 | A |
| 5616387 | Augst et al. | Apr 1997 | A |
| 5618556 | Johns et al. | Apr 1997 | A |
| 5624423 | Anjur et al. | Apr 1997 | A |
| 5633007 | Webb et al. | May 1997 | A |
| 5636643 | Argenta et al. | Jun 1997 | A |
| 5637080 | Geng | Jun 1997 | A |
| 5643189 | Masini | Jul 1997 | A |
| 5645081 | Argenta et al. | Jul 1997 | A |
| 5645981 | Romanet et al. | Jul 1997 | A |
| 5662599 | Reich et al. | Sep 1997 | A |
| 5676650 | Grieshaber et al. | Oct 1997 | A |
| 5678564 | Lawrence et al. | Oct 1997 | A |
| 5681579 | Freeman | Oct 1997 | A |
| 5688225 | Walker | Nov 1997 | A |
| 5701917 | Khouri | Dec 1997 | A |
| 5702356 | Hathman | Dec 1997 | A |
| 5704905 | Jensen et al. | Jan 1998 | A |
| 5707499 | Joshi et al. | Jan 1998 | A |
| 5713384 | Roach et al. | Feb 1998 | A |
| 5713881 | Rezai et al. | Feb 1998 | A |
| 5714225 | Hansen et al. | Feb 1998 | A |
| 5716411 | Orgill et al. | Feb 1998 | A |
| 5730587 | Snyder et al. | Mar 1998 | A |
| 5733253 | Headley et al. | Mar 1998 | A |
| 5733305 | Fleischmann | Mar 1998 | A |
| 5733337 | Carr et al. | Mar 1998 | A |
| 5759570 | Arnold | Jun 1998 | A |
| 5769608 | Seale | Jun 1998 | A |
| 5778890 | Lofgren et al. | Jul 1998 | A |
| 5779657 | Daneshvar | Jul 1998 | A |
| 5785508 | Bolt | Jul 1998 | A |
| 5785688 | Joshi et al. | Jul 1998 | A |
| 5792090 | Ladin | Aug 1998 | A |
| 5795584 | Totakura et al. | Aug 1998 | A |
| 5810755 | LeVeen et al. | Sep 1998 | A |
| 5810765 | Oda | Sep 1998 | A |
| 5827213 | Jensen | Oct 1998 | A |
| 5827246 | Bowen | Oct 1998 | A |
| 5830176 | Mackool | Nov 1998 | A |
| 5830198 | Henniges et al. | Nov 1998 | A |
| 5830496 | Freeman | Nov 1998 | A |
| 5833646 | Masini | Nov 1998 | A |
| 5840049 | Tumey et al. | Nov 1998 | A |
| 5840052 | Johns | Nov 1998 | A |
| 5840777 | Eagles et al. | Nov 1998 | A |
| 5843011 | Lucas | Dec 1998 | A |
| 5843025 | Shaari | Dec 1998 | A |
| 5857502 | Buchalter | Jan 1999 | A |
| 5868933 | Patrick et al. | Feb 1999 | A |
| 5874500 | Rhee et al. | Feb 1999 | A |
| D406899 | Cottle | Mar 1999 | S |
| 5876611 | Shettigar | Mar 1999 | A |
| 5885237 | Kadash et al. | Mar 1999 | A |
| 5893368 | Sugerman | Apr 1999 | A |
| 5893862 | Pratt et al. | Apr 1999 | A |
| 5897296 | Yamamoto et al. | Apr 1999 | A |
| 5897541 | Uitenbrock et al. | Apr 1999 | A |
| 5899893 | Dyer et al. | May 1999 | A |
| 5904659 | Duarte | May 1999 | A |
| 5910125 | Cummings et al. | Jun 1999 | A |
| 5911222 | Lawrence et al. | Jun 1999 | A |
| 5928265 | Fleischmann | Jul 1999 | A |
| 5938626 | Sugerman | Aug 1999 | A |
| 5941859 | Lerman | Aug 1999 | A |
| 5944703 | Dixon et al. | Aug 1999 | A |
| 5954680 | Augustine | Sep 1999 | A |
| 5958420 | Jenson | Sep 1999 | A |
| 5964723 | Augustine | Oct 1999 | A |
| 5970266 | Takato | Oct 1999 | A |
| 5981822 | Addison | Nov 1999 | A |
| 5985990 | Kantner et al. | Nov 1999 | A |
| 6010524 | Fleischmann | Jan 2000 | A |
| 6011194 | Buglino et al. | Jan 2000 | A |
| 6024731 | Seddon et al. | Feb 2000 | A |
| 6040493 | Cooke et al. | Mar 2000 | A |
| 6045541 | Matsumoto et al. | Apr 2000 | A |
| 6068588 | Goldowsky | May 2000 | A |
| 6071247 | Kennedy | Jun 2000 | A |
| 6071267 | Zamierowski | Jun 2000 | A |
| 6075177 | Bahia et al. | Jun 2000 | A |
| 6087549 | Flick | Jul 2000 | A |
| 6102680 | Fraser et al. | Aug 2000 | A |
| 6103951 | Freeman | Aug 2000 | A |
| 6110197 | Augustine et al. | Aug 2000 | A |
| D430674 | Dunshee et al. | Sep 2000 | S |
| 6113548 | deBoisblanc et al. | Sep 2000 | A |
| 6117111 | Fleischmann | Sep 2000 | A |
| 6117444 | Orgill et al. | Sep 2000 | A |
| 6124520 | Roberts | Sep 2000 | A |
| 6124521 | Roberts | Sep 2000 | A |
| 6135116 | Vogel et al. | Oct 2000 | A |
| 6135166 | Paradies et al. | Oct 2000 | A |
| D434150 | Tumey et al. | Nov 2000 | S |
| 6142982 | Hunt et al. | Nov 2000 | A |
| 6156334 | Meyer-Ingold et al. | Dec 2000 | A |
| 6159160 | Hsei et al. | Dec 2000 | A |
| 6168758 | Forsberg et al. | Jan 2001 | B1 |
| 6168800 | Dobos et al. | Jan 2001 | B1 |
| 6174306 | Fleischmann | Jan 2001 | B1 |
| 6176307 | Danos et al. | Jan 2001 | B1 |
| D439341 | Tumey et al. | Mar 2001 | S |
| 6201164 | Wulff et al. | Mar 2001 | B1 |
| 6203563 | Fernandez | Mar 2001 | B1 |
| 6225523 | Masini | May 2001 | B1 |
| 6227825 | Vay | May 2001 | B1 |
| 6231310 | Tojo et al. | May 2001 | B1 |
| 6249198 | Clark et al. | Jun 2001 | B1 |
| 6250005 | Richards | Jun 2001 | B1 |
| 6252129 | Coffee | Jun 2001 | B1 |
| 6254567 | Treu et al. | Jul 2001 | B1 |
| 6255552 | Cummings et al. | Jul 2001 | B1 |
| 6261276 | Reitsma | Jul 2001 | B1 |
| 6261283 | Morgan et al. | Jul 2001 | B1 |
| 6268544 | Court et al. | Jul 2001 | B1 |
| 6287521 | Quay et al. | Sep 2001 | B1 |
| 6291050 | Cree et al. | Sep 2001 | B1 |
| 6293281 | Shultz et al. | Sep 2001 | B1 |
| 6297423 | Schoenfeldt et al. | Oct 2001 | B1 |
| 6323568 | Zabar | Nov 2001 | B1 |
| 6325788 | McKay | Dec 2001 | B1 |
| 6333093 | Burrell et al. | Dec 2001 | B1 |
| 6345623 | Heaton et al. | Feb 2002 | B1 |
| 6348423 | Griffiths et al. | Feb 2002 | B1 |
| 6350339 | Sessions | Feb 2002 | B1 |
| 6362390 | Carlucci et al. | Mar 2002 | B1 |
| 6368311 | Valerio | Apr 2002 | B1 |
| 6371976 | Vrzalik | Apr 2002 | B1 |
| 6383163 | Kelly et al. | May 2002 | B1 |
| 6391294 | Dettmar et al. | May 2002 | B1 |
| 6398761 | Bills et al. | Jun 2002 | B1 |
| 6398767 | Fleischmann | Jun 2002 | B1 |
| 6402724 | Smith et al. | Jun 2002 | B1 |
| 6406447 | Thrash et al. | Jun 2002 | B1 |
| 6413057 | Hong et al. | Jul 2002 | B1 |
| 6420622 | Johnston et al. | Jul 2002 | B1 |
| 6440167 | Shimizu | Aug 2002 | B2 |
| 6450773 | Upton | Sep 2002 | B1 |
| 6458109 | Henley et al. | Oct 2002 | B1 |
| 6465708 | Augustine | Oct 2002 | B1 |
| 6468199 | Satou et al. | Oct 2002 | B1 |
| 6468295 | Augustine et al. | Oct 2002 | B2 |
| 6471685 | Johnson | Oct 2002 | B1 |
| 6471982 | Lydon et al. | Oct 2002 | B1 |
| 6482491 | Samuelsen et al. | Nov 2002 | B1 |
| 6486285 | Fujita | Nov 2002 | B2 |
| 6488643 | Tumey et al. | Dec 2002 | B1 |
| 6491684 | Joshi et al. | Dec 2002 | B1 |
| 6495127 | Wallace et al. | Dec 2002 | B1 |
| 6500112 | Khouri | Dec 2002 | B1 |
| D469175 | Hall et al. | Jan 2003 | S |
| D469176 | Hall et al. | Jan 2003 | S |
| 6506175 | Goldstein | Jan 2003 | B1 |
| 6514047 | Burr et al. | Feb 2003 | B2 |
| 6520982 | Boynton et al. | Feb 2003 | B1 |
| 6527203 | Hurray et al. | Mar 2003 | B2 |
| 6527745 | Kanda et al. | Mar 2003 | B1 |
| 6528696 | Ireland | Mar 2003 | B1 |
| 6536056 | Vrzalik et al. | Mar 2003 | B1 |
| 6540490 | Lilie | Apr 2003 | B1 |
| 6548730 | Patel et al. | Apr 2003 | B1 |
| 6553998 | Heaton et al. | Apr 2003 | B2 |
| D475134 | Randolph | May 2003 | S |
| 6557704 | Randolph | May 2003 | B1 |
| 6564972 | Sawhney et al. | May 2003 | B2 |
| 6566833 | Bartlett | May 2003 | B2 |
| 6569113 | Wirt et al. | May 2003 | B2 |
| 6571825 | Stacy | Jun 2003 | B2 |
| 6586653 | Graeme, III et al. | Jul 2003 | B2 |
| 6589028 | Eckerbom et al. | Jul 2003 | B1 |
| 6595949 | Shapiro | Jul 2003 | B1 |
| 6599262 | Masini | Jul 2003 | B1 |
| D478659 | Hall et al. | Aug 2003 | S |
| 6604908 | Bryant et al. | Aug 2003 | B1 |
| 6607495 | Skalak et al. | Aug 2003 | B1 |
| 6613953 | Altura | Sep 2003 | B1 |
| 6618221 | Gillis et al. | Sep 2003 | B2 |
| 6623255 | Joong et al. | Sep 2003 | B2 |
| 6626827 | Felix et al. | Sep 2003 | B1 |
| 6626891 | Ohmstede | Sep 2003 | B2 |
| 6629774 | Guruendeman | Oct 2003 | B1 |
| 6638035 | Puff | Oct 2003 | B1 |
| 6648862 | Watson | Nov 2003 | B2 |
| 6673028 | Argenta et al. | Jan 2004 | B1 |
| 6673029 | Watson | Jan 2004 | B1 |
| 6676610 | Morton et al. | Jan 2004 | B2 |
| 6680113 | Lucast et al. | Jan 2004 | B1 |
| 6685681 | Lockwood et al. | Feb 2004 | B2 |
| 6695823 | Lina et al. | Feb 2004 | B1 |
| 6695824 | Howard et al. | Feb 2004 | B2 |
| 6706940 | Worthley | Mar 2004 | B2 |
| D488558 | Hall | Apr 2004 | S |
| 6719742 | McCormack et al. | Apr 2004 | B1 |
| 6730299 | Tayot et al. | May 2004 | B1 |
| 6732887 | Bills | May 2004 | B2 |
| 6752794 | Lockwood et al. | Jun 2004 | B2 |
| 6755807 | Risk et al. | Jun 2004 | B2 |
| 6762337 | Boukanov et al. | Jul 2004 | B2 |
| 6764459 | Donaldson | Jul 2004 | B1 |
| 6764462 | Risk, Jr. et al. | Jul 2004 | B2 |
| 6767334 | Randolph | Jul 2004 | B1 |
| 6775807 | Lowther et al. | Aug 2004 | B2 |
| 6787682 | Gilman | Sep 2004 | B2 |
| 6794554 | Sessions et al. | Sep 2004 | B2 |
| 6797855 | Worthley | Sep 2004 | B2 |
| 6800074 | Henley et al. | Oct 2004 | B2 |
| 6814079 | Heaton et al. | Nov 2004 | B2 |
| 6820766 | Keller et al. | Nov 2004 | B2 |
| 6823905 | Smith et al. | Nov 2004 | B1 |
| 6824533 | Risk, Jr. et al. | Nov 2004 | B2 |
| 6838589 | Liedtke et al. | Jan 2005 | B2 |
| 6855135 | Lockwood et al. | Feb 2005 | B2 |
| 6855860 | Ruszczak et al. | Feb 2005 | B2 |
| 6856821 | Johnson | Feb 2005 | B2 |
| 6887228 | McKay | May 2005 | B2 |
| 6887263 | Bleam et al. | May 2005 | B2 |
| 6904631 | Vrzalik et al. | Jun 2005 | B2 |
| 6936037 | Bubb et al. | Aug 2005 | B2 |
| 6942628 | Watson | Sep 2005 | B1 |
| 6942633 | Odland | Sep 2005 | B2 |
| 6942634 | Odland | Sep 2005 | B2 |
| 6945987 | Beard et al. | Sep 2005 | B2 |
| 6951553 | Bubb et al. | Oct 2005 | B2 |
| 6960179 | Gura | Nov 2005 | B2 |
| 6960181 | Stevens | Nov 2005 | B2 |
| 6966901 | Leisner et al. | Nov 2005 | B2 |
| 6974428 | Knutson et al. | Dec 2005 | B2 |
| 6977323 | Swenson | Dec 2005 | B1 |
| 6979324 | Bybordi et al. | Dec 2005 | B2 |
| 6988423 | Bolam et al. | Jan 2006 | B2 |
| 6994702 | Johnson | Feb 2006 | B1 |
| 6998511 | Worthley | Feb 2006 | B2 |
| 7004915 | Boynton et al. | Feb 2006 | B2 |
| 7005556 | Becker et al. | Feb 2006 | B1 |
| 7022113 | Lockwood et al. | Apr 2006 | B2 |
| 7030288 | Liedtke et al. | Apr 2006 | B2 |
| 7037254 | O'Connor et al. | May 2006 | B2 |
| 7041868 | Greene et al. | May 2006 | B2 |
| 7048706 | Cea | May 2006 | B2 |
| 7048951 | Seitz et al. | May 2006 | B1 |
| 7049478 | Smith et al. | May 2006 | B1 |
| 7052167 | Vanderschuit | May 2006 | B2 |
| 7067709 | Murata et al. | Jun 2006 | B2 |
| 7070584 | Johnson et al. | Jul 2006 | B2 |
| 7077832 | Fleischmann | Jul 2006 | B2 |
| 7087806 | Scheinberg et al. | Aug 2006 | B2 |
| 7087807 | Stapf | Aug 2006 | B2 |
| 7108683 | Zamierowski | Sep 2006 | B2 |
| 7117869 | Heaton et al. | Oct 2006 | B2 |
| 7118545 | Boyde | Oct 2006 | B2 |
| 7128719 | Rosenberg | Oct 2006 | B2 |
| 7128735 | Weston | Oct 2006 | B2 |
| 7132170 | Parker | Nov 2006 | B2 |
| 7137968 | Burrell et al. | Nov 2006 | B1 |
| 7141714 | Nielsen | Nov 2006 | B2 |
| 7144390 | Hannigan et al. | Dec 2006 | B1 |
| 7151348 | Ueda et al. | Dec 2006 | B1 |
| 7169151 | Lytinas | Jan 2007 | B1 |
| 7175336 | Voellmicke et al. | Feb 2007 | B2 |
| 7182085 | Larsen et al. | Feb 2007 | B1 |
| 7182758 | McCraw | Feb 2007 | B2 |
| 7195624 | Lockwood | Mar 2007 | B2 |
| 7198046 | Argenta et al. | Apr 2007 | B1 |
| 7211060 | Talish et al. | May 2007 | B1 |
| 7214202 | Vogel et al. | May 2007 | B1 |
| 7216651 | Argenta et al. | May 2007 | B2 |
| D544092 | Lewis | Jun 2007 | S |
| 7238850 | Shimanuki | Jul 2007 | B2 |
| 7273054 | Heaton et al. | Sep 2007 | B2 |
| 7276051 | Henley et al. | Oct 2007 | B1 |
| 7279612 | Heaton et al. | Oct 2007 | B1 |
| 7291762 | Flick | Nov 2007 | B2 |
| 7294751 | Propp et al. | Nov 2007 | B2 |
| 7294752 | Propp | Nov 2007 | B1 |
| 7316672 | Hunt et al. | Jan 2008 | B1 |
| 7322971 | Shehada | Jan 2008 | B2 |
| 7335809 | Riesinger | Feb 2008 | B2 |
| D565177 | Locke et al. | Mar 2008 | S |
| 7338482 | Lockwood et al. | Mar 2008 | B2 |
| 7351250 | Zamierowski | Apr 2008 | B2 |
| 7361184 | Joshi | Apr 2008 | B2 |
| 7374409 | Kawamura | May 2008 | B2 |
| 7381211 | Zamierowski | Jun 2008 | B2 |
| 7381859 | Hunt et al. | Jun 2008 | B2 |
| 7396345 | Knighton et al. | Jul 2008 | B2 |
| 7401703 | McMichael et al. | Jul 2008 | B2 |
| 7410495 | Zamierowski | Aug 2008 | B2 |
| 7413570 | Zamierowski | Aug 2008 | B2 |
| 7413571 | Zamierowski | Aug 2008 | B2 |
| 7422576 | Boynton et al. | Sep 2008 | B2 |
| 7429689 | Chen et al. | Sep 2008 | B2 |
| 7438705 | Karpowicz et al. | Oct 2008 | B2 |
| 7447327 | Kitamura et al. | Nov 2008 | B2 |
| 7470830 | Sigurjonsson et al. | Dec 2008 | B2 |
| 7476205 | Erdmann | Jan 2009 | B2 |
| 7485112 | Karpowicz et al. | Feb 2009 | B2 |
| 7494482 | Orgill et al. | Feb 2009 | B2 |
| 7503910 | Adahan | Mar 2009 | B2 |
| 7507870 | Nielsen et al. | Mar 2009 | B2 |
| 7511187 | Kelly | Mar 2009 | B2 |
| 7518031 | Liedtke et al. | Apr 2009 | B2 |
| 7524286 | Johnson | Apr 2009 | B2 |
| 7524315 | Blott et al. | Apr 2009 | B2 |
| 7534240 | Johnson | May 2009 | B1 |
| 7534927 | Lockwood | May 2009 | B2 |
| 7540848 | Hannigan et al. | Jun 2009 | B2 |
| 7553306 | Hunt et al. | Jun 2009 | B1 |
| 7563940 | Kurata | Jul 2009 | B2 |
| 7569742 | Haggstrom et al. | Aug 2009 | B2 |
| 7576256 | Björnberg et al. | Aug 2009 | B2 |
| 7601129 | Aali | Oct 2009 | B2 |
| 7605298 | Bechert et al. | Oct 2009 | B2 |
| 7611500 | Lina et al. | Nov 2009 | B1 |
| 7612247 | Oyaski | Nov 2009 | B2 |
| 7615036 | Joshi et al. | Nov 2009 | B2 |
| 7622629 | Aail | Nov 2009 | B2 |
| 7625362 | Boehringer et al. | Dec 2009 | B2 |
| 7629384 | Fossel | Dec 2009 | B2 |
| 7645253 | Gura et al. | Jan 2010 | B2 |
| 7645269 | Zamierowski | Jan 2010 | B2 |
| 7670323 | Hunt et al. | Mar 2010 | B2 |
| 7674837 | Gaserod et al. | Mar 2010 | B2 |
| 7678090 | Risk, Jr. | Mar 2010 | B2 |
| 7678102 | Heaton | Mar 2010 | B1 |
| 7686785 | Boehringer et al. | Mar 2010 | B2 |
| 7699823 | Haggstrom et al. | Apr 2010 | B2 |
| 7699830 | Martin | Apr 2010 | B2 |
| 7700819 | Ambrosio et al. | Apr 2010 | B2 |
| 7708724 | Weston | May 2010 | B2 |
| 7708940 | Grunwald et al. | May 2010 | B2 |
| 7717313 | Criscuolo et al. | May 2010 | B2 |
| 7718249 | Russell et al. | May 2010 | B2 |
| 7722582 | Lina et al. | May 2010 | B2 |
| 7723560 | Lockwood et al. | May 2010 | B2 |
| 7723561 | Propp | May 2010 | B2 |
| 7731702 | Bybordi et al. | Jun 2010 | B2 |
| 7745681 | Ferguson | Jun 2010 | B1 |
| 7749531 | Booher | Jul 2010 | B2 |
| 7753894 | Blott et al. | Jul 2010 | B2 |
| 7758554 | Lina et al. | Jul 2010 | B2 |
| 7759537 | Bishop et al. | Jul 2010 | B2 |
| 7759538 | Fleischmann | Jul 2010 | B2 |
| 7759539 | Shaw et al. | Jul 2010 | B2 |
| 7763000 | Risk, Jr. et al. | Jul 2010 | B2 |
| 7775998 | Riesinger | Aug 2010 | B2 |
| 7776028 | Miller et al. | Aug 2010 | B2 |
| 7779625 | Joshi et al. | Aug 2010 | B2 |
| 7785247 | Tatum et al. | Aug 2010 | B2 |
| 7790945 | Watson, Jr. | Sep 2010 | B1 |
| 7790946 | Mulligan | Sep 2010 | B2 |
| 7794438 | Henley et al. | Sep 2010 | B2 |
| 7794450 | Blott et al. | Sep 2010 | B2 |
| 7803980 | Griffiths et al. | Sep 2010 | B2 |
| 7811269 | Boynton et al. | Oct 2010 | B2 |
| 7815616 | Boehringer et al. | Oct 2010 | B2 |
| 7816577 | Aali | Oct 2010 | B2 |
| 7825289 | Vess | Nov 2010 | B2 |
| 7828782 | Suzuki | Nov 2010 | B2 |
| 7838716 | de Luis et al. | Nov 2010 | B2 |
| 7838717 | Haggstrom et al. | Nov 2010 | B2 |
| 7846141 | Weston | Dec 2010 | B2 |
| 7857806 | Karpowicz et al. | Dec 2010 | B2 |
| 7858838 | Holm et al. | Dec 2010 | B2 |
| 7862339 | Mulligan | Jan 2011 | B2 |
| 7867206 | Lockwood et al. | Jan 2011 | B2 |
| 7880050 | Robinson et al. | Feb 2011 | B2 |
| 7882983 | Reidt et al. | Feb 2011 | B2 |
| 7883494 | Martin | Feb 2011 | B2 |
| 7884258 | Boehringer et al. | Feb 2011 | B2 |
| 7896823 | Mangrum et al. | Mar 2011 | B2 |
| 7896856 | Petrosenko et al. | Mar 2011 | B2 |
| 7896864 | Lockwood et al. | Mar 2011 | B2 |
| 7909805 | Weston | Mar 2011 | B2 |
| 7910789 | Sinyagin | Mar 2011 | B2 |
| 7910791 | Coffey | Mar 2011 | B2 |
| 7922703 | Riesinger | Apr 2011 | B2 |
| 7927318 | Risk, Jr. et al. | Apr 2011 | B2 |
| 7927319 | Lawhorn | Apr 2011 | B2 |
| 7931630 | Nishtala et al. | Apr 2011 | B2 |
| 7935066 | Shives et al. | May 2011 | B2 |
| 7959624 | Riesinger | Jun 2011 | B2 |
| 7964766 | Blott et al. | Jun 2011 | B2 |
| 7976519 | Bubb et al. | Jul 2011 | B2 |
| D642594 | Mattson et al. | Aug 2011 | S |
| 7988673 | Wright et al. | Aug 2011 | B2 |
| 7988680 | Lockwood et al. | Aug 2011 | B2 |
| 7998125 | Weston | Aug 2011 | B2 |
| 8007257 | Heaton et al. | Aug 2011 | B2 |
| 8012169 | Joshi | Sep 2011 | B2 |
| 8021347 | Vitaris et al. | Sep 2011 | B2 |
| 8025650 | Anderson et al. | Sep 2011 | B2 |
| 8034037 | Adams et al. | Oct 2011 | B2 |
| 8034038 | Biggie et al. | Oct 2011 | B2 |
| 8062272 | Weston | Nov 2011 | B2 |
| 8062273 | Weston | Nov 2011 | B2 |
| 8062331 | Zamierowski | Nov 2011 | B2 |
| 8070773 | Zamierowski | Dec 2011 | B2 |
| 8080702 | Blott et al. | Dec 2011 | B2 |
| 8084663 | Watson, Jr. | Dec 2011 | B2 |
| 8092436 | Christensen | Jan 2012 | B2 |
| 8096979 | Lina et al. | Jan 2012 | B2 |
| 8100887 | Weston et al. | Jan 2012 | B2 |
| 8105295 | Blott et al. | Jan 2012 | B2 |
| 8118794 | Weston et al. | Feb 2012 | B2 |
| 8123781 | Zamierowski | Feb 2012 | B2 |
| 8128615 | Blott et al. | Mar 2012 | B2 |
| 8133211 | Cavanaugh, II et al. | Mar 2012 | B2 |
| 8147468 | Barta et al. | Apr 2012 | B2 |
| 8152785 | Vitaris | Apr 2012 | B2 |
| 8158844 | McNeil | Apr 2012 | B2 |
| 8162907 | Heagle | Apr 2012 | B2 |
| 8162909 | Blott et al. | Apr 2012 | B2 |
| 8167869 | Wudyka | May 2012 | B2 |
| 8168848 | Lockwood et al. | May 2012 | B2 |
| 8186978 | Tinholt et al. | May 2012 | B2 |
| 8188331 | Barta et al. | May 2012 | B2 |
| 8192409 | Hardman et al. | Jun 2012 | B2 |
| 8202261 | Kazala, Jr. et al. | Jun 2012 | B2 |
| 8207392 | Haggstrom et al. | Jun 2012 | B2 |
| 8211071 | Mormino et al. | Jul 2012 | B2 |
| 8212101 | Propp | Jul 2012 | B2 |
| 8215929 | Shen et al. | Jul 2012 | B2 |
| 8235955 | Blott et al. | Aug 2012 | B2 |
| 8241015 | Lillie | Aug 2012 | B2 |
| 8241261 | Randolph et al. | Aug 2012 | B2 |
| 8246592 | Lockwood et al. | Aug 2012 | B2 |
| 8251979 | Malhi | Aug 2012 | B2 |
| 8252971 | Aali et al. | Aug 2012 | B2 |
| 8257326 | Vitaris | Sep 2012 | B2 |
| 8257327 | Blott et al. | Sep 2012 | B2 |
| 8257328 | Augustine et al. | Sep 2012 | B2 |
| 8267908 | Coulthard | Sep 2012 | B2 |
| 8282611 | Weston | Oct 2012 | B2 |
| 8294586 | Pidgeon et al. | Oct 2012 | B2 |
| 8298200 | Vess et al. | Oct 2012 | B2 |
| 8303552 | Weston | Nov 2012 | B2 |
| 8308714 | Weston et al. | Nov 2012 | B2 |
| 8314283 | Kingsford et al. | Nov 2012 | B2 |
| 8323264 | Weston et al. | Dec 2012 | B2 |
| 8328858 | Barsky et al. | Dec 2012 | B2 |
| 8338402 | Fry et al. | Dec 2012 | B2 |
| 8348910 | Blott et al. | Jan 2013 | B2 |
| 8357188 | Boynton et al. | Jan 2013 | B2 |
| 8366692 | Weston | Feb 2013 | B2 |
| 8372049 | Jaeb et al. | Feb 2013 | B2 |
| 8372050 | Jaeb et al. | Feb 2013 | B2 |
| 8382731 | Johannison | Feb 2013 | B2 |
| 8398614 | Blott et al. | Mar 2013 | B2 |
| 8399730 | Kazala, Jr. et al. | Mar 2013 | B2 |
| 8403899 | Sherman | Mar 2013 | B2 |
| 8404921 | Lee et al. | Mar 2013 | B2 |
| D679819 | Peron | Apr 2013 | S |
| D679820 | Peron | Apr 2013 | S |
| 8425478 | Olson | Apr 2013 | B2 |
| 8444612 | Patel et al. | May 2013 | B2 |
| 8449509 | Weston | May 2013 | B2 |
| 8460255 | Joshi et al. | Jun 2013 | B2 |
| 8494349 | Gordon | Jul 2013 | B2 |
| 8529548 | Blott et al. | Sep 2013 | B2 |
| 8529578 | Daniels et al. | Sep 2013 | B2 |
| 8535283 | Heaton et al. | Sep 2013 | B2 |
| 8535296 | Blott et al. | Sep 2013 | B2 |
| 8540699 | Miller et al. | Sep 2013 | B2 |
| D692565 | Lattimore et al. | Oct 2013 | S |
| 8545464 | Weston | Oct 2013 | B2 |
| 8551061 | Hartwell | Oct 2013 | B2 |
| 8556871 | Mormino et al. | Oct 2013 | B2 |
| 8569566 | Blott et al. | Oct 2013 | B2 |
| 8613734 | Lina et al. | Dec 2013 | B2 |
| 8628505 | Weston | Jan 2014 | B2 |
| 8641691 | Fink | Feb 2014 | B2 |
| 8663198 | Buan et al. | Mar 2014 | B2 |
| 8663200 | Weston et al. | Mar 2014 | B2 |
| 8679079 | Heaton et al. | Mar 2014 | B2 |
| 8680360 | Greener et al. | Mar 2014 | B2 |
| 8708998 | Weston et al. | Apr 2014 | B2 |
| 8715256 | Greener | May 2014 | B2 |
| 8747887 | Coffey | Jun 2014 | B2 |
| 8758313 | Blott et al. | Jun 2014 | B2 |
| 8764732 | Hartwell | Jul 2014 | B2 |
| 8791315 | Lattimore et al. | Jul 2014 | B2 |
| 8791316 | Greener | Jul 2014 | B2 |
| 8795243 | Weston | Aug 2014 | B2 |
| 8795247 | Bennett et al. | Aug 2014 | B2 |
| 8808274 | Hartwell | Aug 2014 | B2 |
| 8814842 | Coulthard et al. | Aug 2014 | B2 |
| 8834451 | Blott et al. | Sep 2014 | B2 |
| 8843327 | Vernon-Harcourt et al. | Sep 2014 | B2 |
| 8845619 | Blott et al. | Sep 2014 | B2 |
| 8852170 | Weston et al. | Oct 2014 | B2 |
| 8864748 | Coulthard et al. | Oct 2014 | B2 |
| 8882746 | Blott et al. | Nov 2014 | B2 |
| 8905985 | Allen et al. | Dec 2014 | B2 |
| 8915896 | Sanders et al. | Dec 2014 | B2 |
| 8926592 | Blott et al. | Jan 2015 | B2 |
| 8951235 | Allen et al. | Feb 2015 | B2 |
| 8998866 | Hicks | Apr 2015 | B2 |
| 9033942 | Vess | May 2015 | B2 |
| 9061095 | Adie et al. | Jun 2015 | B2 |
| 9067003 | Buan et al. | Jun 2015 | B2 |
| 9084845 | Adie et al. | Jul 2015 | B2 |
| 9107998 | Pratt et al. | Aug 2015 | B2 |
| 9127665 | Locke et al. | Sep 2015 | B2 |
| 9205001 | Blott et al. | Dec 2015 | B2 |
| 9375353 | Vitaris et al. | Jun 2016 | B2 |
| 20010000795 | Bolian, II et al. | May 2001 | A1 |
| 20010001278 | Drevet | May 2001 | A1 |
| 20010004082 | Keller et al. | Jun 2001 | A1 |
| 20010018072 | Unger | Aug 2001 | A1 |
| 20010020145 | Satterfield et al. | Sep 2001 | A1 |
| 20010027285 | Heinecke et al. | Oct 2001 | A1 |
| 20010029956 | Argenta | Oct 2001 | A1 |
| 20010031943 | Urie | Oct 2001 | A1 |
| 20010033795 | Humpheries | Oct 2001 | A1 |
| 20010034499 | Sessions et al. | Oct 2001 | A1 |
| 20010037810 | Fine et al. | Nov 2001 | A1 |
| 20010043870 | Song | Nov 2001 | A1 |
| 20010043943 | Coffey | Nov 2001 | A1 |
| 20010051178 | Blatchford et al. | Dec 2001 | A1 |
| 20020002209 | Mork | Jan 2002 | A1 |
| 20020010299 | Guyuron et al. | Jan 2002 | A1 |
| 20020016570 | Cartledge | Feb 2002 | A1 |
| 20020016577 | Ohmstede | Feb 2002 | A1 |
| 20020019602 | Geng | Feb 2002 | A1 |
| 20020038826 | Hurray et al. | Apr 2002 | A1 |
| 20020040687 | van Der Lely et al. | Apr 2002 | A1 |
| 20020068913 | Fleischmann | Jun 2002 | A1 |
| 20020082566 | Stenzler | Jun 2002 | A1 |
| 20020082567 | Lockwood et al. | Jun 2002 | A1 |
| 20020110672 | Muratore-Pallatino et al. | Aug 2002 | A1 |
| 20020114847 | Peshoff | Aug 2002 | A1 |
| 20020122732 | Oh et al. | Sep 2002 | A1 |
| 20020138036 | Babaev | Sep 2002 | A1 |
| 20020143286 | Tumey | Oct 2002 | A1 |
| 20020145007 | Sawhney et al. | Oct 2002 | A1 |
| 20020146662 | Radl et al. | Oct 2002 | A1 |
| 20020151836 | Burden | Oct 2002 | A1 |
| 20020161346 | Lockwood et al. | Oct 2002 | A1 |
| 20020164255 | Burr et al. | Nov 2002 | A1 |
| 20020169405 | Roberts | Nov 2002 | A1 |
| 20020183702 | Henley et al. | Dec 2002 | A1 |
| 20020193721 | Vandruff | Dec 2002 | A1 |
| 20020198490 | Wirt et al. | Dec 2002 | A1 |
| 20020198504 | Risk et al. | Dec 2002 | A1 |
| 20030009122 | Veras | Jan 2003 | A1 |
| 20030014022 | Lockwood et al. | Jan 2003 | A1 |
| 20030014025 | Allen et al. | Jan 2003 | A1 |
| 20030021775 | Freeman | Jan 2003 | A1 |
| 20030035743 | Lee et al. | Feb 2003 | A1 |
| 20030040687 | Boynton et al. | Feb 2003 | A1 |
| 20030045825 | Etheredge, III | Mar 2003 | A1 |
| 20030050590 | Kirsch | Mar 2003 | A1 |
| 20030050594 | Zamierowski | Mar 2003 | A1 |
| 20030069563 | Johnson | Apr 2003 | A1 |
| 20030078532 | Ruszczak et al. | Apr 2003 | A1 |
| 20030088202 | Gilman | May 2003 | A1 |
| 20030093041 | Risk, Jr. et al. | May 2003 | A1 |
| 20030095879 | Oh et al. | May 2003 | A1 |
| 20030099558 | Chang | May 2003 | A1 |
| 20030108430 | Yoshida et al. | Jun 2003 | A1 |
| 20030114818 | Benecke et al. | Jun 2003 | A1 |
| 20030125646 | Whitlock | Jul 2003 | A1 |
| 20030125649 | McIntosh et al. | Jul 2003 | A1 |
| 20030133812 | Puff et al. | Jul 2003 | A1 |
| 20030134332 | Boykin, Jr. | Jul 2003 | A1 |
| 20030144619 | Augustine | Jul 2003 | A1 |
| 20030148959 | Quirk et al. | Aug 2003 | A1 |
| 20030162071 | Yasuda | Aug 2003 | A1 |
| 20030171675 | Rosenberg | Sep 2003 | A1 |
| 20030175125 | Kwon et al. | Sep 2003 | A1 |
| 20030175135 | Heo et al. | Sep 2003 | A1 |
| 20030175798 | Raees et al. | Sep 2003 | A1 |
| 20030180341 | Gooch et al. | Sep 2003 | A1 |
| 20030183653 | Bills | Oct 2003 | A1 |
| 20030199800 | Levin | Oct 2003 | A1 |
| 20030211137 | Sierra | Nov 2003 | A1 |
| 20030212357 | Pace | Nov 2003 | A1 |
| 20030212359 | Butler | Nov 2003 | A1 |
| 20030212431 | Brady et al. | Nov 2003 | A1 |
| 20030219469 | Johnson et al. | Nov 2003 | A1 |
| 20030225347 | Argenta et al. | Dec 2003 | A1 |
| 20040001878 | DeBusk et al. | Jan 2004 | A1 |
| 20040005222 | Yoshida et al. | Jan 2004 | A1 |
| 20040006319 | Lina et al. | Jan 2004 | A1 |
| 20040019252 | Hirata | Jan 2004 | A1 |
| 20040019342 | Nagasuna et al. | Jan 2004 | A1 |
| 20040021123 | Howell et al. | Feb 2004 | A1 |
| 20040030304 | Hunt et al. | Feb 2004 | A1 |
| 20040033466 | Shellard et al. | Feb 2004 | A1 |
| 20040039391 | Argenta et al. | Feb 2004 | A1 |
| 20040039415 | Zamierowski | Feb 2004 | A1 |
| 20040050411 | Lawrence | Mar 2004 | A1 |
| 20040054338 | Bybordi et al. | Mar 2004 | A1 |
| 20040057855 | Gerlach et al. | Mar 2004 | A1 |
| 20040064111 | Lockwood et al. | Apr 2004 | A1 |
| 20040064132 | Boehringer et al. | Apr 2004 | A1 |
| 20040066097 | Kobayashi et al. | Apr 2004 | A1 |
| 20040071568 | Hyeon | Apr 2004 | A1 |
| 20040077977 | Ella et al. | Apr 2004 | A1 |
| 20040078011 | Stevens | Apr 2004 | A1 |
| 20040093026 | Weidenhagen et al. | May 2004 | A1 |
| 20040106888 | Lutri et al. | Jun 2004 | A1 |
| 20040115076 | Lilie et al. | Jun 2004 | A1 |
| 20040121438 | Quirk | Jun 2004 | A1 |
| 20040122434 | Argenta et al. | Jun 2004 | A1 |
| 20040126250 | Tsuchiya et al. | Jul 2004 | A1 |
| 20040127845 | Renz et al. | Jul 2004 | A1 |
| 20040127862 | Bubb et al. | Jul 2004 | A1 |
| 20040127863 | Bubb et al. | Jul 2004 | A1 |
| 20040138602 | Rossen | Jul 2004 | A1 |
| 20040156730 | Lilie et al. | Aug 2004 | A1 |
| 20040162512 | Liedtke et al. | Aug 2004 | A1 |
| 20040163713 | Schulze et al. | Aug 2004 | A1 |
| 20040167482 | Watson | Aug 2004 | A1 |
| 20040167617 | Voellmicke et al. | Aug 2004 | A1 |
| 20040171998 | Marasco, Jr. | Sep 2004 | A1 |
| 20040189103 | Duncan et al. | Sep 2004 | A1 |
| 20040193218 | Butler | Sep 2004 | A1 |
| 20040241213 | Bray | Dec 2004 | A1 |
| 20040241214 | Kirkwood et al. | Dec 2004 | A1 |
| 20040243042 | Lipman | Dec 2004 | A1 |
| 20040249353 | Risk, Jr. et al. | Dec 2004 | A1 |
| 20040260230 | Randolph | Dec 2004 | A1 |
| 20050015036 | Lutri et al. | Jan 2005 | A1 |
| 20050020955 | Sanders et al. | Jan 2005 | A1 |
| 20050031470 | Lee | Feb 2005 | A1 |
| 20050065484 | Watson, Jr. | Mar 2005 | A1 |
| 20050085795 | Lockwood | Apr 2005 | A1 |
| 20050090787 | Risk et al. | Apr 2005 | A1 |
| 20050098031 | Yoon et al. | May 2005 | A1 |
| 20050100450 | Bryant et al. | May 2005 | A1 |
| 20050111987 | Yoo et al. | May 2005 | A1 |
| 20050113733 | Liedtke et al. | May 2005 | A1 |
| 20050119737 | Bene et al. | Jun 2005 | A1 |
| 20050123422 | Lilie | Jun 2005 | A1 |
| 20050129540 | Puff | Jun 2005 | A1 |
| 20050130299 | Suzuki | Jun 2005 | A1 |
| 20050131327 | Lockwood et al. | Jun 2005 | A1 |
| 20050135946 | Kang et al. | Jun 2005 | A1 |
| 20050137272 | Gaserod et al. | Jun 2005 | A1 |
| 20050137539 | Biggie et al. | Jun 2005 | A1 |
| 20050142007 | Lee et al. | Jun 2005 | A1 |
| 20050142008 | Jung et al. | Jun 2005 | A1 |
| 20050143697 | Riesinger | Jun 2005 | A1 |
| 20050147562 | Hunter et al. | Jul 2005 | A1 |
| 20050163635 | Berwanger et al. | Jul 2005 | A1 |
| 20050163904 | Walker et al. | Jul 2005 | A1 |
| 20050164365 | Yonemura et al. | Jul 2005 | A1 |
| 20050177086 | Murata et al. | Aug 2005 | A1 |
| 20050177190 | Zamierowski | Aug 2005 | A1 |
| 20050181163 | Kose | Aug 2005 | A1 |
| 20050182445 | Zamierowski | Aug 2005 | A1 |
| 20050230422 | Muller et al. | Oct 2005 | A1 |
| 20050234485 | Seegert et al. | Oct 2005 | A1 |
| 20050271526 | Chang et al. | Dec 2005 | A1 |
| 20050276706 | Radue | Dec 2005 | A1 |
| 20060003604 | Angerpointner | Jan 2006 | A1 |
| 20060009744 | Edrman et al. | Jan 2006 | A1 |
| 20060017332 | Kang et al. | Jan 2006 | A1 |
| 20060018771 | Song et al. | Jan 2006 | A1 |
| 20060020234 | Chou et al. | Jan 2006 | A1 |
| 20060024181 | Kim | Feb 2006 | A1 |
| 20060029650 | Coffey | Feb 2006 | A1 |
| 20060029675 | Ginther | Feb 2006 | A1 |
| 20060039742 | Cable et al. | Feb 2006 | A1 |
| 20060056979 | Yoo et al. | Mar 2006 | A1 |
| 20060056980 | Yoo et al. | Mar 2006 | A1 |
| 20060057000 | Hyeon | Mar 2006 | A1 |
| 20060061024 | Jung et al. | Mar 2006 | A1 |
| 20060069365 | Sperl et al. | Mar 2006 | A1 |
| 20060070458 | Jones et al. | Apr 2006 | A1 |
| 20060079852 | Bubb et al. | Apr 2006 | A1 |
| 20060100586 | Karpowicz | May 2006 | A1 |
| 20060100597 | Miskie | May 2006 | A1 |
| 20060110259 | Puff et al. | May 2006 | A1 |
| 20060122548 | Abrams | Jun 2006 | A1 |
| 20060142687 | Liedtke et al. | Jun 2006 | A1 |
| 20060149170 | Boynton et al. | Jul 2006 | A1 |
| 20060172000 | Cullen et al. | Aug 2006 | A1 |
| 20060173253 | Ganapathy et al. | Aug 2006 | A1 |
| 20060178608 | Stapf | Aug 2006 | A1 |
| 20060191575 | Naesje | Aug 2006 | A1 |
| 20060206047 | Lampe et al. | Sep 2006 | A1 |
| 20060210411 | Hyeon | Sep 2006 | A1 |
| 20060216165 | Lee | Sep 2006 | A1 |
| 20060217016 | Lin et al. | Sep 2006 | A1 |
| 20060222532 | Lee et al. | Oct 2006 | A1 |
| 20060228224 | Hong et al. | Oct 2006 | A1 |
| 20060241689 | Leiboff et al. | Oct 2006 | A1 |
| 20060251523 | Lee et al. | Nov 2006 | A1 |
| 20060271020 | Huang et al. | Nov 2006 | A1 |
| 20060273109 | Keller | Dec 2006 | A1 |
| 20060286886 | Komura et al. | Dec 2006 | A1 |
| 20070003604 | Jones | Jan 2007 | A1 |
| 20070004896 | Ito et al. | Jan 2007 | A1 |
| 20070005028 | Risk et al. | Jan 2007 | A1 |
| 20070014837 | Johnson et al. | Jan 2007 | A1 |
| 20070016152 | Karpowicz et al. | Jan 2007 | A1 |
| 20070021697 | Ginther et al. | Jan 2007 | A1 |
| 20070027414 | Hoffman et al. | Feb 2007 | A1 |
| 20070032754 | Walsh | Feb 2007 | A1 |
| 20070032755 | Walsh | Feb 2007 | A1 |
| 20070032762 | Vogel | Feb 2007 | A1 |
| 20070032778 | Heaton et al. | Feb 2007 | A1 |
| 20070038172 | Zamierowski | Feb 2007 | A1 |
| 20070041856 | Hansen et al. | Feb 2007 | A1 |
| 20070052144 | Knirck et al. | Mar 2007 | A1 |
| 20070055209 | Patel et al. | Mar 2007 | A1 |
| 20070073200 | Hannigan et al. | Mar 2007 | A1 |
| 20070078467 | Mullen | Apr 2007 | A1 |
| 20070100308 | Miyairi | May 2007 | A1 |
| 20070142761 | Aali | Jun 2007 | A1 |
| 20070167927 | Hunt et al. | Jul 2007 | A1 |
| 20070179460 | Adahan | Aug 2007 | A1 |
| 20070185463 | Mulligan | Aug 2007 | A1 |
| 20070196214 | Bocchiola | Aug 2007 | A1 |
| 20070219497 | Johnson et al. | Sep 2007 | A1 |
| 20070219513 | Lina et al. | Sep 2007 | A1 |
| 20070219532 | Karpowicz et al. | Sep 2007 | A1 |
| 20070225663 | Watt et al. | Sep 2007 | A1 |
| 20070233022 | Henley et al. | Oct 2007 | A1 |
| 20070237811 | Scherr | Oct 2007 | A1 |
| 20070239139 | Weston | Oct 2007 | A1 |
| 20070256428 | Unger et al. | Nov 2007 | A1 |
| 20070260207 | Ugander et al. | Nov 2007 | A1 |
| 20070282236 | LaGreca | Dec 2007 | A1 |
| 20070292286 | Hell et al. | Dec 2007 | A1 |
| 20070292397 | McNulty et al. | Dec 2007 | A1 |
| 20070292488 | Bassiri et al. | Dec 2007 | A1 |
| 20070295201 | Dadd | Dec 2007 | A1 |
| 20080004549 | Anderson et al. | Jan 2008 | A1 |
| 20080008607 | Schade et al. | Jan 2008 | A1 |
| 20080009812 | Riesinger | Jan 2008 | A1 |
| 20080058691 | Sorensen | Mar 2008 | A1 |
| 20080069855 | Bonutti | Mar 2008 | A1 |
| 20080071235 | Locke et al. | Mar 2008 | A1 |
| 20080082059 | Fink et al. | Apr 2008 | A1 |
| 20080089796 | Schade et al. | Apr 2008 | A1 |
| 20080095979 | Hatanaka et al. | Apr 2008 | A1 |
| 20080132821 | Propp et al. | Jun 2008 | A1 |
| 20080167592 | Greer | Jul 2008 | A1 |
| 20080167593 | Fleischmann | Jul 2008 | A1 |
| 20080188820 | Joshi | Aug 2008 | A1 |
| 20080191399 | Chang | Aug 2008 | A1 |
| 20080199513 | Beretta et al. | Aug 2008 | A1 |
| 20080200905 | Heaton | Aug 2008 | A1 |
| 20080200906 | Sanders et al. | Aug 2008 | A1 |
| 20080208147 | Argenta et al. | Aug 2008 | A1 |
| 20080211435 | Imagawa | Sep 2008 | A1 |
| 20080213344 | McCarthy et al. | Sep 2008 | A1 |
| 20080223378 | Henderson et al. | Sep 2008 | A1 |
| 20080226720 | Kemp et al. | Sep 2008 | A1 |
| 20080234641 | Locke et al. | Sep 2008 | A1 |
| 20080240942 | Heinrich et al. | Oct 2008 | A1 |
| 20080243044 | Hunt et al. | Oct 2008 | A1 |
| 20080267797 | Hell et al. | Oct 2008 | A1 |
| 20080294147 | Radl et al. | Nov 2008 | A1 |
| 20080306407 | Taylor | Dec 2008 | A1 |
| 20080306456 | Riesinger | Dec 2008 | A1 |
| 20080312572 | Riesinger | Dec 2008 | A1 |
| 20090005746 | Nielsen et al. | Jan 2009 | A1 |
| 20090012441 | Mulligan | Jan 2009 | A1 |
| 20090012501 | Boehringer et al. | Jan 2009 | A1 |
| 20090030383 | Larsen et al. | Jan 2009 | A1 |
| 20090036873 | Nielsen et al. | Feb 2009 | A1 |
| 20090054855 | Blott et al. | Feb 2009 | A1 |
| 20090060750 | Chen et al. | Mar 2009 | A1 |
| 20090081049 | Tian et al. | Mar 2009 | A1 |
| 20090082740 | Lockwood et al. | Mar 2009 | A1 |
| 20090087323 | Blakey et al. | Apr 2009 | A1 |
| 20090099519 | Kaplan | Apr 2009 | A1 |
| 20090105671 | Daggar et al. | Apr 2009 | A1 |
| 20090124988 | Coulthard | May 2009 | A1 |
| 20090125004 | Shen et al. | May 2009 | A1 |
| 20090126103 | Dietrich et al. | May 2009 | A1 |
| 20090129955 | Schubert | May 2009 | A1 |
| 20090130186 | McCarthy et al. | May 2009 | A1 |
| 20090131888 | Joshi | May 2009 | A1 |
| 20090131892 | Karpowicz et al. | May 2009 | A1 |
| 20090137973 | Karpowicz et al. | May 2009 | A1 |
| 20090148320 | Lucas | Jun 2009 | A1 |
| 20090157016 | Adahan | Jun 2009 | A1 |
| 20090157024 | Song | Jun 2009 | A1 |
| 20090163882 | Koch et al. | Jun 2009 | A1 |
| 20090169402 | Stenberg | Jul 2009 | A1 |
| 20090177136 | Liedtke et al. | Jul 2009 | A1 |
| 20090192499 | Weston et al. | Jul 2009 | A1 |
| 20090198201 | Adahan | Aug 2009 | A1 |
| 20090204085 | Biggie et al. | Aug 2009 | A1 |
| 20090206778 | Roh et al. | Aug 2009 | A1 |
| 20090216170 | Robinson et al. | Aug 2009 | A1 |
| 20090221977 | Blott et al. | Sep 2009 | A1 |
| 20090227935 | Zanella et al. | Sep 2009 | A1 |
| 20090227969 | Jaeb et al. | Sep 2009 | A1 |
| 20090234306 | Vitaris | Sep 2009 | A1 |
| 20090234309 | Vitaris et al. | Sep 2009 | A1 |
| 20090240185 | Jaeb et al. | Sep 2009 | A1 |
| 20090240218 | Braga et al. | Sep 2009 | A1 |
| 20090254053 | Svensby et al. | Oct 2009 | A1 |
| 20090254054 | Blott et al. | Oct 2009 | A1 |
| 20090264837 | Adahan | Oct 2009 | A1 |
| 20090270820 | Johnson | Oct 2009 | A1 |
| 20090275872 | Addison et al. | Nov 2009 | A1 |
| 20090275922 | Coulthard et al. | Nov 2009 | A1 |
| 20090292263 | Hudspeth et al. | Nov 2009 | A1 |
| 20090292264 | Hudspeth et al. | Nov 2009 | A1 |
| 20090293887 | Wilkes et al. | Dec 2009 | A1 |
| 20090299249 | Wilkes et al. | Dec 2009 | A1 |
| 20090299251 | Buan | Dec 2009 | A1 |
| 20090299255 | Kazala, Jr. et al. | Dec 2009 | A1 |
| 20090299257 | Long et al. | Dec 2009 | A1 |
| 20090299303 | Seegert | Dec 2009 | A1 |
| 20090299306 | Buan | Dec 2009 | A1 |
| 20090299308 | Kazala et al. | Dec 2009 | A1 |
| 20090299340 | Kazala et al. | Dec 2009 | A1 |
| 20090304534 | Richter | Dec 2009 | A1 |
| 20090306580 | Blott et al. | Dec 2009 | A1 |
| 20090312723 | Blott et al. | Dec 2009 | A1 |
| 20090312725 | Braga | Dec 2009 | A1 |
| 20100004611 | Aali | Jan 2010 | A1 |
| 20100016767 | Jones et al. | Jan 2010 | A1 |
| 20100022972 | Lina et al. | Jan 2010 | A1 |
| 20100030170 | Keller et al. | Feb 2010 | A1 |
| 20100030171 | Canada et al. | Feb 2010 | A1 |
| 20100030178 | MacMeccan et al. | Feb 2010 | A1 |
| 20100036334 | Heagle et al. | Feb 2010 | A1 |
| 20100036367 | Krohn | Feb 2010 | A1 |
| 20100055158 | Vitaris et al. | Mar 2010 | A1 |
| 20100063483 | Adahan | Mar 2010 | A1 |
| 20100063484 | Heagle | Mar 2010 | A1 |
| 20100069829 | Hutchinson et al. | Mar 2010 | A1 |
| 20100069850 | Fabo | Mar 2010 | A1 |
| 20100069858 | Olson | Mar 2010 | A1 |
| 20100069863 | Olson | Mar 2010 | A1 |
| 20100069885 | Stevenson et al. | Mar 2010 | A1 |
| 20100084074 | McClernon et al. | Apr 2010 | A1 |
| 20100087767 | McNeil | Apr 2010 | A1 |
| 20100094234 | Ramella et al. | Apr 2010 | A1 |
| 20100098566 | Kang | Apr 2010 | A1 |
| 20100100063 | Joshi et al. | Apr 2010 | A1 |
| 20100106112 | Vogel | Apr 2010 | A1 |
| 20100106114 | Weston et al. | Apr 2010 | A1 |
| 20100106117 | Lockwood et al. | Apr 2010 | A1 |
| 20100106120 | Holm | Apr 2010 | A1 |
| 20100106121 | Holm | Apr 2010 | A1 |
| 20100121286 | Locke et al. | May 2010 | A1 |
| 20100122417 | Vrzalik et al. | May 2010 | A1 |
| 20100125234 | Smith | May 2010 | A1 |
| 20100125258 | Coulthard et al. | May 2010 | A1 |
| 20100135915 | Greener et al. | Jun 2010 | A1 |
| 20100150991 | Bernstein | Jun 2010 | A1 |
| 20100159192 | Cotton | Jun 2010 | A1 |
| 20100160881 | Lin et al. | Jun 2010 | A1 |
| 20100174251 | Weston | Jul 2010 | A1 |
| 20100191196 | Heagle | Jul 2010 | A1 |
| 20100191198 | Heagle | Jul 2010 | A1 |
| 20100210986 | Sanders | Aug 2010 | A1 |
| 20100211030 | Turner et al. | Aug 2010 | A1 |
| 20100217177 | Cali et al. | Aug 2010 | A1 |
| 20100249733 | Blott et al. | Sep 2010 | A9 |
| 20100262090 | Riesinger | Oct 2010 | A1 |
| 20100262091 | Larsson | Oct 2010 | A1 |
| 20100268198 | Buan et al. | Oct 2010 | A1 |
| 20100274207 | Weston | Oct 2010 | A1 |
| 20100280468 | Haggstrom et al. | Nov 2010 | A1 |
| 20100298866 | Fischvogt | Nov 2010 | A1 |
| 20100305490 | Coulthard et al. | Dec 2010 | A1 |
| 20100305526 | Robinson et al. | Dec 2010 | A1 |
| 20100318043 | Malhi et al. | Dec 2010 | A1 |
| 20100318052 | Ha et al. | Dec 2010 | A1 |
| 20100320659 | Chen et al. | Dec 2010 | A1 |
| 20100324510 | Andresen et al. | Dec 2010 | A1 |
| 20100324516 | Braga et al. | Dec 2010 | A1 |
| 20110004171 | Blott et al. | Jan 2011 | A1 |
| 20110004172 | Eckstein et al. | Jan 2011 | A1 |
| 20110015593 | Svedman et al. | Jan 2011 | A1 |
| 20110028290 | Ozawa | Feb 2011 | A1 |
| 20110028917 | Hall | Feb 2011 | A1 |
| 20110028918 | Hartwell | Feb 2011 | A1 |
| 20110028919 | Johnnison et al. | Feb 2011 | A1 |
| 20110028921 | Hartwell et al. | Feb 2011 | A1 |
| 20110034888 | Aali | Feb 2011 | A1 |
| 20110034892 | Buan | Feb 2011 | A1 |
| 20110043055 | Chiang | Feb 2011 | A1 |
| 20110046580 | Saitou | Feb 2011 | A1 |
| 20110052664 | Tennican et al. | Mar 2011 | A1 |
| 20110054422 | Locke et al. | Mar 2011 | A1 |
| 20110054423 | Blott et al. | Mar 2011 | A1 |
| 20110081267 | McCrone et al. | Apr 2011 | A1 |
| 20110087178 | Weston | Apr 2011 | A2 |
| 20110092927 | Wilkes et al. | Apr 2011 | A1 |
| 20110092958 | Jacobs | Apr 2011 | A1 |
| 20110098621 | Fabo et al. | Apr 2011 | A1 |
| 20110105963 | Hu et al. | May 2011 | A1 |
| 20110106030 | Scholz | May 2011 | A1 |
| 20110112492 | Bharti et al. | May 2011 | A1 |
| 20110118683 | Weston | May 2011 | A1 |
| 20110125066 | Robinson et al. | May 2011 | A1 |
| 20110130712 | Topaz | Jun 2011 | A1 |
| 20110137222 | Masini | Jun 2011 | A1 |
| 20110169348 | Park | Jul 2011 | A1 |
| 20110172612 | Greener | Jul 2011 | A1 |
| 20110172617 | Riesinger | Jul 2011 | A1 |
| 20110176946 | Drevet | Jul 2011 | A1 |
| 20110178375 | Forster | Jul 2011 | A1 |
| 20110178451 | Robinson et al. | Jul 2011 | A1 |
| 20110186765 | Jaeb et al. | Aug 2011 | A1 |
| 20110205646 | Sato et al. | Aug 2011 | A1 |
| 20110205647 | Osaka et al. | Aug 2011 | A1 |
| 20110218509 | Dontas | Sep 2011 | A1 |
| 20110224631 | Simmons | Sep 2011 | A1 |
| 20110237863 | Ricci et al. | Sep 2011 | A1 |
| 20110245788 | Marquez Canada | Oct 2011 | A1 |
| 20110247636 | Pollack | Oct 2011 | A1 |
| 20110257572 | Locke et al. | Oct 2011 | A1 |
| 20110275964 | Greener | Nov 2011 | A1 |
| 20110282309 | Adie et al. | Nov 2011 | A1 |
| 20110295220 | Heaton et al. | Dec 2011 | A1 |
| 20110313373 | Riesinger | Dec 2011 | A1 |
| 20110313374 | Lockwood et al. | Dec 2011 | A1 |
| 20120004628 | Blott et al. | Jan 2012 | A1 |
| 20120040013 | Owens et al. | Feb 2012 | A1 |
| 20120041399 | Blott et al. | Feb 2012 | A1 |
| 20120053538 | Blott et al. | Mar 2012 | A1 |
| 20120065664 | Avitable et al. | Mar 2012 | A1 |
| 20120083755 | Lina et al. | Apr 2012 | A1 |
| 20120095380 | Gergley et al. | Apr 2012 | A1 |
| 20120095426 | Visscher et al. | Apr 2012 | A1 |
| 20120101465 | Mcguire, Jr. | Apr 2012 | A1 |
| 20120123311 | Weidemann-Hendrickson et al. | May 2012 | A1 |
| 20120123356 | Greener | May 2012 | A1 |
| 20120130332 | Cotton et al. | May 2012 | A1 |
| 20120157942 | Weston | Jun 2012 | A1 |
| 20120160091 | Dadd et al. | Jun 2012 | A1 |
| 20120172778 | Rastegar et al. | Jul 2012 | A1 |
| 20120177513 | Lilie et al. | Jul 2012 | A1 |
| 20120203145 | Nilsson | Aug 2012 | A1 |
| 20120203189 | Barta et al. | Aug 2012 | A1 |
| 20120232502 | Lowing | Sep 2012 | A1 |
| 20120238932 | Atteia et al. | Sep 2012 | A1 |
| 20120251359 | Neelakantan et al. | Oct 2012 | A1 |
| 20120302976 | Locke et al. | Nov 2012 | A1 |
| 20130066285 | Locke et al. | Mar 2013 | A1 |
| 20130066289 | Song et al. | Mar 2013 | A1 |
| 20130090615 | Jaeb et al. | Apr 2013 | A1 |
| 20130096519 | Blott et al. | Apr 2013 | A1 |
| 20130102979 | Coulthard et al. | Apr 2013 | A1 |
| 20130110058 | Adie et al. | May 2013 | A1 |
| 20130116635 | Fleischmann | May 2013 | A1 |
| 20130138054 | Fleischmann | May 2013 | A1 |
| 20130138060 | Haqqstrom et al. | May 2013 | A1 |
| 20130144230 | Wu et al. | Jun 2013 | A1 |
| 20130150814 | Buan | Jun 2013 | A1 |
| 20130165878 | Heagle | Jun 2013 | A1 |
| 20130267921 | Weston | Oct 2013 | A1 |
| 20130274688 | Weston | Oct 2013 | A1 |
| 20130296818 | Bradford et al. | Nov 2013 | A1 |
| 20130310781 | Phillips et al. | Nov 2013 | A1 |
| 20130331822 | Patel et al. | Dec 2013 | A1 |
| 20130338613 | Haggstrom et al. | Dec 2013 | A1 |
| 20130338614 | Heaton et al. | Dec 2013 | A1 |
| 20140018753 | Joshi et al. | Jan 2014 | A1 |
| 20140031771 | Locke et al. | Jan 2014 | A1 |
| 20140039423 | Riesinger | Feb 2014 | A1 |
| 20140094761 | Corley | Apr 2014 | A1 |
| 20140100539 | Coulthard et al. | Apr 2014 | A1 |
| 20140114263 | Weston | Apr 2014 | A1 |
| 20140114268 | Auguste et al. | Apr 2014 | A1 |
| 20140155849 | Heaton et al. | Jun 2014 | A1 |
| 20140188061 | Locke et al. | Jul 2014 | A1 |
| 20140200535 | Locke et al. | Jul 2014 | A1 |
| 20140228791 | Hartwell | Aug 2014 | A1 |
| 20140236109 | Greener | Aug 2014 | A1 |
| 20140249493 | Hartwell | Sep 2014 | A1 |
| 20140276490 | Locke et al. | Sep 2014 | A1 |
| 20140276491 | Luckemeyer et al. | Sep 2014 | A1 |
| 20140276497 | Robinson | Sep 2014 | A1 |
| 20140309601 | Hall et al. | Oct 2014 | A1 |
| 20140316359 | Collinson et al. | Oct 2014 | A1 |
| 20140343519 | Weston | Nov 2014 | A1 |
| 20140371691 | Blott et al. | Dec 2014 | A1 |
| 20150018786 | Locke et al. | Jan 2015 | A1 |
| 20150032035 | Banwell et al. | Jan 2015 | A1 |
| 20150065966 | Addie | Mar 2015 | A1 |
| 20150080787 | Blott et al. | Mar 2015 | A1 |
| 20150080788 | Blott et al. | Mar 2015 | A1 |
| 20150157508 | Blott et al. | Jun 2015 | A1 |
| 20150159066 | Hartwell et al. | Jun 2015 | A1 |
| 20150165101 | Blott et al. | Jun 2015 | A1 |
| 20150173954 | Blott et al. | Jun 2015 | A1 |
| 20150174306 | Blott et al. | Jun 2015 | A1 |
| 20150209492 | Blott et al. | Jul 2015 | A1 |
| 20150224238 | Hartwell | Aug 2015 | A1 |
| 20150308994 | Hammond et al. | Oct 2015 | A1 |
| 20150320604 | Adie et al. | Nov 2015 | A1 |
| 20160081859 | Hartwell | Mar 2016 | A1 |
| 20170252496 | Blott et al. | Sep 2017 | A1 |
| Number | Date | Country |
|---|---|---|
| 2 369 000 | Oct 1990 | CA |
| 2 414 393 | Nov 1992 | CA |
| 2 198 243 | Feb 1996 | CA |
| 2 238 413 | May 1997 | CA |
| 2 471 780 | Mar 1999 | CA |
| 2349638 | May 2000 | CA |
| 2 367 460 | Oct 2000 | CA |
| 2 369 024 | Oct 2000 | CA |
| 2 390 513 | May 2001 | CA |
| 2 121 688 | Jul 2001 | CA |
| 2 408 305 | Nov 2001 | CA |
| 2 432 293 | Feb 2003 | CA |
| 2 458 285 | Mar 2003 | CA |
| 2 157 772 | Sep 2003 | CA |
| 2 103 033 | Aug 2005 | CA |
| 2 369 022 | Aug 2005 | CA |
| 33446 | Oct 1885 | DE |
| 561757 | Oct 1932 | DE |
| 847475 | Aug 1952 | DE |
| 1000684 | Jan 1957 | DE |
| 2 809 828 | Sep 1978 | DE |
| 3 137 839 | Mar 1983 | DE |
| 3 032 092 | Oct 1984 | DE |
| 34 43 101 | May 1986 | DE |
| 3 539 533 | May 1987 | DE |
| 3838587 | May 1990 | DE |
| 3 935 818 | May 1991 | DE |
| 4 012 232 | Oct 1991 | DE |
| 4 016 034 | Nov 1991 | DE |
| 90 17 289 | Apr 1992 | DE |
| 4 102 684 | Aug 1992 | DE |
| 4 111 122 | Apr 1993 | DE |
| 38 50 798 | Feb 1995 | DE |
| 295 04 378 | Sep 1995 | DE |
| 195 17 699 | Nov 1996 | DE |
| 2 961 8426 | Feb 1997 | DE |
| 19722075 | Oct 1998 | DE |
| 198 44 355 | Apr 2000 | DE |
| 20 2004 017 052 | Jul 2005 | DE |
| 0 020 662 | Jul 1984 | EP |
| 0194198 | Dec 1986 | EP |
| 0 099 748 | May 1987 | EP |
| 0 122 085 | Jun 1987 | EP |
| 0 257 916 | Mar 1988 | EP |
| 0 298 726 | Jan 1989 | EP |
| 0 340 018 | Nov 1989 | EP |
| 0 355 186 | Feb 1990 | EP |
| 0 355 536 | Feb 1990 | EP |
| 0 358 302 | Mar 1990 | EP |
| 0 418 607 | Mar 1991 | EP |
| 0 425 164 | May 1991 | EP |
| 0174803 | Aug 1991 | EP |
| 0 485 657 | May 1992 | EP |
| 0 521 434 | Jan 1993 | EP |
| 0 541 251 | May 1993 | EP |
| 0325771 | Sep 1993 | EP |
| 0 617 152 | Sep 1994 | EP |
| 0 617 938 | Oct 1994 | EP |
| 0 619 105 | Oct 1994 | EP |
| 0 638 301 | Feb 1995 | EP |
| 0 648 122 | Apr 1995 | EP |
| 0 392 640 | Jun 1995 | EP |
| 0 441 418 | Jul 1995 | EP |
| 0 670 705 | Sep 1995 | EP |
| 0 690 736 | Jan 1996 | EP |
| 0578999 | May 1996 | EP |
| 0 724 888 | Aug 1996 | EP |
| 0549781 | Sep 1996 | EP |
| 0 465 601 | Jan 1997 | EP |
| 0 754 064 | Jan 1997 | EP |
| 0759521 | Feb 1997 | EP |
| 0 762 860 | Mar 1997 | EP |
| 0 772 464 | May 1997 | EP |
| 0 793 019 | Sep 1997 | EP |
| 0 537 559 | Jan 1998 | EP |
| 0 620 720 | Mar 1998 | EP |
| 0 853 950 | Jul 1998 | EP |
| 0 856 318 | Aug 1998 | EP |
| 0 858 810 | Aug 1998 | EP |
| 0 651 983 | Sep 1998 | EP |
| 0 777 504 | Oct 1998 | EP |
| 0 876 165 | Nov 1998 | EP |
| 0 888 141 | Jan 1999 | EP |
| 0 912 251 | May 1999 | EP |
| 0 782 421 | Jul 1999 | EP |
| 0 941 726 | Sep 1999 | EP |
| 1 068 451 | Oct 1999 | EP |
| 0774242 | Mar 2000 | EP |
| 1 169 071 | Apr 2000 | EP |
| 1 007 015 | Jun 2000 | EP |
| 1 013 290 | Jun 2000 | EP |
| 1 021 180 | Jul 2000 | EP |
| 1 029 585 | Aug 2000 | EP |
| 1 030 657 | Aug 2000 | EP |
| 0 688 189 | Sep 2000 | EP |
| 1 169 071 | Oct 2000 | EP |
| 0 690 706 | Nov 2000 | EP |
| 1 085 925 | Mar 2001 | EP |
| 1 088 569 | Apr 2001 | EP |
| 1092404 | Apr 2001 | EP |
| 1 105 110 | Jun 2001 | EP |
| 1 105 171 | Jun 2001 | EP |
| 1 105 180 | Jun 2001 | EP |
| 1 107 813 | Jun 2001 | EP |
| 0 865 304 | Jul 2001 | EP |
| 1 411 874 | Jul 2001 | EP |
| 0674892 | Jul 2001 | EP |
| 1114933 | Jul 2001 | EP |
| 1 129 734 | Sep 2001 | EP |
| 1 138 336 | Oct 2001 | EP |
| 1139951 | Oct 2001 | EP |
| 1 156 839 | Nov 2001 | EP |
| 1 283 702 | Nov 2001 | EP |
| 0 921 775 | Dec 2001 | EP |
| 0 564 502 | Jan 2002 | EP |
| 1 177 781 | Feb 2002 | EP |
| 1 339 366 | Jun 2002 | EP |
| 0948951 | Jun 2002 | EP |
| 0 875 222 | Jul 2002 | EP |
| 1 218 437 | Jul 2002 | EP |
| 1 897 569 | Aug 2002 | EP |
| 1 306 123 | Feb 2003 | EP |
| 0729334 | Mar 2003 | EP |
| 0 708 620 | May 2003 | EP |
| 1 088 569 | Aug 2003 | EP |
| 0 993 317 | Sep 2003 | EP |
| 0 880 953 | Oct 2003 | EP |
| 1 565 219 | Dec 2003 | EP |
| 1 219 311 | Jul 2004 | EP |
| 1 440 667 | Jul 2004 | EP |
| 1 440 737 | Jul 2004 | EP |
| 1 578 477 | Jul 2004 | EP |
| 1 018 967 | Aug 2004 | EP |
| 1449971 | Aug 2004 | EP |
| 1 488 816 | Dec 2004 | EP |
| 1503474 | Feb 2005 | EP |
| 1 513 478 | Mar 2005 | EP |
| 0898471 | May 2005 | EP |
| 1620720 | Feb 2006 | EP |
| 1 440 667 | Mar 2006 | EP |
| 1 632 252 | Mar 2006 | EP |
| 1 637 088 | Mar 2006 | EP |
| 1633830 | Mar 2006 | EP |
| 1 284 777 | Apr 2006 | EP |
| 1 263 366 | Jul 2006 | EP |
| 0 982 015 | Aug 2006 | EP |
| 0 620 720 | Nov 2006 | EP |
| 1 448 261 | Feb 2007 | EP |
| 1 171 065 | Mar 2007 | EP |
| 1 772 160 | Apr 2007 | EP |
| 1 476 217 | Mar 2008 | EP |
| 1 121 163 | Nov 2008 | EP |
| 2 079 507 | Jul 2009 | EP |
| 2 111 804 | Oct 2009 | EP |
| 1314410 | Feb 2010 | EP |
| 2 172 164 | Apr 2010 | EP |
| 2 255 837 | Dec 2010 | EP |
| 2 021 046 | Mar 2012 | EP |
| 2 462 908 | Jun 2012 | EP |
| 2 711 034 | Mar 2014 | EP |
| 2 305 325 | Apr 2014 | EP |
| 2 345 437 | Apr 2014 | EP |
| 2 687 245 | Sep 2014 | EP |
| 2 544 642 | Jan 2015 | EP |
| 2 648 668 | Jan 2015 | EP |
| 1 163 907 | Oct 1958 | FR |
| 114754 | Apr 1918 | GB |
| 236350 | Jul 1925 | GB |
| 641061 | Aug 1950 | GB |
| 821959 | Oct 1959 | GB |
| 1063066 | Mar 1967 | GB |
| 1224009 | Mar 1971 | GB |
| 1255395 | Dec 1971 | GB |
| 1273342 | May 1972 | GB |
| 1400124 | Jul 1975 | GB |
| 1549756 | Aug 1979 | GB |
| 2041756 | Sep 1980 | GB |
| 2047438 | Nov 1980 | GB |
| 2099306 | Dec 1982 | GB |
| 2085305 | Jan 1985 | GB |
| 2195255 | Apr 1988 | GB |
| 2235877 | Mar 1991 | GB |
| 2272645 | May 1994 | GB |
| 2273133 | Jun 1994 | GB |
| 2288734 | Nov 1995 | GB |
| 2306580 | May 1997 | GB |
| 2307180 | May 1997 | GB |
| 2329127 | Mar 1999 | GB |
| 2305610 | Jul 1999 | GB |
| 2336546 | Oct 1999 | GB |
| 2378392 | Feb 2003 | GB |
| 2357286 | Nov 2003 | GB |
| 2389794 | Dec 2003 | GB |
| 2365350 | Aug 2004 | GB |
| 2415908 | Jan 2006 | GB |
| 2422545 | Aug 2006 | GB |
| 2423019 | Aug 2006 | GB |
| 2424581 | Oct 2006 | GB |
| 2424582 | Oct 2006 | GB |
| 2435419 | Feb 2007 | GB |
| 59-87824 | Jun 1984 | JP |
| S5987824 | Jun 1984 | JP |
| 59-502014 | Dec 1984 | JP |
| S62279885 | Dec 1987 | JP |
| H10-277143 | Oct 1998 | JP |
| 2001-314479 | Nov 2001 | JP |
| 2003154003 | May 2003 | JP |
| 2003-165843 | Jun 2003 | JP |
| 2004-121819 | Apr 2004 | JP |
| 2005-261376 | Sep 2005 | JP |
| 1005726 | Oct 1998 | NL |
| 240188 | Mar 1969 | SU |
| 1251912 | Apr 1983 | SU |
| 1762940 | Sep 1992 | SU |
| WO 198001139 | Jun 1980 | WO |
| WO 198002182 | Oct 1980 | WO |
| WO 198300742 | Mar 1983 | WO |
| WO 198401904 | May 1984 | WO |
| WO 198700759 | Feb 1987 | WO |
| WO 198704626 | Aug 1987 | WO |
| WO 198905133 | Jun 1989 | WO |
| WO 199010424 | Sep 1990 | WO |
| WO 199011795 | Oct 1990 | WO |
| WO 199100718 | Jan 1991 | WO |
| WO 199116030 | Oct 1991 | WO |
| WO 199209651 | Jun 1992 | WO |
| WO 199213713 | Aug 1992 | WO |
| WO 199219313 | Nov 1992 | WO |
| WO 199220299 | Nov 1992 | WO |
| WO 199300056 | Jan 1993 | WO |
| WO 199306802 | Apr 1993 | WO |
| WO 199309176 | May 1993 | WO |
| WO 199309727 | May 1993 | WO |
| WO-9324083 | Dec 1993 | WO |
| WO-9324627 | Dec 1993 | WO |
| WO 199420041 | Sep 1994 | WO |
| WO 1994020133 | Sep 1994 | WO |
| WO 199423677 | Oct 1994 | WO |
| WO 199503838 | Feb 1995 | WO |
| WO 199504511 | Feb 1995 | WO |
| WO 199514451 | Jun 1995 | WO |
| WO 199516416 | Jun 1995 | WO |
| WO 1995029959 | Nov 1995 | WO |
| WO 199600760 | Jan 1996 | WO |
| WO-9601731 | Jan 1996 | WO |
| WO 199605873 | Feb 1996 | WO |
| WO 199621410 | Jul 1996 | WO |
| WO 199624316 | Aug 1996 | WO |
| WO 199640174 | Dec 1996 | WO |
| WO 199703717 | Feb 1997 | WO |
| WO 199711658 | Apr 1997 | WO |
| WO 199713520 | Apr 1997 | WO |
| WO-9714384 | Apr 1997 | WO |
| WO 199718737 | May 1997 | WO |
| WO-9722371 | Jun 1997 | WO |
| WO 199733922 | Sep 1997 | WO |
| WO 199742986 | Nov 1997 | WO |
| WO 199743991 | Nov 1997 | WO |
| WO 199806444 | Feb 1998 | WO |
| WO 199813000 | Apr 1998 | WO |
| WO 199838955 | Sep 1998 | WO |
| WO 199901173 | Jan 1999 | WO |
| WO 199913793 | Mar 1999 | WO |
| WO 199915121 | Apr 1999 | WO |
| WO 199917698 | Apr 1999 | WO |
| WO-9919013 | Apr 1999 | WO |
| WO 199923010 | May 1999 | WO |
| WO 199930629 | Jun 1999 | WO |
| WO 199939671 | Aug 1999 | WO |
| WO 1999047097 | Sep 1999 | WO |
| WO-9948621 | Sep 1999 | WO |
| WO 199964081 | Dec 1999 | WO |
| WO 199965536 | Dec 1999 | WO |
| WO-0000016 | Jan 2000 | WO |
| WO 200007653 | Feb 2000 | WO |
| WO 200009199 | Feb 2000 | WO |
| WO-0017968 | Mar 2000 | WO |
| WO 200021586 | Apr 2000 | WO |
| WO 200038752 | Jul 2000 | WO |
| WO 200042957 | Jul 2000 | WO |
| WO-0040190 | Jul 2000 | WO |
| WO 200050143 | Aug 2000 | WO |
| WO 200059424 | Oct 2000 | WO |
| WO 200061206 | Oct 2000 | WO |
| WO 200062827 | Oct 2000 | WO |
| WO 2000064396 | Nov 2000 | WO |
| WO-0076353 | Dec 2000 | WO |
| WO 2001005443 | Jan 2001 | WO |
| WO 200110363 | Feb 2001 | WO |
| WO 200119430 | Mar 2001 | WO |
| WO 200134223 | May 2001 | WO |
| WO 200135882 | May 2001 | WO |
| WO 200137773 | May 2001 | WO |
| WO 200137922 | May 2001 | WO |
| WO 200137922 | May 2001 | WO |
| WO 2001041779 | Jun 2001 | WO |
| WO 200149233 | Jul 2001 | WO |
| WO 2001062312 | Aug 2001 | WO |
| WO 2001066017 | Sep 2001 | WO |
| WO-0172251 | Oct 2001 | WO |
| WO 2001085248 | Nov 2001 | WO |
| WO 2001089431 | Nov 2001 | WO |
| WO 200193793 | Dec 2001 | WO |
| WO 2002000268 | Jan 2002 | WO |
| WO 200202079 | Jan 2002 | WO |
| WO 200205737 | Jan 2002 | WO |
| WO 200209765 | Feb 2002 | WO |
| WO 200217840 | Mar 2002 | WO |
| WO 200220026 | Mar 2002 | WO |
| WO-0224132 | Mar 2002 | WO |
| WO 200226180 | Apr 2002 | WO |
| WO 2002034304 | May 2002 | WO |
| WO 200238096 | May 2002 | WO |
| WO 200239940 | May 2002 | WO |
| WO 200241878 | May 2002 | WO |
| WO 200245761 | Jun 2002 | WO |
| WO-02056927 | Jul 2002 | WO |
| WO 2002064182 | Aug 2002 | WO |
| WO 2002072113 | Sep 2002 | WO |
| WO 2002072800 | Sep 2002 | WO |
| WO-02070040 | Sep 2002 | WO |
| WO 2002076379 | Oct 2002 | WO |
| WO 2002083046 | Oct 2002 | WO |
| WO 2002091965 | Nov 2002 | WO |
| WO 2002092783 | Nov 2002 | WO |
| WO 2002094256 | Nov 2002 | WO |
| WO 2002102864 | Dec 2002 | WO |
| WO 2003005943 | Jan 2003 | WO |
| WO 2003009796 | Feb 2003 | WO |
| WO 2003018098 | Mar 2003 | WO |
| WO 2003020358 | Mar 2003 | WO |
| WO-03022333 | Mar 2003 | WO |
| WO 2003030966 | Apr 2003 | WO |
| WO 2003041686 | May 2003 | WO |
| WO-03041786 | May 2003 | WO |
| WO 2003045492 | Jun 2003 | WO |
| WO 2003057070 | Jul 2003 | WO |
| WO 2003057307 | Jul 2003 | WO |
| WO 2003063923 | Aug 2003 | WO |
| WO-03065877 | Aug 2003 | WO |
| WO 2003071991 | Sep 2003 | WO |
| WO 2003074100 | Sep 2003 | WO |
| WO-03072748 | Sep 2003 | WO |
| WO 2003085810 | Oct 2003 | WO |
| WO 2003086232 | Oct 2003 | WO |
| WO 2003092620 | Nov 2003 | WO |
| WO 2003094813 | Nov 2003 | WO |
| WO 2003101385 | Nov 2003 | WO |
| WO 2003101508 | Dec 2003 | WO |
| WO 2004012678 | Feb 2004 | WO |
| WO-2004016313 | Feb 2004 | WO |
| WO 2004018020 | Mar 2004 | WO |
| WO 2004024300 | Mar 2004 | WO |
| WO 2004032977 | Apr 2004 | WO |
| WO 2004037334 | May 2004 | WO |
| WO 2004045498 | Jun 2004 | WO |
| WO 2004054632 | Jul 2004 | WO |
| WO 2004073566 | Sep 2004 | WO |
| WO 2004081421 | Sep 2004 | WO |
| WO-2004077387 | Sep 2004 | WO |
| WO 2004091370 | Oct 2004 | WO |
| WO-2004098474 | Nov 2004 | WO |
| WO-2004108175 | Dec 2004 | WO |
| WO 2005009225 | Feb 2005 | WO |
| WO 2005009488 | Feb 2005 | WO |
| WO 2005017000 | Feb 2005 | WO |
| WO 2005018695 | Mar 2005 | WO |
| WO 2005025447 | Mar 2005 | WO |
| WO-2005019343 | Mar 2005 | WO |
| WO 2005034875 | Apr 2005 | WO |
| WO 2005046760 | May 2005 | WO |
| WO 2005046761 | May 2005 | WO |
| WO 2005046762 | May 2005 | WO |
| WO 2005051461 | Jun 2005 | WO |
| WO 2005070480 | Aug 2005 | WO |
| WO 2005082435 | Sep 2005 | WO |
| WO 2005105174 | Nov 2005 | WO |
| WO 2005105175 | Nov 2005 | WO |
| WO 2005105176 | Nov 2005 | WO |
| WO 2005123170 | Dec 2005 | WO |
| WO 2006052839 | May 2006 | WO |
| WO 2006130594 | Dec 2006 | WO |
| WO 2007019038 | Feb 2007 | WO |
| WO 2007075379 | Jul 2007 | WO |
| WO 2008010094 | Jan 2008 | WO |
| WO 2008039839 | Apr 2008 | WO |
| WO 2008040681 | Apr 2008 | WO |
| WO 2008064503 | Jun 2008 | WO |
| WO 2008104609 | Sep 2008 | WO |
| WO 2009011856 | Jan 2009 | WO |
| WO 2009021523 | Feb 2009 | WO |
| WO 2009066105 | May 2009 | WO |
| WO 2009070905 | Jun 2009 | WO |
| WO 2009124100 | Oct 2009 | WO |
| WO 2009158128 | Dec 2009 | WO |
| WO 2010016791 | Feb 2010 | WO |
| WO 2010033271 | Mar 2010 | WO |
| WO 2010033574 | Mar 2010 | WO |
| WO 2010033613 | Mar 2010 | WO |
| WO 2010051068 | May 2010 | WO |
| WO 2010051073 | May 2010 | WO |
| WO 2010072309 | Jul 2010 | WO |
| WO 2010142959 | Dec 2010 | WO |
| WO 2010147533 | Dec 2010 | WO |
| WO 2011135285 | Nov 2011 | WO |
| WO 2011135286 | Nov 2011 | WO |
| WO 2011135287 | Nov 2011 | WO |
| WO 2011144888 | Nov 2011 | WO |
| WO 2012001371 | Jan 2012 | WO |
| WO 2012069793 | May 2012 | WO |
| WO 2012069794 | May 2012 | WO |
| WO 2012131237 | Oct 2012 | WO |
| WO 2012140378 | Oct 2012 | WO |
| WO 2012143665 | Oct 2012 | WO |
| WO 2013010907 | Jan 2013 | WO |
| WO 2013083800 | Jun 2013 | WO |
| WO 2013090810 | Jun 2013 | WO |
| WO 2013136181 | Sep 2013 | WO |
| WO 2013149078 | Oct 2013 | WO |
| WO 2014008348 | Jan 2014 | WO |
| WO 2014016759 | Jan 2014 | WO |
| WO 2014020440 | Feb 2014 | WO |
| WO 2014020443 | Feb 2014 | WO |
| WO 2014108476 | Jul 2014 | WO |
| WO 2014113253 | Jul 2014 | WO |
| WO 2014113504 | Jul 2014 | WO |
| WO 2014107285 | Sep 2014 | WO |
| WO 2014143488 | Sep 2014 | WO |
| WO 2015022334 | Feb 2015 | WO |
| WO 2015022340 | Feb 2015 | WO |
| Entry |
|---|
| US 6,216,701 B1, 04/2001, Heaton et al. (withdrawn) |
| US 6,306,115 B1, 10/2001, Kelly et al. (withdrawn) |
| US 7,186,244 B1, 03/2007, Hunt et al. (withdrawn) |
| U.S. Appl. No. 10/599,720, filed Oct. 6, 2006, Blott et al. |
| “Hydrocolloids,” J. of Wound Care, vol. 1, No. 2, Jul.-Aug. 1992, pp. 27-30. |
| Achterberg, V., Ph.D., Hydroactive dressings and serum proteins: an in vitro study, Journal of Wound Care, February, vol. 5, No. 2, 1996, pp. 79-82. |
| Alexander, J. Wesley, “Prevention of Wound Infections,” The American Journal of Surgery, Jul. 1976, pp. 59-63, vol. 132, USA. |
| Alper, J.C., et al., An Effective Dressing for a Large, Draining Abdominal wound, RN, Dec. 1988, 24-25. |
| Alper, J.C., et al., Moist Wound Healing under a Vapor Permeable Membrane, Journ. of Amer. Acad. of Derm., Mar. 1983, 8(3),347-353. |
| Alper, Joseph, C., “Recent Advances in Moist Wound Healing,” Southern Medical Journal, Nov. 1986, pp. 1398-1404, vol. 79, No. 11 USA. |
| Argenta, Louis C., et al., “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment; Clinical Experience”, Ann Plas Surg 1997;38:563-577 (Dec. 10, 1996). |
| Arnljots, B. et al., “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers”, Scandinavian Journal of Plastic and Reconstructive Surgery, vol. 19, 1985, pp. 211-213. |
| Ashrafov, A.A. and K.G. Ibishov, An Experimental and Clinical Validation for the Use of a Collagen Sponge for Treating the Suppurative-Inflammatory Complications of Wound Healing in Emergency Abdominal Surgery, Pub Med, Abs. Downloaded from Internet, Apr. 24, 2006. |
| Aubrey, D.A. et al., “Treatment of the Perineal Wound after Proctectomy by Intermittent Irrigation”, Arch. Surg., vol. 119, Oct. 1984, pp. 1141-1144. |
| Bagautdinov, N.A., “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues”, in Current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye. Volkov et al. (Chuvash State University, Cheboksary, USSR 1986) pp. 94-96. |
| Barker et al., “Vacuum Pack Technique of Temporary Abdominal Closure”; J. of Traumatic Injury, Infection, and Critical Care, vol. 48, No. 2 (2000). |
| Barker, D.E., et al., Vacuum Pack Technique of Temporary Abdominal Closure: A 7-Year Experience with 112 Patients, Journ. of Trauma: Injury and Critical Care, Feb. 2000, 4892), 201-207. |
| Benjamin, P.J., Feculent Peritonitis: A Complication of Vacuum Drainage, Br. J. Surg., 1980, 67, 453-454. |
| Berman and Fabiano, Closed Suction Drainage, Orthopedics, Mar. 1990, 13(3), 310-314. |
| Berman, A. T., et al., Comparison Between Intermittent (Spring-Loaded) and Continuous Closed Suction Drainage of Orthopedic Wounds: A Controlled Clinical Trial, Orthopedics, Mar. 1990, 13(3), 9 pgs. |
| Besst, J.A., Wound Healing-Intraoperative Factors, Nursing Clinics of North America, Dec. 1979, 14(4), 701-712. |
| Bevan, Damon, et al.: “Diverse and potent activities of HGF/SF in skin wound repair”, Journal of Pathology, 2004; 203: 831-838. |
| Biblehimer, Helen L., “Dealing With a Wound that Drains 1.5 Liters a Day,” RN, Aug. 1986, pp. 21-23, USA. |
| Bier, A., Hyperemia as a Therapeutic Agent, Ed. Dr. Gustavus M. Blech, A. Robertson & Co., Chicago 1905, (the entire reference has been submitted, but pp. 74-85 may be the most relevant). |
| Bier, A., “Hyperemia as a Therapeutic Agent”, Ed. Dr. Gustavus M. Blech, A. Robertson & Co., Chicago 1905. |
| Birdsell, D.C., et al., The Theoretically Ideal Donor Site Dressing; Annals of 2 Plastic Surgery, vol. 2, Jun. 1979; Gadgetry, Div. of Plastic Surgery, Foothills, Hospital, Calgarv, Canada, 535-537. |
| Bischoff, et al., Vacuum-Sealing Fixation of Mesh Grafts, Euro. Journ. Plast. Surg., Jul. 2003, 26(4), 189-190, Abs. Downloaded from internet Apr. 6, 2006. |
| Britton, B.J., et al., A Comparison Between Disposable and Non-Disposable Suction Drainage Units: A Report of a Controlled Trial, Br. J. Surg. 1979, 66, 279-280. |
| Brock, W.B., et al., “Temporary closure of open abdominal wounds: the vacuum pack”, Am. Surg. Jan. 1995; 61(1)30-5—abstract. |
| Brubacher, Lynda L., “To Heal a Draining Wound”, RN, Mar. 1982, pp. 30-35, USA. |
| Brummelkamp, W.H., et ai, “High-vacuum drainage and primary perineal wound closure in abdominoperineal excision of the rectum”, The Netherlands Journal of Surgery, 1991 pp. 236-238, Netherlands. |
| Bucalo, B. et al., “Inhibition of Cell Proliferation by Chronic Wound Fluid”, Wound Repair and Regeneration, Miami, 1993, pp. 181-186. |
| Carroll, P.L., The Principles of Vacuum and its Use in the Hospital Environment, 2nd Ed., 1986, 30p. |
| Chardak et al., “Experimental Studies on Synthetic Substitutes for Skin and Their Use in the Treatment of Burns,” Annals of Surgery, 1961, vol. 155, No. 1, pp. 127-139. |
| Chariker, M.E. et al., “Effective Management of Incisional and Cutaneous Fistulae with Closed Suction Wound Drainage”, Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63. |
| Chintamani, et al., “Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer—a prospective randomized clinical trial”, Research Article (Jan. 27, 2005), 1-5. |
| Chua Patel, C.T., et al., Vacuum-Assisted Closure, AJN, Dec. 2000, 100(12),45-49. |
| Columbia Electronic Encyclopedia, The: the effect of body temperature on wound healing, printed Jan. 16, 2009, in 3 pages. URL: http://encyclopedia2.thefreedictionary.com/body+temperature. |
| Cooper, S.M. and E. Young, Topical Negative Pressure, Commentary, International Journal of Dermatology 2000, 39, 892-898. |
| Costunchenok, B.M., et al., Effect of Vacuum on Surgical Purulent Wounds, Vestnik Chirurgia, Sep. 1986, 18-20 (in Russian with English translation). |
| Crisp, w.J. and A Gunn, Granuflex Dressings for Closed Surgical Wounds Combined with Suction Drainage, Annals of the Royal College of Surgeons of England, 1990, 72, p. 76. |
| Cucuroos, Y.C., Vacuum Drainage of Post Operative Wounds, Kiev Army Hospital, Dept. of Hospital Surgery, Kiev medical University, 64-65 (in Russian with English translation). |
| Curtin, L.L., Wound Management: care and Cost—an Overview, Nursing Management, Feb. 1984, 15 (_), 22-25. |
| Davidov, YA, et al. Justifying the Usage of Force Early Secondary Sutures in treatment of Purulent Wounds by the Vacuum Therapy, Vestnik Chirurgia, Mar. 1990 Edition, 126-129 (in Russian with English translation). |
| Davydov et al. “Pathogenic Mechanism of the Effect of Vacuum Therapy on the Course of the Wound Process” pp. 43-46 (Dec. 1990). |
| Davydov, Y. A. et al., “The Bacteriological & Cytological Assessment of Vacuum Therapy of Purulent Wounds”, Vestnik Chirurgia, Oct. 1988 Edition 1987, pp. 48-52. |
| Davydov, Yu A., et al., “Concepts for Clinical Biological Management of the Wound Process in the Treatment of Purulent Wounds Using Vacuum Therapy”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), 15-17. |
| Davydov, Yu A., et al., “The Bacteriological and Cytological Assessment of Vacuum Therapy of Purulent Wounds”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), 11-14, in 4 pages. |
| Davydov, Yu A., et al., “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), 5-7. |
| De Lange, M.Y. , et al., “Vacuum-Assisted Closure: Indications and Clinical Experience”, Eur J Plast Surg (2000) 2;178-182 (Feb. 9, 2000). |
| Dilmaghani et al., “A Method for Closed Irrigation and Suction Therapy in Deep Wound Infections,” Journal of Bone and Joint Surgery, 1969, vol. 51-A, No. 2, pp. 323-342. |
| Domkowski, P.W., et al., Evaluation of Vacuum-Assisted Closure in the Treatment of Poststernotomy Mediastinitis, Journ. of Thorac. and Cardiovascular Surg., Aug. 2003, 126(2), 386-390. |
| Doss, Mirko, et al., Vacuum-Assisted Suction Drainage Versus Conventional Treatment in the Management of Poststernotomy Osteomyelitis, Euro. Journ. Cardio-Thoracic. Surg. 22 (2002) 934-938. |
| Eaglstein, W.H., et al., Wound Dressings: Current and Future, Clin. and Exper. Approaches to Dermal and Epidermal Repair: Normal and Chronic Wounds, 1991, 257-265. |
| ECRI, Target Report, Negative Pressure Wound Therapy for Chronic Wounds, Jan. 24, 2006, 1-7, Downloaded from internet, http://www.target.ecri.org/summary/detail.aspx?dox_id=1155. |
| Eisenbud, D.E., Modern Wound Management, Anadem Publishing, Chap. 16, 109-116, 2000. |
| Elwood, E.T., and D.G. Bolitho, Negative-Pressure Dressings in the Treatment of Hidradenitis Suppurative, Annals of Plastic Surgery, Jan. 2001, 46(1), 49-51. |
| Fabian, T.S., The Evaluation of Subatmospheric Pressure and Hyperbaric Oxygen in Ischemic Full-Thickness Wound Healing, Ischemic Full-Thickness Wound Healing, Dec. 2000, 66(12), 1136-1143. |
| Fay, M.F., Drainage Systems: Their Role in Wound Healing, AORN Journal, Sep. 1987, 46(3), 442-455. |
| Fingerhut, A., et al., Passive vs. Closed Suction drainage after Perineal Wound Closure Following Abdominoperineal Rectal Excision for Carcinoma, Dis Colon Rectum, Sep. 1995, 926-932. |
| Finley, John M.,“Practical Wound Management,” pp. 45, 127, 143, 149, 207, 1981. |
| Firlit, C.F. and J.R. Canning, Surgical Wound Drainage: A Simple Device for Collection, Journ. of Urology, Aug. 1972, 108, p. 327. |
| Fleischmann et al., “Vacuum Sealing: Indication, Technique, and Results”, Eur J Orthop Surg Traumatol, vol. 5, 1995, pp. 37-40. |
| Fleischmann, W. Acta Orthopaedical Belgica, “Treatment of Bone and Soft Tissue Defects in Infected Nonunion,” vol. 58, Suppl. I—1992, pp. 227-235. |
| Fleischmann, W. Unfall Chirurg, Springer-Variag, “Vakuumversiegelung zur Behandlung des Weichteilschadens bei offenen Frakturen,” (English abstract, no English translation), 1993, pp. 488-492. |
| Fleischmann, W. Wund Forum Spezial, “Vakuumversiegelung zur Behandlung von Problemwunden” (with English translation: Vacuum Sealing for Treatment of Problematical Wounds), IHW '94, 6 pages. |
| Fleischmann, W., et al. “Vacuum Sealing for Treatment of Soft Tissue Injury in Open Fractures,” Emergency Surgery (1993) 96:488-492. |
| Fox, J.W. and G.T. Golden, The Use of Drains in Subcutaneous Surgical Procedures, Amer. Journ. of Surg, Nov. 1976, 132, 673-674. |
| Garcia-Rinaldi, R. et al., “Improving the Efficiency of Wound Drainage Catheters”, Amer. Journ. of Surg., Sep. 1975, vol. 130, pp. 372-373. |
| Garner et al., “Vacuum-assisted wound closure provides early fascial reapproximation in trauma patients with open abdomens,” Am. J. of Surgery 1282 (2001) 630-638. |
| Gill, P., What is a Counter-Irritant? Name Three and the Method of Applying them, Brit. Journ. Nurs., Jun. 1934, 142. |
| Zivadinovic, G. et al., “Vacuum Therapy in the Treatment of Peripheral Blood Vessels”, Conference Papers of the Fifth Timok Medical Days, Majdanpek, 1986, pp. 161-164, in 10 pages. |
| Grobmyer, et al., High-Pressure Gradients Generated by Closed-Suction Surgical Drainage Systems, Surg. Infect. (Larchmt), Autumn 2002, 3(3), 245-249, Abs., Downloaded Nov. 30, 2003. |
| Gwan-Nulla, D.N. and R.S. Casal, Toxic Shock Syndrome Associated with the Use of the Vacuum-Assisted Closure Device, Ann. Plast. Surg., Nov. 2001, 47(5), 552-554. |
| Harris, “A new technique of skin grafting using Stei-Greffe and a self-adhering foam pad,” Brit. J. of Plastic Surg., vol. 34, No. 2, (Apr. 1981), pp. 181-185. |
| Hartz, R.S. et al., Healing of the Perineal Wound, Arch. Surg., Apr. 1980, 115, 471-474. |
| Health Technology, Literature R., “Vacuum Assisted Closure Therapy for Wound Care”, Health Technology Literature Review, Dec. 2004, pp. 3-59. |
| Hugh, T.B., Abdominal Wound Drainage, Med. Journ. of Australia, May 4, 1987, 146, p. 505 (Correspondence). |
| Izmailov, S.G., et al., Device for Treatment of wounds and Abdominal Cavity, Contents, Surg. No. 8 1997, Downloaded from internet http://www.mediasPhera.ru/surqerY/97/8/e8-97ref.htm. |
| Jahns et al., Poster “Problemwundversorgung mit einem neuen anschmiegsamen Silikonschaumverband mit Anwendung der Vakuumtechnik,” 2nd Congress of German Wound Treatment Society 1998. |
| Jeter, K. et al., “Managing Draining Wounds and Fistulae: New and Established Methods”, Chronic Wound Care, 1990, pp. 240-246. |
| Johnson, F.E., An Improved Technique for Skin Graft Placement using a Suction Drain, Surgery, Gynecology & Obstetrics, Dec. 1984, 159(6), 584-585. |
| Kazan Medical Institute Doctors, A Gadget to Bring the Wound Edges Close, 78-79 (in Russian with English translation). Aug. 20, 1985. |
| KCI Introduces New Vacuum Assisted Closure Product; VAC. Freedom Device Continues Company's Leadership in Advanced Wound Healing Systems, PR Newswire, Oct. 2002. |
| KCI Licensing, “V.A.C. Abdominal Dressing System Advanced Management of the Open Abdomen,” 2004. |
| KCI, Inc., The V.A.C. System, 2000-2001, Brochure, 2 pgs. |
| Kendall ULTEC Hydrocolloid Dressing (4″×4″), product ordering page, web page downloaded Jul. 13, 2014. |
| Khan, et al., “Influence of Chitosan Molecular Weight on its Physical Properties”, IMJM (2003); 2(1); pp. 1-8. |
| Khirugii, Vestnik, “A Collection of Published Studies Complementing the Research and Innovation of Wound Care”, The Kremlin Papers, Perspectives in Wound Care, Russian Medical Journal, Vestnik Khirurgii, Blue Sky Publishing (2004), 2-17. |
| Kim, S.H., et al., Wangensteen Suction Drainage, apparatus in Neurosurgical Practice, Dept. of Neurosurgery, Yonsei University of College of Medicine, Seoul, Korea, 1975, 159-160, Abs. (in Korean and Abstract in English). |
| Kloth, L.C. and J.M. McCulloch, Wound Healing Alternatives in Management, 3rd Ed., Chap. 10, 339-352, 2002. |
| Knight, Marie Ray, A Second Skin for Patients with Large Draining Wounds, Nursing, Jan. 1976, p. 37, USA. |
| Kordasiewicz, “Abdominal Wound with a Fistula and Large Amount of Drainage,” Journal of Wound, Ostomy and Continence Nursing, May/Jun. 2004, pp. 150-153. |
| Kostiuchenok, B. M. et al., “The Vacuum Effect in the Surgical Treatment of Purulent Wounds”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California, 2004, pp. 3-4 (English translation only). |
| Kremlin Papers, A Collection of Published Studies Complementing the Research and Innovation of Wound Care, from Vestnik Khirurgii, BlueSky Publishing, A Div. of BlueSky Medical Group Inc., 2004. 17 pages. |
| Landes, R.R. and I. Melnick, An Improved Suction Device for Draining Wounds, Arch. Surg., May 1972, 104, p. 707. |
| Landis, E.M. and J.H. Gibbon, Jr., The Effects of Alternate Suction and Pressure on Blood Flow to the Lower Extremities, Alternate Suction and Pressure, J Clin Invest. Sep. 1933, 12(5): 925-961. |
| Lee, J.H. and H.J. Yang, Application of Medifoam B® & Negative Pressure Therapy for the Auxiliary Treatment of Pressure Sore, Dept. Plastic and Reconstructive Surg., College of Medicine, Eulji Univ., Daejeon, Korea, Abs. Sep. 2004, 1 page. |
| Linden van der, Willem, Randomized Trial of Drainage After Cholecystectomy, Modern Operative Techniques, Voluje 141, Feb. 1981, pp. 289-294. |
| Luchette, F.A., When Should the General Surgeon Leave the Abdomen Open?, Division of 324 Trauma, Surgical Critical Care and Burns, Loyola University Medical Center, Maywood, Illinois. 37 oaces (2004) (Uploaded in 4 parts). |
| Lumley, J.S.P., et al., The Physical and bacteriological Properties of Disposable and Non-Disposable Suction Drainage Units in the Laboratory, Br. J. Surg., 1974, 61, 832-837. |
| Lundvall, J. and T. Lanne, Transmission of Externally applied Negative pressure to the Underlying Tissue: A Study on the Upper Arm of Man, Acta Physiol. Scand. 1989, 136, 403-409. |
| Maitland and Mathieson, Suction Drainage, Brit. J. Surg., Mar. 1970, 57(3), 195-197. |
| Mayo, C.W., The One-Stage Combined Abdominoperineal Resection for Carcinoma of the Rectum, RectoSigmoid and Sigmoid, Surgical Clinics of North America, Aug. 1939, Mayo Clinic No. 1011-1012. |
| McFarlane, R. M., “The Use of Continuous Suction Under Skin Flaps”, F.R.C.S.(c), vol. 1, pp. 77-86 (1958). |
| McGuire, S., Drainage after Abdominal Section, Br. Journ. of Nurs., Dec. 15, 1903, 447-449. |
| McLaughlan, J., “Sterile Microenvironment for Postoperative Wound Care”, The Lancet, Sep. 2, 1978, pp. 503-504. |
| Advantec MFS, Inc., “Membrane Filters” (catalog), accessed Jan. 29, 2016 (publication date unknown, but believed to be copyright 2001-2011), in 17 pages. URL: http://www.advantecmfs.com/catalog/filt/membrane.pdf#page=11. |
| Mendez-Eastman, S., Guidelines for Using Negative Pressure Wound Therapy, Advances in Skin & Wound Care, 14(6), Nov./Dec. 2001, 314-325. |
| Meyer, W. et al., Bier's Hyperemic Treatment, published 1908, W. B. Saunders Company, pp. 44-65, in 12 pages. |
| Meyer, W. et al., “In Surgery, Medicine, and the Specialties A Manual of its Practical Application”, Bier's Hyperemic Treatment, Second Revised Edition, W B. Saunders Company, 1909. |
| Miles, W.E., A Method of Performing Abdominoperineal Excision for Carcinoma of the 341 Rectum and of the Terminal Portion of the Pelvic Colon, The Lancet, Dec. 19, 1908, 1812-1813. |
| Milsom, I. and A. Gustafsson, An Evaluation of a Post-Operative Vacuum Drainage System, Curr. Med. Res. Opin. (1979), 6, 160-164. |
| Mitchell, Richard N., et al.: “Role of Stem Cells in Tissue Homeostasis”, Pocket Companion to Robbins and Cotran Pathologic Basis of Diseas, 7th Edition., 2006. |
| Moloney, G. E., “Apposition and Drainage of Large Skin Flaps by Suction”, ANZ Journal of Surgery vol. 26, Issue 3, Feb. 1957, pp. 173-179. |
| Morykwas, M. J., et al., “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation,” Annals of Plastic Surgery 38 (1997) 553-562. |
| Morykwas, M. J., et al.: “Nonsurgical Modalities to Enhance Healing and Care of Soft Tissue Wounds”, Journal of the Southern Orthopaedic Association, vol. 6, No. 4 Winter 1997 in 12 pages. |
| Morykwas, M.J., et al., Effects of Varying Levels of Subatmospheric Pressure on the Rate of Granulation Tissue Formation in Experimental Wounds in Swine, Abs., Ann. Plast. Surg. 2001, 47: 547. |
| Moserova, J. and E. Houskova, The Healing and Treatment of Skin Defects, 1989, 116-143. |
| Mulder, G.D. et al., “Clinicians' Pocket Guide to Chronic Wound Repair”, Wound Healing Publications, Spartanburg, SC, 1991, pp. 54-55, in 3 pages. |
| Mullner, T., et al., The Use of Negative Pressure to Promote the Healing of Tissue Defects: A Clinical Trial Using the Vacuum Sealing Technique, Br. J. Plast. Surg., Apr. 1997, 51(1), 79, Abs. |
| Nakayama et al., Ann. Plast. Surg., 26: 499-502 (1991), “A New Dressing Method for Free Skin Grafting in Hands.” |
| Nakayama, Y., et al., “A New Method for the Dressing of Free Skin Grafts”, Plastic and Reconstructive Surgery, Dec. 1990 pp. 1216-1219, UK. |
| Nasser, A.N., The Use of the Mini-Flap Wound Suction Drain in maxillofacial Surgery, Annals of the Royal College of Surgeons of England, 1986, 68, 151-153. |
| Navsaria, et al.: “Temporary closure of open abdominal wounds by the modified sandwich-vacuum pack technique”, British Journal of Surgery 2003; 90: 718-722. |
| Nicholas, J.M., Options for Management of the Open Abdomen, Presentation from Emory University School of Medicine, 66 pgs. Invited Speaker American College of Surgeons 32nd Annual Spring Meeting, General Session 12—Presentation and Panel Discussion on the Open Abdomen in General Surgery—How Do You Close the Abdomen When You Can't—Boston Marriott Copley Place Hotel, Boston, MA Apr. 26, 2004. |
| Nursing75, Wound Suction: Better Drainage with Fewer Problems, Nursing, vol. 5, No. 10, Oct. 1975, pp. 52-55. |
| Ohotskii, V.P., et al., Usage of Vacuum Suction During the Primary Surgical Debridement of Open Limb Injuries, Sovetskaya Medicina, Jan. 1973, 17-20 (in Russian with English translation). |
| Orgill, D. P., et al., Microdeformational Wound Therapy—A New Era in Wound Healing, Tissue Engin. and Wound Healing Laboratory, Brigham and Women's Hospital, Business Briefing: Global Surgery—Future Direction 2005, 22. |
| Orgill, D.P., et al., Guidelines for Treatment of Complex Chest Wounds with Negative Pressure Wound Therapy, Wounds, a Compendium of Clinical Research and Practice, Suppl. B, Dec. 2004, 1-23. |
| Patel, C.T, et al., Vacuum-Assisted Closure, AJN, Dec. 2000, 100(12),45-49. |
| Protz, Kerstin: “Moderne Wundauflagen unterstutzen Heilungsprozess”, Wundversorgung: Indikation und Anwendung, Geriatrie Journal, Apr. 2005, pp. 3333-3339, with translation. |
| Putney F. Johnson, “The Use of Continuous Negative Pressure after Laryngectomy and Radical Neck Dissection”, Surgery, Gynecology & Obstetrics, Aug. 1956, pp. 244-246, USA. |
| Raffl, Arthur B., “Use of Negative Pressure Under Skin Flaps After Radical Mastectomy,” Dept. of Surgery, State Univ. of N.Y., College of Medicine, Syracuse, NY, Submitted for publication Apr. 1953, p. 1048, USA. |
| Ramirez, O.M., et al., Optimal Wound Healing under Op-Site Dressing, Ideas and Innovations, 73(3), pp. 474-475. |
| Ranson, J., “Safer Intraperitoneal Sump Drainage”, Surgery, Gynecology & Obstetrics, vol. 137, Nov. 1973, pp. 841-842, in 3 pages. |
| Reimann, D., et al., Successful Treatment Due to Vacuum Seal Technique of a Severe Scedosporium Apiospermum Skin Infection in a Renal Transplant Recipient, Nephrol. Dial. Transplant, 2004, 19 (1), 245-248. |
| Robertson, “The Influence upon Wound Contraction of a Negative Interstitial Fluid Pressure Within Granulation Tissue,” Journal of Anatomy, 1969, vol. 105, No. 1, pp. 189. |
| Sames, C.P., “Sealing of Wounds with Vacuum Drainage”, British Medical Journal, Nov. 5, 1977, p. 1223, Correspondence. |
| Schaffer, D.B., Closed Suction Wound Drainage, Nursing97, Nov., Downloaded from Internet www.springnet.com, 62-64. 1997. |
| Schein et al., “The ‘Sandwich Technique’ in the Management of the Open Abdomen,” British Journal of Surgery, 1986, vol. 73, May, pp. 369-370. |
| Shaer, W.D., et al., Inexpensive Vacuum-Assisted Closure Employing a Conventional Disposable Closed-Suction Drainage System, Plastic and Reconstructive Surgery, Jan. 2001, 292. |
| Smith, et al.; Vacuum Pack Technique of Temporary Abdominal Closure: A Four-Year Experience; The American Surgeon; Dec. 1997; p. 1102-1108; vol. 63, No. 12. |
| Smith & Nephew, “PICO Single Use Negative Pressure Wound Therapy System”, spiral booklet, Mar. 2011, in 7 pages. |
| Solovev, V. A., et al., “The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract—Guidelines” USSR Ministry of Health, S. M. Kirov Gorky State Medical Institute, 1987 (with English translation). |
| Solovev, V.A. “Treatment and Prevention of Suture Failures after Gastric Resection” (Dissertation Abstract) (S.M. Kirov Gorky State Medical Institute, Gorky USSR 1988). |
| Spengler, Michael D., el al, “Performance of Filtered Sump Wound Drainage Tubes”, Surgery, Gynecology & Obstetrics, Mar. 1982, pp. 333-336, vol. 54, USA. |
| Stewart, J., “World Wide Wounds—Next Generation of Products for Wound Management”, 2002, in 13 pages. |
| Svedman, P., “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers,” Scand J. Plast. Reconstr. Surg., 19:211-213, 1985. |
| Svedman, P., “Irrigation Treatment of Leg Ulcers”, The Lancet, Sep. 1983, pp. 532-534. |
| Svedman, P., “A Dressing Allowing Continuous Treatment of a Biosurface”, IRCS Med. Science: Biomed. Tech.; Clinic. Med.; Surg. and Transplantation, 1979, 7, p. 221. |
| Svedman, P. et al., “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous or Intermittent Irrigation”, Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133. |
| Swift, et al, “Quorum Sensing in Aeromonas hydrophila and Aeromonas salmonicida: Identification of LuxRI Homologs AhyRI and AsaRI and Their Cognate N-Acylhomoserine Lactone Signal Molecules,” J. Bacteriol., 179(17):5271-5281 (1997). |
| Teder, H. et al., “Continuous Wound Irrigation in the Pig,” Journal of Investigative Surgery, vol. 3, 1990, pp. 399-407. |
| Tennant, C.E., “The Use of Hyperemia in the Postoperative Treatment of Lesions of the Extremities and Thorax,” Jour. A. M. A., May 8, 1915, pp. 1548-1549. |
| Tenta, L.T., et al., Suction Drainage of Wounds of the Head and Neck, Surg. Gyn. & Ob., Dec. 1989, 169, p. 558. |
| Tribble, D.E., “An Improved Sump Drain-Irrigation Device of Simple Construction”, Archives of Surgery New York, vol. 105, Sep. 1972, in 4 pages. |
| Urschel, J.D., et al., The Effect of Mechanical Stress on Soft and Hard Tissue Repair; A Review, Br. Journ. Plast. Surg., 1988, 41, 182-186. |
| Usupov, Y. N., et al., “Active Wound Drainage”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), pp. 8-10. |
| Usypov, Y. N. and M.V. Ephfanov, Active Drainage of wounds, Dept. of Hospital Surgery, Army Medical Academy, Leningrad, Vestnik Chirurgia, Apr. 1987 Edition, 42-45 (in Russian with English translation). |
| Valenta, A.L., Using the Vacuum Dressing Alternative for Difficult Wounds, AIN, Apr. 1994, 44-45. |
| Van Heurn, L.W.E. and P.R.G. Brink, Prospective Randomized Trial of High versus Low Vacuum Drainage after Axillary Lymphadenectomy, Br. Journ. Surg. 1995, 82, 931-932. |
| Venturi, Mark L., “Mechanisms and Clinical Applications of the Vacuum-Assisted Closure (VAC) Device”, Am J Clin Dermatol (2005) 693, 185-194; Review Article (2005),185-194. |
| Vijanto, J. and J. Raekallio, Local Hyperalimentation of Open Wounds, Br. J. surg., 1976, 63, 427-430. |
| Wackenfors, A., et al., Effects of Vacuum-Assisted Closure Therapy on Inguinal Wound Edge Microvascular Blood Flow, Wound Rep. Reg, 2004, 12, 600-606. |
| Webb, New Techniques in Wound Management: Vacuum-Assisted Wound Closure, Journal of the American Academy of Orthopadic Surgeons, vol. 10, No. 5, Sep. 2002, pp. 303-311. |
| Webster's Revised Unabridged Dictionary, published 1913 by C. & G. Merriam Co., definition of Flapper Valve, downloaded from Free Online Dictionary. |
| Westaby, S., et al., “A Wound Irrigation Device”, The Lancet, Sep. 2, 1978, pp. 503-504. |
| Williams, et al., Survey of the Use of Suction Drains in head and Neck Surgery and Analysis of Their Biomechanical Properties, J. Otolaryngol., Feb. 2003, 32(1), 16-22, Abs. Downloaded from internet Nov. 30, 2003. |
| Windows on Medical Technology, Vacuum-Assisted Wound Closure for Chronic and Acute Wounds, , ECRI Health Technology Assessment Information Service, Oct. 2000, 38, 1-21. |
| Wolthuis, Roger A., et al, “Physiological Effects of Locally Applied Reduced Pressure in Man,” Physiological Reviews, Jul. 1974, pp. 566-595 vol. 54, No. 3, USA. |
| Wooding-Scott, Margaret, et al., “No Wound is Too Big for Resourceful Nurses,” RN Dec. 1988, pp. 22-25 USA. |
| Worth, M.H., M.D. and H.W. Anderson, M.D., “The Effectiveness of Bacterial Filtration in Vented Wound Drains,” Journal of Surgical Research, 1979, pp. 405-407. |
| Wound Suction, Nursing, Oct. 1975, USA pp. 52-53. |
| Wu, P., et al., In Vitro Assessment of Water Vapour Transmission of Synthetic Wound Dressings, Biomaterials, 1995, 16(3), 171-175. |
| Wu, S.H. et al., “Vacuum therapy as an intermediate phase in wound closure: a clinical experience”, Eur J Past Surg, vol. 23, 2000, pp. 174-177, in 6 pages. |
| Davydov, Y. A. et al., “Vacuum Therapy in Treatment of Acute Purulent Diseases of Soft Tissues and Purulent Wounds”, Vestnik Khirurgii, (Surgeon's Herald), Medicine Publishers, 1986. |
| Alexander J.W., et al., “Clinical Evaluation of Epigard, A New Synthetic Substitute for Homograft and Heterograft Skin,” The Journal of Trauma, vol. 13, No. 4, Apr. 1973, pp. 374-383. |
| Blumberg J.B., et al., “The Effect of Specific Compression on Soft-Tissue Response to Formalinized Polyvinyl Alcohol (Ivalon) Sponge: A Critical Evaluation,” Annals of Surgery, vol. 151, No. 3, Mar. 1960, pp. 409-418. |
| Boland E.D., et al., “Tailoring Tissue Engineering Scaffolds Using Electrostatic Processing Techniques: A Study of Poly (Glycolic Acid) Electrospinning,” Journal of Macromolecular Science, Pure and Applied Chemistry, vol. A38, No. 12, 2001, pp. 1231-1243. |
| Boretos J.W., “Cellular Polymers for Medical Use: The Vital Role of Porosity and Permeability,” Cellular Polymers, vol. 3, 1984, pp. 345-358. |
| Bragina, I.O. et al., “Radical Phenylation of Amides of Thiocinnamic Acid”, Russian Chemical Bulletin, Dec. 31, 1983, 3 pages. |
| Burdette-Taylor S.R., “Use of the Versatile One (V1) for Closed Suction Drainage to Stimulate Closure in Chronic Wounds in Home Care,” Case Study Presentation, 2003, 2 pages. |
| Chernavskii V.A., et al., “Free Skin Plasty of Wounds and Ulcers using the Vacuum Method,” Meditsina Publishers of the Uzbek SSR, 1970, pp. 5-37. |
| Chinn S.D., et al., “Closed Wound Suction Drainage,” The Journal of Foot Surgery, vol. 24, No. 1, 1985, pp. 76-81. |
| Communication of a Notice of Opposition for European Patent No. EP2902068, dated May 12, 2020, 16 pages. |
| Communication of Further Notices of Opposition for European Patent No. EP2902068, dated Jun. 18, 2020, 2 pages. |
| Derwent Publication Ltd., Database WPI Week 200624, Derwent Publication Ltd., London, GB, AN 2006-231788, XP002456707, 2006, 3 pages. |
| Greene M.A., et al., “Laparotomy Wound Closure with Absorbable Polyglycolic Acid Mesh,” Surgery, Gynecology and Obstetrics, vol. 176, Mar. 1993, pp. 213-218. |
| Greer S.E., et al., “Techniques for Applying Subatmospheric Pressure Dressing to Wounds in Difficult Regions of Anatomy,” JWOCN, vol. 26(5), Sep. 1999, pp. 250-253. |
| Grounds for the Decision and Annex to the Communication, re the Opposition of European Patent No. EP2305341, dated May 8, 2020, 83 pages. |
| Grover R., et al., “Recent Advances: Plastic Surgery,” Clinical Review, BMJ, vol. 317, Aug. 8, 1998, pp. 397-400. |
| Hersle K., et al., “Uses of Dextranomer Absorbent Pads After Cryosurgery of Cutaneous Malignancies,” The Journal of Dermatologic Surgery and Oncology, vol. 8, Jan. 1982, pp. 35-37. |
| Instech, “Model P720 Peristaltic Pump—Operation Manual,” Dec. 1997, pp. 1-11 (7 pages). |
| International Search Report for Application No. PCT/GB2003/004647, dated Feb. 25, 2004, 3 pages. |
| International Preliminary Report on Patentability and Written Opinion for Application No. PCT/US2011/026347, dated Sep. 7, 2012. |
| International Preliminary Report on Patentability for Application No. PCT/GB2003/04647, dated Sep. 9, 2004, 2 pages. |
| International Search Report for Application No. PCT/US2011/026347, dated Jun. 6, 2011, 5 pages. |
| Karev I.D., et al., “Foam Drainage System for Treating Purulent Wounds,” Second All-Union Conference, Wounds and Wound Infections (Presentation Abstracts), Moscow, USSR, 1986, pp. 87-88. |
| Kuznetsov V.A., et al., “Vacuum and Vacuum-Sorption Treatment of Open Septic Wounds,” in Second All-Union Conference “Wounds and Wound Infections” Presentation Abstracts, Moscow, USSR, 1986, pp. 91-92. |
| Lokhvitskii S.V., et al., “Treatment of Carbuncles,” USSR Ministry of Health, All Union Society of Surgeons and Pirogov Surgical Society, vol. 132 (1), Jan. 1984, 20 pages. |
| Medela, “Manualectric Breastpump,” Catalog, 4 pages. |
| Middleton J.C., et al., “Synthetic Biodegradable Polymers as Medical Devices,” Medical Plastics and Biomaterials Magazine, Mar. 1998, 14 pages. |
| Mullner T.M., et al., “The Use of Negative Pressure to Promote the Healing of Tissue Defects: A Clinical Trial Using the Vacuum Sealing Technique,” The British Journal Plastic Surgery, vol. 51, No. 1, Apr. 1997, pp. 194-199, Abstract only, 2 pages. |
| Opponent's Written Submission Preparation for the Oral Proceedings, re the Opposition of European Patent No. EP2305341, dated Dec. 6, 2019, 7 pages. |
| Proprietor's Written Submission Preparation for the Oral Proceedings, re the Opposition of European Patent No. EP2305341, dated Dec. 6, 2019, 7 pages. |
| Roberts R.H., et al., “Randomised Trial of Medinorm LVS® and Surgivac™ Drainage System after Operations for Breast Cancer,” American Journal of Surgery, vol. 173, Feb. 1997, 2 pages. |
| “Technology Watch,” May 1989, 1 page. |
| Thomas S., “Wound Management and Dressings,” 1990, 24 pages. |
| Written Opinion for Application No. PCT/US2011/026347, dated Jun. 6, 2011, 6 pages. |
| Notice of Appeal against the Interlocutory Decision of the Opposition Division for European Patent No. 2305341, mailed on Jul. 8, 2020, 5 pages. |
| Notice of Appeal on behalf of Smith & Nephew, PLC against the decision of opposition by KCI Licensing, Inc. to European Patent No. 2305341 mailed on Jul. 2, 2020, 4 pages. |
| Opponents Ground of Appeal for European Patent No. 2305341, dated Sep. 7, 2020, 279 pages. |
| Statement of Grounds of Appeal filed by Proprietor for European Patent No. 2305341 filed on Sep. 18, 2020, 16 pages. |
| Appeal Annex dated Dec. 6, 2019 by the Proprietor for European Patent No. 2305341 filed on Sep. 18, 2020, 2 pages. |
| Appeal Annex dated Feb. 25, 2019 by the Proprietor for European Patent No. 2305341 filed on Sep. 18, 2020, 4 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20180193200 A1 | Jul 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 12416829 | Apr 2009 | US |
| Child | 13363320 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15647111 | Jul 2017 | US |
| Child | 15864586 | US | |
| Parent | 14585786 | Dec 2014 | US |
| Child | 15647111 | US | |
| Parent | 14584274 | Dec 2014 | US |
| Child | 14585786 | US | |
| Parent | 14485633 | Sep 2014 | US |
| Child | 14584274 | US | |
| Parent | 13363320 | Jan 2012 | US |
| Child | 14485633 | US | |
| Parent | 10533275 | US | |
| Child | 12416829 | US |
